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Summary 
 
Maternal age is a significant risk factor for adverse pregnancy outcomes and is strongly 
associated with an increased risk of aneuploidy of the conceptus, as well as a significantly 
higher frequency of serious pregnancy complications known as the “Great Obstetrical 
Syndromes”, including miscarriage, pre-eclampsia and fetal growth restriction. In the last 40 
years average maternal age has increased considerably in many wealthy countries, and in 
the UK the number of babies born to women aged 35 and over is set to surpass those born 
to women under 25. The high incidence of aneuploidy in older mothers can be attributed to 
abnormalities in the oocyte and embryo, however the “Great Obstetrical Syndromes” do not 
appear to be related to the oocyte and may instead be linked to abnormal development of 
the placenta. 
 In this thesis, I show that advanced maternal age in the mouse is associated with a 
drastically increased variability of developmental progression in utero, including 
developmental delays and growth restriction, severe embryonic abnormalities and higher 
resorption rates. I find that these embryonic defects are always accompanied by gross 
morphological and transcriptomic abnormalities in the placenta. Notably, I show that the 
increased risk of these complications can be rescued by transfer of embryos from aged 
females to a young surrogate mother, thus implicating the aged maternal uterus as the basis 
for embryonic and placental defects. Transcriptomic analysis of the decidua compartment in 
placentas from aged pregnancies revealed abnormal expression of genes involved in the 
decidualization process, which occurs during early pregnancy and facilitates implantation 
and development of the conceptus. I show that these defects are already obvious in the 
peri-implantation window, with endometrial stromal cells from aged females being unable 
to mount an adequate decidualization response due to a decline in their ability to respond to 
pregnancy hormones. This blunted decidualization reaction in turn may lead to abnormal 
development of the placenta. These age-associated decidualization defects are cell-intrinsic 
and can be recapitulated in vitro. The detected insufficient activation levels and abnormal 
intracellular distribution of phospho-STAT3, combined with highly variable progesterone 
receptor expression, may be possible causes of these defects.  
 In addition, I examined the possible effects of ageing on the epigenome as a potential 
contributor to the decline in endometrial function. My results indicate that ageing of the 
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uterus displays some of the common epigenetic hallmarks of tissue ageing. However, more 
importantly, decidual cells of aged females exhibit abnormal distributions of the histone 
modification H3K4me3, and are refractory to the profound DNA methylation remodelling 
that I find takes place during pregnancy. These age-related changes in the epigenome may 
underpin, or contribute to, the observed decline in uterine function during pregnancy. 
Understanding the mechanism underlying these epigenomic and functional changes 
in the ageing reproductive tract may pave the way for new therapeutic strategies to improve 
maternal and fetal outcomes of pregnancy in older mothers. 
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1.1 Reproductive decline with advanced maternal age 
 
1.1.1 Trends in the timing of childbearing 
 
Pregnancy in women of advanced age has become increasingly common in high income 
countries, in recent decades. In the UK, the number of live births to women ≥35 years of age 
has increased steadily from the late 1970’s (Fig 1.1), culminating in average maternal age 
reaching 30 years for the first time, in 2013 (Statistics, 2014). In 2013 the largest group of 
babies were born to mothers aged between 25-34. However, in the near future the number 
of babies born to the 35 years and over group looks set to surpass those born to women >25 
(Fig 1.1). Surveys in other countries have reported a similar pattern of increasing average 
age at first birth, with the greatest increases in the 35-39 year old group (ABS, 2008; Breart 
et al., 2003; Martin et al., 2010; Ventura et al., 2009).  
 
 
 
 
 
 
Figure 1.1 - Live births by age group of the mother in England and Wales 1938-2013. Black line 
indicates number of live births to women <25 years old, blue dashed line to women aged 25-24, 
and the red line to women aged 35 and over. Adapted from (Statistics, 2014). 
 
  4 
1.1.2 Oocyte ageing 
 
Advanced maternal age is associated with a rapid decline in reproductive success in women 
(Baird et al., 2005; Broekmans et al., 2007; te Velde and Pearson, 2002), most commonly due 
to a decline in the number and quality of oocytes available. As a result, older women 
experience reduced fertility and an increased risk of early miscarriage due to reduced oocyte 
availability and poor oocyte quality, respectively (Block, 1952; Faddy et al., 1992). Oocyte 
development begins during embryonic life, when the primordial follicle pool is established – 
at approximately 18 weeks of gestation in humans, and embryonic day 13.5 (E13.5) in the 
mouse (Baker, 1963; Borum, 1961; Fulton et al., 2005; Motta et al., 1997; Pepling, 2012). At 
this time, primordial germ cells which give rise to the oocyte begin to enter meiosis, and 
become arrested in prophase of meiosis I. Prophase arrest persists until meiotic resumption 
is stimulated by ovulation, and the oocyte can be fertilised and lead to pregnancy. 
 It is widely believed that the full complement of primordial follicles is established in 
fetal life, and no new follicles are produced postnatally (Findlay et al., 2015; Kerr et al., 
2013), thereby rendering the oocyte particularly vulnerable to the effects of ageing. 
 
1.1.2.1 Aneuploidy 
 
Oocyte ageing has been studied extensively and is associated with the development of 
chromosomal abnormalities such as aneuploidy. Aneuploidy describes deviations from the 
normal chromosome complement of the diploid nucleus, i.e. the presence of 2 copies of 
each autosome.  Aneuploidy can affect one or multiple chromosomes, and manifests as 
trisomy where there are three copies of a chromosome, monosomy where there is only one 
copy, or nullisomy when a chromosome is completely absent.  
In humans, most aneuploidies are incompatible with development to term. 
Aneuploid pregnancies commonly fail either because the embryo is pre-implantation lethal 
and will not even implant, or it does implant but leads to miscarriage during the first 
trimester of pregnancy (Hardy and Hardy, 2015; Macklon et al., 2002). These outcomes stem 
from chromosomal aberrations either inherited from the oocyte, or acquired during the 
early mitotic divisions (van Echten-Arends et al., 2011), although mitotic errors during 
preimplantation development are not affected by maternal ageing (McCoy et al., 2015). 
Implantation failure in aneuploid pregnancies occurs as a result of developmental arrest and 
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degeneration in the early cleavage stages of embryogenesis (Maurer et al., 2015). This 
occurs during the preclinical stage of pregnancy when the mother will be unaware she is 
pregnant. Therefore, implantation failure due to aneuploidy manifests as a reduction in 
pregnancy rates amongst older women (Heffner, 2004; Joseph et al., 2005; Menken et al., 
1986; Munne, 2002). Pregnancy rates in older women can be improved in IVF cycles by the 
use of karyotypically normal oocytes from young donors (Cohen et al., 1999; Munne, 2002; 
Wang et al., 2012), or after excluding aneuploid embryos upon karyotyping by pre-
implantation genetic diagnosis (Harton et al., 2013). This suggests that chromosomal 
aberrations are a major cause of infertility and early embryonic demise in older mothers. 
 Even when an aneuploid embryo is able to implant successfully, the result is often 
miscarriage in the first trimester of pregnancy, or less commonly live birth with congenital 
abnormalities in the offspring (Beckman and Brent, 1984; Farfalli et al., 2007; Hardy and 
Hardy, 2015). As a result, the dramatic increase in aneuploidy in older mothers is reflected in 
the significantly increased rates of miscarriage in this group (Dai et al., 2017; Khalil et al., 
2013; Kroon et al., 2011; Mills and Lavender, 2011).  
Reflecting the prevalence of aneuploidies in older women, the incidence of those 
aneuploidies that are able to lead to live birth is also significantly increased, including 
Down’s Syndrome - caused by trisomy  of chromosome 21 - which rises from 1 in 1500 births 
in women at 25 years of age, to 1 in 16 at 40 years (Nelson et al., 2013). The correlation 
between aneuploidy and increasing maternal age has been shown to stem from the 
increased risk of chromosomal non-disjunction in the oocyte with age, although the precise 
mechanism leading to this increase is not well understood (Hassold and Hunt, 2001). 
The majority of aneuploidies in the ageing oocyte arise as a result of chromosomal 
non-disjunction during meiosis I (McCoy et al., 2015). In meiosis I, homologous 
chromosomes are replicated and undergo meiotic recombination, leading to the generation 
of chiasmata which physically connect the homologous chromosomes, keeping them 
together. Chiasmata are maintained by cohesion between the sister chromatids, mediated 
by the cohesin complex (Nasmyth and Haering, 2009). The oocyte remains arrested in this 
state until meiotic resumption is triggered at ovulation, allowing progression into metaphase 
I. In metaphase I the homologous chromosomes remain firmly attached at chiasmata and 
  6 
align at the metaphase plate, where they are connected to opposing metaphase spindles at 
their centromeres. In anaphase, cohesion between the homologous chromosomes is 
released allowing them to segregate to opposite spindle poles. One set of chromosomes 
becomes the haploid complement of the oocyte, whereas the other is extruded as the first 
polar body. The maintenance of chiasmata in metaphase oocytes is crucial to ensure  
 
balanced chromosome segregation (MacLennan et al., 2015). Failure of these attachments 
results in chromosomal non-disjunction, generating an aneuploid oocyte with an 
inappropriate complement of chromosomes (Herbert et al., 2015). 
The period between prophase I arrest and meiotic resumption spans the lifetime of 
the individual. As such an oocyte can be arrested in prophase for more than 40 years, 
rendering it susceptible to perturbation by maternal ageing (Nagaoka et al., 2012). Studies of 
naturally ageing mice and humans show that cohesion between homologous chromosomes 
Figure 1.2 - The incidence of trisomic pregnancies rises exponentially with increasing age of the 
mother. Figure taken from (Stindl, 2011), data from (Hassold and Chiu, 1985). 
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decreases with age. This enhances the likelihood that chromosome attachments at the 
chiasmata will fail during meiosis, leading to increased levels of unbalanced chromosome 
segregations, and the generation of aneuploid oocytes (MacLennan et al., 2015). As such, 
chromosomal aberrations and aneuploidies in the oocyte become increasingly common with 
age. 50% of the oocytes to women over 35 years, and 80% to women over 40 years show 
defects in spindle formation and chromosomal alignment at the first meiotic division 
(Battaglia et al., 1996; Volarcik et al., 1998). Thus, the incidence of trisomy increases, from 
less than 5% in women under 25, to nearly 40% in women over 40 (Fig 1.2) (Hassold and 
Chiu, 1985). 
 
1.1.2.2. Mitochondrial dysfunction 
 
During the very early cell divisions of embryo development, the conceptus does not produce 
its own proteins, RNA, metabolites, or organelles. Therefore, the metabolic and 
macromolecular needs of the conceptus must be met by the oocyte, and as such the 
ooplasm supplies all the factors necessary for the first cell divisions of the embryo. The 
quality of the ooplasm deteriorates with maternal ageing, leading to biochemical changes 
which affect oocyte competence and embryo quality (Qiao et al., 2014). Of particular 
interest is the contribution of mitochondrial dysfunction to age-related decline in oocyte 
function, as the mitochondria and mitochondrial DNA are inherited solely from the ooplasm, 
with no contribution of paternal mitochondria (Sato and Sato, 2013). 
In general, mitochondrial function deteriorates with ageing in terms of their capacity 
to produce energy, their involvement in various signalling pathways, and the stability of 
mitochondrial DNA (Bratic and Larsson, 2013; Corral-Debrinski et al., 1992; Eichenlaub-
Ritter, 2012; Tilly and Sinclair, 2013). Specifically in the oocyte, ageing is associated with 
mitochondrial swelling and alterations in structure of the cristae (Kushnir et al., 2012; 
Simsek-Duran et al., 2013), as well as alterations to mitochondrial membrane potential (Ben-
Meir et al., 2015) and a reduction in their capacity to generate ATP (Selesniemi et al., 2011). 
Ageing of the oocyte mitochondria directly affects early embryonic cellular function, leading 
to premature biogenesis of mitochondria in the embryo, affecting embryo quality (May-
Panloup et al., 2016). These defects in mitochondrial function may be mechanistically 
associated with chromosome segregation defects (Eichenlaub-Ritter, 1998; Schon et al., 
2000), and may be one mechanism by which the frequency of aneuploidy increases in 
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oocytes from older women (Zhang et al., 2006). Mitochondrial ageing has been shown to 
impact on chromosome segregation during the early cleavage stages. This is associated with 
decreased embryo implantation potential, probably due to growth arrest and degeneration 
of aneuploid embryos during preimplantation development (Diez-Juan et al., 2015; Farfalli et 
al., 2007; Wells et al., 2014). 
 
1.1.3 Uterine ageing 
 
Advanced maternal age is associated with an increased risk of poor fetal outcomes and 
obstetric complications in the mother. This includes early miscarriages and birth defects 
caused by chromosomal abnormalities in the oocyte, as discussed above. However, poor 
outcomes are also significantly increased in euploid pregnancies in women over the age of 
35. Pregnancy in advanced maternal age carries an increased risk of non-chromosomal 
abnormalities in the offspring, including - for example - congenital heart defects, club foot, 
and diaphragmatic hernia (Hollier et al., 2000; Miller et al., 2011). It is also a risk factor for 
the “Great Obstetrical Syndromes”, which include pre-eclampsia, intrauterine growth 
restriction, miscarriage, and stillbirth (Brosens et al., 2011; Carolan and Frankowska, 2011; 
Huang et al., 2008; Jacobsson et al., 2004; Mills and Lavender, 2011; Ozalp et al., 2003). For 
example, the rate of stillbirth increases from 1:1000 in women <35 years to 1:440 in women 
>35 (Fretts and Usher, 1997), and continues to increase in women >40 years of age (Huang 
et al., 2008; Nybo Andersen et al., 2000). The risk of preeclampsia increases by almost 50% 
in women over the age of 35 (Lamminpaa et al., 2012), and one study found an almost 2-fold 
increase in the risk of preterm birth and low birth weight in older mothers (Nelson and 
Lawlor, 2011). Importantly, these outcomes occur independently of karyotypic abnormalities 
in the embryo, and may instead be attributed to poor placental function caused by ageing of 
the uterus. 
 The “Great Obstetrical Syndromes” are disorders of deep placentation, which come 
about as a result of insufficient remodelling of the maternal spiral arteries in the placental 
bed. These defects occur as a consequence of abnormal communication between the 
maternal decidua and fetal trophoblast during the first trimester of pregnancy (Brosens et 
al., 2011). The prevalence of these conditions during pregnancy in older women suggests 
that communication between embryonic and maternal tissues may become abnormal in 
advanced age, leading to defective placental development, and consequently, abnormal 
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embryonic development. The prevalence of congenital heart malformations (Hollier et al., 
2000; Schulkey et al., 2015) in the offspring of aged pregnancies provides further evidence 
for this link between maternal age and uteroplacental function, as they can result from 
placental insufficiency as a result of defects in placentation (Linask, 2013; Llurba et al., 2013; 
Matthiesen et al., 2016). 
 This evidence is in line with the hypothesis that adverse pregnancy outcomes with 
advanced maternal age - which are independent of chromosomal abnormalities - may be 
caused by age-related placental insufficiency (Lean et al., 2017), as a result of poor 
performance of the ageing uterus (Main et al., 2000). In support of this, studies looking at 
older women undergoing IVF show improved implantation and pregnancy rates when using 
donor oocytes from younger women, compared to using their own “old” oocytes. However, 
the subsequent rates of miscarriage, preterm birth, and fetal growth restriction remain 
significantly increased in older compared to younger women (Cano et al., 1995; Soares et al., 
2005), thus implicating age-related dysfunction of the endometrium as the root cause. 
This evidence in humans is supported by early work in ageing rodents. Uteri from old 
mice and rats exhibit a diminished artificial decidualization response after mechanical 
stimulation or intraluminal oil injection of the hormonally primed endometrium (Finn, 1966; 
Holinka and Finch, 1977; Ohta, 1987; Shapiro and Talbert, 1974), indicative of a lesser 
capacity of the older uterus to support pregnancy. Decidualization failure could be a 
consequence of an abnormal hormonal milieu, as the rodent estrous cycle becomes irregular 
after 10-12 months of age, with fluctuating levels of steroid hormones (LeFevre and 
McClintock, 1988; Lu et al., 1979; Nelson et al., 1982). However, the artificial decidualization 
response is still significantly decreased in aged mice, even after hormonal supplementation 
(Holinka and Finch, 1977). In addition, a study by Holinka and colleagues in 1979 found that 
plasma levels of progesterone do show a small, but significant decrease on day 4 of 
gestation in older females, however this did not correlate with fetal viability or resorption at 
mid-gestation, suggesting that altered levels of progesterone per se do not cause abnormal 
development or pregnancy loss (Holinka et al., 1979). Histological examination of the ageing 
rodent uterus shows age-related structural changes, such as the accumulation of collagen 
fibres in the stromal compartment - although this in itself is not thought to be responsible 
for the decline in uterine function (Hsueh et al., 1979; Loeb et al., 1938; Ohta, 1987). Altered 
morphology of the endometrial luminal epithelium during pregnancy, and accumulation of 
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lipofuscin deposits in uterine stromal cells have also been noted in aged females (Craig, 
1981; Kong et al., 2012; Martin et al., 1970). Taken together, these studies implicate age-
related changes to uterine morphology and physiology that may impact on reproductive 
performance independent of subtle alterations in hormone levels in older females.  
 
1.1.5 The maternal ageing phenotype and placentation 
 
As mentioned earlier, pregnancies in advanced maternal age are at increased risk of 
what have been termed the “Great Obstetrical Syndromes”, encompassing pre-eclampsia, 
fetal growth restriction, preterm birth, and stillbirth. These disorders are associated with 
abnormal placental development, where the perturbation of deep placentation and spiral 
artery remodelling leads to such complications due to restriction of the size of the placental 
bed and the reduced supply of maternal blood that is achieved (Brosens et al., 2011). In 
addition to the “Great Obstetrical Syndromes”, advanced maternal age is also associated 
with an increased risk of congenital heart malformations in the offspring (Hollier et al., 2000; 
Miller et al., 2011).  
The origins of the susceptibility of the developing heart to maternal ageing have 
recently been teased apart in an elegant study by Schulkey and colleagues (Schulkey et al., 
2015). These authors assessed the effect of maternal ageing on congenital heart defects in 
mice carrying a heterozygous mutation of the Nkx2-5 gene, which have an increased risk of 
ventricular septal defects (VSDs) in the offspring with increasing maternal age. By reciprocal 
ovarian transplantation between young and old females, the authors showed that the risk of 
VSDs in the offspring resides within the uterine environment of the older mother, and not 
the older oocyte. Interestingly, this risk was independent of maternal diet and obesity, and 
could be mitigated by maternal exercise begun either in early or later life, suggesting such 
interventions aimed at the mother could reduce the risk of maternal age-related cardiac 
malformations in the offspring. 
 The fetal heart and placenta develop in parallel and are linked by common signalling 
pathways and the continuous fetal blood circulation (Linask, 2013). Thus, abnormal vascular 
development in the placenta can affect fetal heart development. This is in particular the case 
because the blood pressure of the fetal circulation is set by the placental microvasculature, 
which in turn is required for normal heart tube formation. In mice, deletion of p38⍺ MAP 
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kinase leads to cardiac defects (and malformation of blood vessels in the head region), which 
are secondary to placental insufficiency (Adams et al., 2000). Similar examples are provided 
by the Map3k3 and PPAR-gamma mutations in which heart defects occur solely due to 
deficiencies in the placental trophoblast lineage (Barak et al., 1999; Yang et al., 2000). A 
recent study by Perez-Garcia, Fineberg et al showed that even in a systematic screen of 
genes required for embryonic survival, placental defects correlated strongly with 
abnormalities in the brain, heart, and vasculature (Perez-Garcia et al., 2018). Thus, it is 
tempting to speculate that the increase in heart defects depending on maternal uterine age 
found by Schulkey et al. originate in placental abnormalities, a possibility also hinted at in 
the News & Views article that accompanied this paper (Hitz and Andelfinger, 2015).  
  
1.2 Gestation in the mouse: Key events in pregnancy and 
development 
 
Successful implantation and the immediately following steps of extra-embryonic 
development, which ultimately lay the foundations for normal placentation, requires highly 
orchestrated communication between the embryo at the blastocyst stage and the receptive 
uterus (Cha and Dey, 2014). Therefore, abnormal uterine function can alter this tightly 
regulated dialogue, implicating uterine ageing in the genesis of disorders of placentation 
including the “Great Obstetrical Syndromes”, and embryonic defects as a consequence.  
 
1.2.1 Structure of the mouse uterus 
 
 The mouse uterus has a bicornate structure consisting of 2 horns which connect and 
open into a single vagina. Each horn of the uterus is a hollow tube consisting of an outer 
muscular layer called the myometrium, and an inner layer called the endometrium. The 
endometrium is comprised of a basal layer of uterine stromal cells (USCs), overlaid by 
luminal epithelial (LE) cells, which line the lumen of the uterus (Fig 1.3). The luminal 
epithelium becomes highly invaginated in parts, extending into the uterine stroma (Goad et 
al., 2017). This forms the glandular epithelium (GE), composed of secretory epithelial cells 
that form the uterine glands (Fig 1.3). 
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1.2.2 Early pregnancy in the mouse 
 
The successful achievement of pregnancy requires that formation of the mature blastocyst is 
synchronised with the acquisition of uterine receptivity, which in turn is achieved by the 
tightly controlled action of ovarian hormones. Disruption of this synchronicity can lead to 
adverse ripple effects in development, the consequences of which can manifest through the 
remaining course of pregnancy (Cha and Dey, 2014; Song et al., 2002). 
 
1.2.2.1 Implantation 
 
The main events of early pregnancy are the acquisition of uterine receptivity and 
concomitant implantation of a competent blastocyst. The acquisition of uterine receptivity 
occurs as a result of priming of the uterus under the influence of ovarian hormones. In the 
first 2 days of pregnancy - with E0.5 the appearance of the vaginal plug - the uterus is 
predominantly regulated by ovarian estrogen (E2) acting through the estrogen receptor 
(Esr1). This drives proliferation of the LE and GE. On E2.5, E2 levels begin to decline while 
progesterone (P4) increases due to secretion from the newly formed corpora lutea. The 
action of P4, superimposed on an E2 primed uterus, causes proliferation to cease in the LE 
and GE cells that instead start to differentiate. In contrast to the LE and GE, P4 promotes 
proliferation in the stromal compartment from E2.5 onwards (Dey et al., 2004). This 
transition from epithelial to stromal proliferation, mediated by P4, is critical for implantation 
(Large and DeMayo, 2012). Uterine receptivity is achieved on E4 of pregnancy and persists 
only until E5 (Paria et al., 2002), during which time blastocyst competency must be achieved 
for successful implantation.  
In a receptive uterus, embryo implantation proceeds in 3 main stages of apposition, 
attachment, and invasion (Fig 1.3) (Enders, 1967). Firstly, in the mouse, the blastocyst 
trophectoderm (TE) becomes closely apposed to the anti-mesometrial LE of the receptive 
uterus (note: in humans, apposition occurs at the polar TE). This is followed by the 
attachment reaction (Fig 1.3), when contacts between the TE and LE are strengthened by the 
expression of cell adhesion molecules such as L-selectins (Achache and Revel, 2006; Cha et 
al., 2012). Once this has occurred the blastocyst can no longer be dislodged by uterine 
flushing (Enders, 1967). The attachment reaction coincides with increased vascular 
permeability at the site of attachment, which can be visualised by intravenous injection of 
Chicago blue dye into the tail vein (Psychoyos, 1973). Following attachment, the blastocyst 
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 begins to penetrate the uterine wall by invasion of the TE into the LE (Fig 1.3). Mechanisms 
of TE penetration through the LE are species specific; in the mouse LE cells contacting the TE 
undergo apoptosis, thereby allowing invasion of the TE into the underlying uterine stroma, 
whereas in primates the syncytiotrophoblast intrudes between LE cells to penetrate the  
basal lamina (Wang and Dey, 2006). Invasion of the TE into the underlying uterine stroma is 
thought to be facilitated by matrix metalloproteinases, most notably Mmp9 (Fig 1.3) (Zhu et 
al., 2012). 
 
 
 
Figure 1.3 - The mouse uterus in early pregnancy. Implantation of the blastocyst into the 
uterine wall proceeds in 3 main stages. Apposition of the blastocyst to the receptive luminal 
epithelium (LE) is dependent on priming with estrogen (E2). The embryo attaches more 
strongly to the LE in the attachment phase, and then starts to invade through the LE into the 
underlying stroma. Invasion occurs under the control of Mmp9, and triggers decidualization of 
uterine stromal cells, under the control of progesterone (P4). ICM, inner cell mass. TE, 
trophectoderm. GE, glandular epithelium. Adapted from (Qi et al., 2014). 
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1.2.2.2 Decidualization 
 
The processes of blastocyst attachment and invasion of the TE into the stromal 
compartment trigger the surrounding uterine stromal cells to undergo the decidualization 
reaction (Fig 1.3, 1.4). Decidualization facilitates further invasion and allows the blastocyst to 
embed itself completely into the uterine stromal bed. In mice, decidualization during 
pregnancy is dependent on the presence of the blastocyst, however a decidualization 
response can be stimulated artificially by intraluminal injection of oil, application of a 
mechanical stimulus, or the introduction of Sepharose beads into a hormonally primed 
uterus (Herington et al., 2009). The resulting growth is termed a deciduoma. 
 Decidualization involves the extensive proliferation and differentiation of the 
fibroblastic uterine stromal cells into large decidual cells with a unique secretory phenotype. 
During decidualization the uterine stromal compartment undergoes proliferation and 
differentiation to form the decidua, which constitutes the maternally derived portion of the 
placenta. The decidua performs a variety of functions, including regulation of trophoblast 
invasion, the production of growth factors and cytokines which influence embryo 
development, and synthesis of E2. In addition, the decidua acts as the interface between 
fetus and mother with the accompanying immuno-regulatory challenges (Alam et al., 2008; 
Das et al., 2009; Dudley et al., 1992; Oreshkova et al., 2012; Sharma et al., 2016; Singh et al., 
2011). The decidua also acts to regulate the invasiveness of the trophoblast, allowing 
trophoblast invasion to occur in order to anchor the placenta to the uterus and allow 
remodelling of the maternal spiral arteries. Disruption of this process can lead to disorders 
such as placental abruption and pre-eclampsia, when invasion is too shallow, whereas 
excessive invasion leads to placenta accreta and choriocarcinoma (Goldman-Wohl and Yagel, 
2002; Sharma et al., 2016). Decidual cells also play a pro-angiogenic role, supporting 
maternal blood vessel formation which is necessary for perfusion of the placenta and 
nourishment of the developing embryo (Lima et al., 2014; Ma et al., 2001). As 
decidualization progresses, cells in the secondary decidual zone at the anti-mesometrial pole 
of the implantation site undergo successive rounds of DNA replication without cell division 
and become polyploid (Fig 1.4) (Cha et al., 2012; Sroga et al., 2012). This is thought to enable 
the synthesis and secretion of large volumes of signalling factors, and may limit the life-span 
of decidual cells to enable regression of the decidua later in pregnancy, and allows 
expansion of the placenta (Ogle et al., 1999; Ogle et al., 1998) 
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1.2.2.3 Hormonal regulation of decidualization 
 
Decidualization is under the control of the steroid hormones E2 and P4. The actions of E2 
and P4 are mediated by their receptors, estrogen receptor (Esr1/2) and progesterone 
receptor (Pgr), respectively. Each controls a large and context specific repertoire of 
downstream signalling factors necessary for successful pregnancy. The Pgr and Esr1/2 are 
both nuclear receptors. In their inactive form they reside in the cytoplasm, but upon binding 
of their respective ligands they homo-dimerise and translocate to the nucleus (Sever and 
Glass, 2013). On nuclear translocation, Pgr and Esr1/2 bind to specific genomic regions, to 
regulate the transcription of target genes. In the case of Pgr, when inactive it is bound by a 
complex of heat shock proteins and the immunophilins Fkbp4 and Fkbp5, which act to 
maintain the structure and competence of the Pgr in preparation for hormone binding and 
transcriptional regulation (Pratt and Toft, 1997; Renoir et al., 1990). Disruption of this 
complex by deletion of Fkbp4 leads to female infertility with complete failure of 
implantation and decidualization due to impaired transcriptional activation of Pgr target 
genes (Tranguch et al., 2005; Yang et al., 2006).  
 Evidence from mouse KO models shows that the action of E2 and P4 is a requirement 
for successful establishment of pregnancy. Esr1 knockout (KO) females are infertile, with 
hypoplastic uteri and ovaries that do not respond to E2 (Lubahn et al., 1993). These mice fail 
to undergo artificial decidualization (Pawar et al., 2015), suggesting the action of E2 is 
necessary for the decidualization response. Furthermore, KO mice which lack Esr1 in the LE 
and GE but retain expression in the stroma are also unable to decidualize. This study showed 
that epithelial Esr1 is required for decidualization of the underlying stromal compartment, 
suggesting that paracrine signals from the LE are essential for stromal cell decidualization 
(Pawar et al., 2015). Esr1 also induces the expression of Pgr in the endometrium, suggesting 
it is also involved in regulating the capacity of the uterus to respond to P4. 
 Pgr KO mice are infertile and exhibit defects in all female reproductive tissues, 
including abnormal mammary gland development, failure of ovulation and decidualization, 
and hyperplasia of the LE due to the unopposed action of E2 (Dey et al., 2004; Lydon et al., 
1995). Subsequent studies showed that uterine receptivity and stromal decidualization are 
mediated primarily by the progesterone receptor A (PgrA) isoform in mice (Conneely et al., 
2001) and in humans (Brosens et al., 1999; Wang et al., 1998). 
 Collectively, these studies established that E2 primarily regulates the window of 
receptivity and is required to prime the stroma to enable it to decidualize in response to P4, 
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whereas P4 is the predominant regulator of decidualization itself, stimulating the 
proliferation and differentiation of USCs (Franco et al., 2008; Lee and DeMayo, 2004). 
 
1.2.2.4 Molecular mechanisms of decidualization 
 
E2 and P4 control the events of early pregnancy through the regulation of numerous target 
genes, including the Epidermal Growth Factor Receptor (Egfr), Bone Morphogenetic Protein 
2 (Bmp2), and Wingless-Type MMTV Integration Site Family, Member 4 (Wnt4) (Fig 1.4). 
Bmp2 is a P4 regulated gene induced in uterine stromal cells during decidualization (Lee et 
al., 2007; Li et al., 2007; Paria et al., 2001). It is expressed in the uterine stroma underlying 
the implantation site in early pregnancy (Ying and Zhao, 2000), and in stromal cells 
surrounding the embryo once implantation has occurred (Lee et al., 2007). Bmp2 KO mice 
are unable to decidualize in response to an artificial stimulus with defects in proliferation 
and differentiation of uterine stromal cells. This can be partially rescued by supplementation 
with recombinant human BMP2, showing its necessity in decidualization (Lee et al., 2007). In 
addition, Bmp2 is itself able to accelerate decidualization in vitro (Li et al., 2007). The 
induction of decidualization by Bmp2 is mediated by Wnt4, also implicating the Wnt 
pathway in decidualization (Fig 1.4). A more recent study found that Bmp2 and Wnt4 also 
play distinct roles in decidualization, both of which are regulated by the upstream activity of 
Egfr, which is itself necessary for decidualization (Large et al., 2014) (Fig 1.4). 
Interestingly, Egfr mediated decidualization of uterine stromal cells is regulated by secretion 
of the paracrine signalling factor Indian hedgehog (Ihh) by the luminal epithelium (Fig 1.4) 
(Franco et al., 2010; Lee et al., 2006). Pgr works synergistically with Lif secreted from the 
uterine glands in response to E2 to induce Ihh production (Fig 1.4) (Pawar et al., 2015). Ihh 
from the LE triggers decidualization in the uterine stroma through its receptor Patched-1 
(Ptch1), which is expressed by uterine stromal cells. Thus, factors produced by the LE and GE 
mediate a cross-talk to induce stromal cell decidualization and signalling from both 
compartments is indispensable for this process. This may be the mechanism which 
necessitates epithelial Esr1 in the stromal decidualization response. 
Implantation and decidualization are vital events in early pregnancy, which must be 
tightly regulated in order for successful development of the placenta to occur. Aberrant 
signalling through Pgr and Esr1, and consequent effects on the regulation of their target 
genes, can lead to defects in implantation, decidualization and placentation (Cha and Dey, 
2014). They are also implicated in disorders of pregnancy such as recurrent pregnancy loss  
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(Carranza-Lira et al., 2000; Itsekson et al., 2007; Su et al., 2011), and human endometrial 
disorders such as endometriosis and endometrial cancer (Ishikawa et al., 2010; Patel et al., 
2015; Ramathal et al., 2010) 
 
 
 
 
 
 
Figure 1.4 - Molecular control of decidualization. Implantation of the blastocyst into the 
uterine wall triggers decidualization of the uterine stroma. This requires paracrine secretion 
of Indian Hedgehog (Ihh) from the LE to the stroma under the control of P4 and Lif. This 
paracrine signal, along with Pgr actvity, triggers decidualization via downstream effectors 
including Egfr, Bmp2, and Wnt4. Adapted from Cha and Dey 2012. 
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1.2.1 Placental development in the mouse 
 
 The blastocyst is composed of two distinct groups of cells: the inner cell mass (ICM) 
from which epiblast cells emerge and give rise to the embryo proper, and an outer layer of 
trophectoderm (TE) cells that give rise to placental lineages (Fig 1.5). Once the blastocyst has 
implanted into the uterine wall, the polar TE (i.e. the cells overlying the ICM) proliferates in 
response to Fgf4 secreted by the ICM, whilst cells of the mural TE cease to proliferate and 
instead start to differentiate into trophoblast giant cells (TGCs). It is these mural TE cells that  
 
initiate the early penetration into the receptive uterus. Within the next 2-3 days following 
implantation, the continued proliferation of the polar TE leads to the formation of the 
extraembryonic ectoderm (ExE) and ectoplacental cone (EPC), bounded by a layer of mural 
TE-derived TGCs which surrounds the conceptus at E6 (Fig 1.5) (Rossant and Cross, 2001; 
Senner and Hemberger, 2010). By E7.5, morphogenetic events that occur as a consequence 
of gastrulation give rise to extra-embryonic mesoderm cells. Through these events, cells of 
the extra-embryonic ectoderm and mesoderm form the chorion, while mesodermal cells at 
the posterior end of the primitive streak form the allantois (Fig 1.5). Continued migration 
and proliferation cause the allantois to expand until it makes contact with the chorion, 
triggering these two layers to undergo chorio-allantoic fusion at around E8. This process is 
critical to generate the site at which fetal blood vessels, derived from the allantoic 
mesoderm, start to invaginate into the chorionic ectoderm to form the fetal vasculature of 
the emerging placenta. Chorio-allantoic fusion is vital for placental development, and its 
failure results in mid-gestational lethality (Downs, 2002; Rossant and Cross, 2001).  
Figure 1.5 - Placental development in the mouse. Early development of the mouse embryo and 
placenta between E3.5-E12.5. ICM, inner cell mass. TE, trophectoderm. EPC, ectoplacental cone. 
TGCs, trophoblast giant cells. Adapted from (Rossant and Cross, 2001). 
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At E9.5 the chorio-allantois undergoes extensive branching morphogenesis to form 
the placental labyrinth. When formed, the labyrinth consists of an intricate network of fetal 
blood vessels that are in close contact with the maternal blood circulation. This architecture 
enables the efficient exchange of gases and nutrients between the maternal and fetal blood 
circulations. Unlike the fetal vessels, maternal blood percolates into lacunae that are 
established by one fenestrated layer of sinusoidal TGCs and two layers of 
syncytiotrophoblast. The layer closest to the maternal blood is commonly referred to as 
syncytiotrophoblast layer I (SynT-I), which is apposed to SynT-II, followed by the fetal 
endothelial cells and then the fetal blood (Georgiades et al., 2002). Fetal blood enters and 
flows through the labyrinth through a highly branched network of fetal vasculature, and as 
such the labyrinth contains a population of endothelial cells and supporting pericytes, which 
originate from the allantois. The proper development and function of these cell layers is vital 
for ensuring adequate nourishment of the conceptus.  
 Separating the labyrinth compartment from the maternal side is a layer of 
spongiotrophoblast (SpT) (Fig 1.5). The function of the SpT is poorly understood, but may 
provide structural support as well as additional hormonal supply, growth factor production 
(e.g. Igf2), and glycogen stores (Cross et al., 2002; Iwatsuki et al., 2000), and is characterised 
by the expression of Ascl2 and Tpbpa (Fig 1.6). In direct contact with the remaining maternal 
decidual layer is a thin layer of parietal trophoblast giant cells (Fig 1.5). This, the mature 
placenta consists of the three main layers: (i) the labyrinth, (ii) the SpT and TGC layer, the 
combination of which is sometimes termed the junctional zone, and (iii) the maternal 
decidua. 
 
1.2.3.1 Trophoblast differentiation 
 
Not only does the placenta form the feto-maternal interface for the exchange of gases and 
nutrients between mother and conceptus, it also produces large quantities of hormones, 
angiogenic factors, and tissue remodelling factors (Rossant and Cross, 2001), which are vital 
for successful pregnancy and fetal development. As such, it consists of multiple cell types 
which are specialised for performing these various functions, including SynT, SpT, and TGCs. 
These differentiate during the first half of gestation from a trophoblast stem cell-like 
precursor cell pool that ultimately arises from the polar TE. Indeed, the stem cell potential 
can be maintained in trophoblast stem (TS) cells in vitro. TS cells can be derived from the TE 
of blastocyst stage embryos, and from the ExE and chorion up to E8.5 (Tanaka et al., 1998; 
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Uy et al., 2002), and cultured in vitro to investigate their self-renewal capacity, and 
differentiation to the various trophoblast lineages. TS cells represent the progenitor  
 
population of the early placenta, and as such are able to give rise to all trophoblast cell 
lineages in vitro and in chimeras in vivo (Tanaka et al., 1998). The TS cell state is specified 
and maintained by a complex transcriptional network consisting of a number of transcription 
factors, including Cdx2, Eomes, Elf5, and Esrrb (Fig 1.6). Cdx2 is essential for maintenance of 
TS cell identity and is also required for the specification of TE fate during early lineage 
Figure 1.6 - Model of TS cell differentiation showing marker genes expressed at each stage 
of differentiation. TS cells, trophoblast stem cells. P-TGC, parietal trophoblast giant cells. 
SpA-TGC, spiral artery trophoblast giant cells. GlyT, glycogen trophoblast. SpT, 
spongiotrophoblast. S-TGC, sinusoidal trophoblast. SynT, syncytiotrophoblast. Adapted from 
(Natale et al., 2017). 
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commitment. Cdx2 restricts the expression of the embryonic stem cell pluripotency factors 
Oct4 and Nanog, which specify the embryonic fate (Senner and Hemberger, 2010; Strumpf 
et al., 2005). The transcription factors Eomes and Elf5 are not required for specification of 
the TS cell fate, but rather are important for the establishment and maintenance of the 
multipotent state, and expansion of the trophoblast stem or progenitor cell niche in early 
placental tissues (Latos and Hemberger 2014; Senner and Hemberger 2010). 
The TS cell state is dependent on activation of the Fgf signalling pathway. TS cells can 
be maintained in vitro when cultured with Fgf and heparin in the presence of mouse 
embryonic fibroblast (MEF) conditioned medium, and withdrawal of these factors promotes 
differentiation (Tanaka, 2006). TS cells have the capacity to differentiate into all major 
trophoblast lineages. On differentiation stem cell factors are down-regulated, and 
differentiation progresses along two main routes (Fig 1.6). The major route is generally 
referred to as the “TGC pathway”. This occurs via intermediate stages when cells are still 
diploid and express markers such as Ascl2 and Tpbpa; hence this “intermediate trophoblast” 
is reminiscent of cells of the EPC (Carney et al., 1993; Cierna et al., 2016; Guillemot et al., 
1994; Simmons et al., 2007). Apart from various TGC subtypes that differentiate as the main 
component (parietal TGCs, spiral-artery-associated TGCs), these cells also give rise to 
terminally differentiated cells in the junctional zone, consisting of SpT and glycogen 
trophoblast cells (Fig 1.6) (Mould et al., 2012; Simmons et al., 2007) . The second prominent 
route is the “SynT pathway”. These cells are believed to originate from the basal part of the 
extraembryonic ectoderm, i.e. the part closer to the epiblast. This region contains Esrrb+ and 
Eomes+ TS-like cells, which give rise to Epcam+ progenitors that are routed towards the 
labyrinth fate (Fig 1.6) (Simmons et al., 2007; Simmons et al., 2008; Ueno et al., 2013; Uy et 
al., 2002). These progenitors differentiate further to form the SynT as well as sinusoidal TGCs 
which together make up the labyrinth trophoblast (Fig 1.6). 
 In vitro, TS cells differentiate most readily down the TGC route, as TS cell self-renewal 
factors in the culture medium actively suppress TGC formation, and their removal allows 
rapid differentiation to the TGC lineage (Erlebacher et al., 2004; Guzman-Ayala et al., 2004; 
Hughes et al., 2004; Tanaka et al., 1998). Thus, TS cells give rise to terminally differentiated 
TGCs, that undergo multiple rounds of DNA synthesis in the absence of cytokinesis to 
produce large, polyploid cells (Gardner and Davies, 1993; MacAuley et al., 1998), which are 
characterised by the expression of members of the prolactin family of hormones (Fig 1.6) 
(Simmons et al., 2007). In vivo, TGCs mediate the invasion of trophoblast into the 
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endometrial stroma, a feature first exhibited by the TE and later by the parietal and spiral 
artery-associated TGCs differentiating at the margins of the ectoplacental cone (Cross, 2000; 
Simmons et al., 2007). TGCs also produce large quantities of steroid hormones and paracrine 
factors, which promote adaptation of the maternal vasculature to pregnancy (Carney et al., 
1993; Cross et al., 2002; Hu and Cross, 2010; Simmons and Cross, 2005).  
The SynT cells characteristic of the labyrinth are defined by expression of Syncytins A 
and B (Syna, Synb) (Fig 1.6), with Syna being specific for the SynT-I layer and Synb for SynT-II 
(Dupressoir et al., 2009; Dupressoir et al., 2011). SynT precursors in the chorionic plate 
initially express Gcm1, defining the sites where branching morphogenesis is initiated (Anson-
Cartwright et al., 2000). Gcm1 expression is then restricted as precursors exit the cell cycle 
and fuse to form a syncytium, in a process that is currently not well understood (Simmons 
and Cross, 2005). 
Trophoblast differentiation is essential for the successful development of the placenta 
and embryo. Perturbations to this tightly regulated differentiation programme often results 
in abnormalities in the formation of these trophoblast cell types and placental layers. This 
can result, for example, in disproportionate compartment sizes between labyrinth and SpT, 
or a general under-development of the intricate vascular organization of the labyrinth, 
leading to defects in fetal growth and development (Perez-Garcia et al., 2018). Many of 
these events continue to be influenced by the cross-talk between the trophoblast and 
maternal decidual compartment. As mentioned, the remodelling of maternal spiral arteries 
is chiefly mediated by invasive TGCs and later aided by glycogen cells, trophoblast cells 
secrete pro-angiogenic and vasodilatory factors to promote blood flow into the developing 
placenta, and at the same time the decidua generally limits trophoblast invasion and 
controls these tightly coordinated events. 
 
1.3 Comparison of mouse and human reproductive biology 
 
The mouse is the most commonly used model of human pregnancy due to the relative 
similarities in mouse and human reproduction. There are however important structural and 
functional differences between the two systems which may impact on the translational 
impact of mouse studies. 
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1.3.1 Structure and function of the uterus and endometrium 
 
The most striking differences between pregnancy in the mouse and human are the number 
of progeny per birth and length of gestation. Mice give birth to litters consisting of 6-8 pups 
on average after a short gestation time of 19.5 days, whereas the vast majority of human 
pregnancies produce one baby with a much longer gestation period of about 40 weeks. The 
structure of the mouse uterus is well adapted to polytocous pregnancy, consisting of two 
uterine horns which join to form a single vagina. After conception multiple embryos implant 
simultaneously in both uterine horns, generating multiple implantation sites each containing 
an individual conceptus. In contrast, the human uterus is pyriform, and is comprised of a 
single chamber into which a single embryo (most commonly) implants. Multiple pregnancy 
in humans occurs in only 1-3% of all cases with the vast majority of those being twin 
pregnancies, and, in stark comparison with mouse pregnancy, presents significant risks to 
mother and baby. Obstetric complications including pre-term birth, fetal growth restriction, 
fetal demise, gestational diabetes and pre-eclampsia occur in 80% of multiple pregnancies 
compared to 25% of singleton pregnancies (Norwitz et al., 2005). 
 The mouse and human uterus are both lined by an inner layer of hormonally 
responsive endometrium into which the embryo must implant for successful pregnancy. The 
female mouse and human undergo a regular reproductive cycle, regulated primarily by the 
secretion of luteinising hormone and follicle stimulating hormone from the pituitary gland. 
These act on the ovarian follicles to regulate oocyte maturation ovulation, and on the 
endometrium to regulate its growth and differentiation. The mouse estrous cycle is 4-7 days 
long whereas the human menstrual cycle lasts for 28 days on average, but despite this 
significant difference in length the pattern of hormone secretion is relatively comparable 
between humans and rodents (Staley and Scharfman, 2005). There are however some subtle 
differences; during mouse pregnancy, the window of implantation is initiated by a nidatory 
surge of estrogen whereas this is not the case in the human, probably reflecting the need for 
synchronised implantation of multiple embryos in the mouse which is not necessary in 
human pregnancy (de Ziegler et al., 1992). During human pregnancy P4 is initially produced 
by the corpus luteum, but this is subsequently taken over by the placenta (luteo-placental 
shift), whereas in the mouse the corpora lutea are responsible for P4 production for the 
duration of pregnancy (Ratajczak and Muglia, 2008). The most striking difference between 
the mouse and human reproductive cycles is the cyclical shedding of the endometrium 
which occurs at the end of each menstrual cycle in humans, termed menstruation. 
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Menstruation does not occur in the vast majority of mammals, including the mouse and may 
be a result of the spontaneous decidualization which occurs during every human menstrual 
cycle, but is not present in the mouse. Recent evidence suggests that this cyclical shedding 
of the endometrium may allow for endometrial remodelling, thus potentially altering the 
cellular composition of the endometrium between cycles (Brighton et al., 2017).  
In both species the endometrium consists of an upper layer of luminal epithelial cells, 
and the underlying uterine stroma containing uterine stromal cells and uterine glands. Both 
the mouse and human undergo endometrial decidualization during early pregnancy, in 
response to the action of E2 and P4 which act as critical regulators of endometrial growth 
and decidualization during the reproductive cycle. As in the mouse, human endometrial 
decidualization is regulated by signalling pathways including the ESR, PGR, BMP2 and WNT 
pathways (Kaya Okur et al., 2016; Li et al., 2007; Ramathal et al., 2010; Sonderegger et al., 
2010), suggesting that the underlying molecular pathways are somewhat conserved and that 
findings from studies performed in mouse may be translated to the human condition. 
However, a major difference between the human and mouse is the timing of onset of 
decidualization. The mouse endometrium undergoes decidualization only in response to the 
implanting blastocyst, whereas the human endometrium initially undergoes spontaneous 
decidualization during the secretory phase of each menstrual cycle, immediately following 
ovulation (Gellersen and Brosens, 2014; Ramathal et al., 2010). While some clear differences 
exist between the reproductive cycles of the mouse and human, there appears to be 
significant conservation of the molecular regulation of implantation and decidualization, and 
the mouse remains the most widely used, well defined model of human endometrial 
function. 
 
1.3.2 Comparison of the mouse and human placenta 
 
Mammalian placentation is functionally convergent, however placental morphology can vary 
significantly between species. Both mouse and human placenta are discoid in shape, and 
exhibit a haemochorial type of placentation, where the fetal trophoblast cells are in direct 
contact with maternal blood. The placenta is a heterogeneous tissue consisting of multiple 
cell types with various functions. Some analogous cell types can be identified in mouse and 
human, through overlapping patterns of gene expression as well as similar cellular 
morphology and function, however in some cases a direct comparison is not 
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straightforward. In the mouse and human the structures responsible for gas and nutrient 
exchange between the fetal and maternal circulation are the labyrinth and the placental villi 
respectively. Both structures share a similar syncytial cell-type which is directly bathed in 
maternal blood. However, in humans there is only one syncytial layer overlying a layer of 
cytotrophoblast which are thought to continuously fuse with and replenish the syncytium 
throughout pregnancy, whereas the mouse exhibits a trilaminar structure with two adjacent 
layers of syncytium and a single fenestrated layer of TGCs. Despite these structural 
differences between the mouse and human exchange surfaces, the development of the 
mouse labyrinth and human villi may be regulated by some common factors. For example, 
GCM1, a marker of labyrinth progenitors required for branching morphogenesis in the 
mouse placenta (Anson-Cartwright et al., 2000), is similarly expressed by the syncytio- and 
cytotrophoblast of the human placental villi (Nait-Oumesmar et al., 2000).  
 Although there are significant morphological and functional similarities between the 
mouse labyrinth and human placental villi, a direct equivalent of the mouse junctional zone 
is less clear cut. The closest comparison that can be made is with the human cytotrophoblast 
cell column, which anchor the placenta to the uterine wall. They consist of tightly packed 
cytotrophoblast cells which are highly proliferative at the base of the column, thus 
contributing to its growth. At its distal tip the column cytotrophoblast in contact with the 
maternal decidua undergoes an epithelial-mesenchymal transition and differentiates into an 
invasive cell type called extravillous trophoblast (EVT) (DaSilva-Arnold et al., 2015; E. Davies 
et al., 2016). EVT cells invade deeply into the decidua, migrating to erode the vasoactive 
lining of the maternal spiral arteries and also becoming polyploid in a similar way to the 
mouse TGCs, although to a lesser extent. As such, the cytotrophoblast cell column shows 
some similarities with the mouse junctional zone in terms of the invasive characteristics of 
the EVT, and its remodelling of the maternal vasculature which is instrumental in regulating 
the flow of maternal blood to the placenta, as is seen with mouse TGCs (Pijnenborg et al., 
2011). 
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1.4 Preliminary data 
 
A study from Lopes and colleagues in 2009 showed that pregnancy during advanced 
maternal age in C57BL/6 (B6) mice results in a higher frequency of abnormal development in 
the offspring (Fig 1.7a). In the litters that were studied, they reported developmental 
abnormalities including enlargement of the heart, hindbrain defects, and embryo resorption 
(Fig 1.7a). As discussed earlier, these particular defects suggest abnormalities of the 
placenta. In line with this, gross histological examination performed in that study indicated 
that the placentas from older B6 mothers exhibited developmental defects in the 
trophoblast compartment (Fig 1.7b).  
 
This study suggested that placentation is adversely affected by maternal ageing. 
However, only a limited number of pregnancies in aged females were studied (n=3), leaving 
open questions about the penetrance and reproducibility of this phenotype. Importantly the 
authors noted that these defects could arise due to a) poor quality of the aged oocyte, or b) 
Figure 1.7 - Effects of maternal age on embryonic and placental development at E12.5, showing 
a) the variability of embryonic development, and the incidence of heart and brain defects, and 
resorption, b) normal placentation at one implantation site from a young mother, and two sites 
from an aged mother. Black bar and arrow in Young and Aged 1 show thickness of the TGC layer. 
Arrow in Aged 2 points to abnormal labyrinth development. Taken from (Lopes et al., 2009). 
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alterations in the uterine environment of aged females, however, this question has 
remained open and the origin of placental defects remains unknown. 
 It has previously been suggested that maternal ageing impairs the ability of the 
uterus to successfully achieve and maintain pregnancy, leading to defects in placentation, 
however there is so far no direct evidence to support this. If placental defects do originate 
from the aged maternal environment and not the embryo, they may arise from 
perturbations to the molecular cross-talk between the blastocyst and endometrium in early 
pregnancy. 
Most of these data are from very early studies and/or have remained at an 
observational level lacking molecular insights, including the above-mentioned study by 
Lopes et al. in aged B6 females. Thus, the aim of my project was to use the B6 model to 
systematically analyse the effect of advanced maternal age on embryonic and placental 
development, and investigate the molecular basis of the reproductive decline in ageing 
females. 
1.5 Hypotheses and aims 
 
There is a significant body of work investigating the relationship between advanced 
maternal age and decline in the size and quality of the oocyte pool, however research into 
the contribution of uterine ageing and placental dysfunction to reproductive decline in 
advanced maternal age has been largely neglected. 
My primary hypothesis is that a significant proportion of the developmental 
abnormalities in offspring from older B6 mothers occur as a result of defective placentation. 
My secondary hypothesis is that maternal age-related placentation defects are rooted in 
ageing of the maternal uterus, and do not reside with the oocyte. The aim of this project is 
to delineate the causes and consequences of reproductive decline with advanced maternal 
age, with a view to gain a better understanding of the mechanisms of reproductive ageing. 
 
The sub-aims of this project are: 
• To systematically characterise defects in embryonic and placental development in the 
offspring of older mothers. 
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• To establish whether the underlying basis for embryonic and placental defects resides with 
the aged oocyte, or uterus. 
• To assess the functional capability of endometrial cells to respond to pregnancy hormones 
in young versus aged females. 
• To identify the potential mechanism that underlies abnormal uterine function and 
placental development in advanced maternal age. 
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2.1 Mice 
 
C57BL/6Babr mice were used throughout this study. Virgin females were housed in groups 
of up to 5 per cage until reaching the desired age as indicated for each experiment. All 
animal experiments were conducted in full compliance with UK Home Office regulation and 
with approval of the local animal welfare committee (AWERB) at The Babraham Institute, 
with relevant project and personal licences in place. Where “young” females were used, 
they were between 8-12 weeks of age. Timed matings were set up with 8-16 week old 
C57BL/6Babr stud males, with the morning of the vaginal plug designated as E0.5. Where 
“aged” males were used, they were 1 year old. Pregnancy was confirmed by presence of the 
plug, and subsequently females were dissected at the gestational age indicated in each 
experiment. Dissected tissue was processed for histology, RNA isolation, or uterine stromal 
cell isolation as indicated. 
2.2 Deciduoma assay 
 
Mice were maintained in the designated animal care facility at Baylor College of Medicine 
according to the institutional guidelines for the care and use of laboratory animals. The 
artificial decidual response has been previously described (Finn, 1966). Briefly, 
ovariectomized mice were injected 3 times a day with 100 ng of estradiol (E2) per mouse. 
After 2 days of rest, mice were then injected daily with 1 mg of progesterone (P4) and 6.7 ng 
of E2 per mouse for 3 days, subcutaneously. One uterine horn was subjected to an 
intraluminal injection of 50μl of sesame oil 6 h after the final P4 and E2 injection. The other 
horn was not subjected to sesame oil injection and served as a control. Mice were given 
daily subcutaneous injections of 1 mg of P4 and 6.7 ng of E2 per mouse each day after the 
trauma. Mice were sacrificed 2 days after the trauma by cervical dislocation while under 
anaesthetic, Avertin (2,2-tribromoethyl alcohol; Sigma-Aldrich, St. Louis, MO), and uteri 
dissected out.  
2.3 Histology 
 
Dissected tissues for histology were fixed overnight in 4% paraformaldehyde, before being 
embedded in paraffin wax and cut into 7μm thick sections on a Leica paraffin microtome. 
For haematoxylin and eosin (H&E) staining, sections were deparaffinised and incubated in 
Mayer’s Haematoxylin (Sigma #51275) for 10 minutes, before washing briefly in tap water. 
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Staining was differentiated by incubating in 70% acid alcohol (70% ethanol, 1% hydrochloric 
acid) for 10 seconds, and then in cold tap water for 10 minutes. Eosin staining (alcoholic 
Eosin, Sigma HT110116) was performed for 30 seconds, followed by dehydration, and 
mounting of sections with Eukitt quick-hardening mounting medium (Sigma #03989). For 
immunohistochemistry slides were deparaffinised in xylene and rehydrated in an ethanol 
series. Antigen retrieval was performed by microwave boiling of sections in 10mM Na-citrate 
pH 6.0, or 10mM Tris pH9.5, 1mM EDTA for 30 minutes, and washed 3 times in 50mM Tris 
pH7.8, 330mM NaCl, 0.1% NP-40. Slides were then blocked in PBS, 0.5% BSA, 0.01% Tween-
20 for 30 minutes, before incubation with primary antibody diluted in PBS, 0.5% BSA, 0.01% 
Tween-20 overnight at 4oC, in the dark. Antibodies used were Ki67 (Abcam ab15580, 1:200), 
Pgr (DAKO A0098, 1:1000), pStat3 (Cell Signaling 9138S, 1:200), Esr1 (Santa Cruz sc-543, 
1:200), pEsr1 (Santa Cruz sc-101675, 1:200), 5-methylcitidine (Eurogentec BI-MECY-0100), 
and 5-hydroxymethylcytosine (Active motif 39769). Secondary antibodies were either the 
appropriate AlexaFluor or horseradish-peroxidase (HRP) conjugated antibodies at 1:500 and 
1:100 respectively. uNK staining was performed using HRP-conjugated Dolichus biflorus 
agglutinin (Sigma #L1287) at 1:75 dilution, after boiling in 10mM Na-citrate buffer pH 6.0. 
Sections were counterstained with DAPI for immunofluorescence and haematoxylin for 
immunohistochemistry. For RNA in situ hybridization, slides were deparaffinised and 
rehydrated as described above. Linearised plasmids containing cDNA inserts from Plf cDNA 
were used to generate digoxigenin (DIG) labelled probes, using the DIG RNA-labelling kit 
according to the manufacturer’s instructions (Roche 11277073910). In situ hybridisation was 
performed overnight at 52oC using, and signals were detected using an anti-DIG-alkaline 
phosphatase conjugated antibody (Roche). Staining was carried out overnight using NBT and 
BCIP reagants (Promega S3771). Sections were counterstained with nuclear fast red (Sigma 
N3020). 
2.4 DNA and RNA isolation 
 
RNA and DNA from tissues were isolated simultaneously using the Allprep DNA/RNA Mini Kit 
(Qiagen 80204), following the manufacturer’s instructions. DNA and RNA concentration was 
measured on a Nanodrop and run on a 2% agarose gel to determine quality. RNA from cells 
was isolated using Tri reagent (Sigma T9424), following the manufacturer’s instructions. 
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2.5 RT-qPCR expression analysis 
 
0.5μg of purified RNA from the decidua and trophoblast portion of each placenta was pooled 
to make 1μg of RNA. RNA was reverse transcribed using a mixture of random hexamer 
(Thermo Scientific EP0451), and oligodT18 primers (Fermentas S0132) at 0.2 and 0.5μg/ml 
respectively, incubated for 5 mins at 70oC, followed by cDNA synthesis at 42oC for 90 mins, 
resulting cDNA was diluted 1:30 in H20. RT-qPCR was performed using SYBR green Jump Start 
Taq Ready mix (Sigma 4438) and run on a Bio-Rad CFX96 or CFX384 thermocycler, using 
gene-specific intron-flanking primers. Gene expression analysis was performed on samples in 
triplicate, and Ct values normalised to Sdha as a housekeeping gene. Where appropriate, 
student’s t-test was performed to calculate statistical significance of differential gene 
expression (p<0.05). 
2.6 RNA sequencing 
 
For RNA-seq of E11.5 trophoblast and decidua, and E3.5 uteri, the mRNA fraction was 
isolated form 350ng total RNA using the Dynabeads mRNA purification kit (Life Technologies 
61006). Indexed, strand specific libraries were generated using the ScriptSeq V2 RNA-Library 
preparation kit (Epicentre SSV21106) per manufacturer’s instructions, and purified using 
Agencourt AMPure XP beads (Beckman Coulter A63881). 
For RNA-seq of uterine stromal cells, the mRNA fraction was isolated from 350ng 
total RNA, and indexed, strand specific libraries were generated using the Agilent SureSelect 
Strand Specific RNA Library kit (Agilent G9691A) per manufacturer’s instructions, and 
purified using Agencourt AMPure XP beads (Beckman Coulter A63881). 
Libraries were quantified and assessed for quality using both the BioAnalyzer 2100 
System (Agilent), and KAPA Library Quantification Kit (KAPA Biosystems KK4824). Indexed 
libraries were pooled and sequenced on an Illumina HiSeq2500 sequencer, using a 100bp 
single-end protocol. Raw fastq data were mapped to the Mus musculus GRCm38 genome 
assembly using TopHat v2.0.12. 
2.7 Methylated DNA immunoprecipitation sequencing 
 
DNA was purified using Allprep DNA/RNA Mini Kit (Qiagen 80204). 3μg of DNA was sonicated 
into fragments between 200-700bp using a BioRuptor (Diagenode), and quantified on a 
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Nanodrop before running on a 1% agarose gel to confirm fragment size. DNA libraries were 
prepared using the NEBNext DNA Library Prep Master Mix Set for Illumina (New England 
BioLabs E6040L), following the manufacturer’s instructions with some modifications. Briefly, 
1.5μg of sonicated DNA was used in the end repair reaction and incubated at 20oC for 30 
mins, before purification with Agencourt AMPure XP beads (Beckman Coulter A63881), 
without elution of DNA from the beads. End repair was followed by the dA-tailing reaction, 
incubated at 37 oC for 30 mins. 20% PEG 8000 in 1.35M NaCl was then added to bind DNA to 
the beads, before washing with 80% ethanol. Adaptor ligation was then performed for 15 
mins at 20 oC using Illumina paired-end adaptors at a final concentration of 1.5μM. Again, 
PEG 8000 was added to the beads to allow washing, before eluting in warm EB.  
Methylated DNA immunoprecipitation (MeDIP) was performed on the resulting DNA 
libraries to isolate only methylated DNA fragments. Three immunoprecipitations (IPs) were 
performed per sample, each using 500ng of library DNA, plus an input sample of 500ng. IP 
samples were denatured at 99 oC before incubation with 1.25μl of 5mC antibody 
(Eurogentec BI-MECY-0100) for 2 hours at 4 oC, and then for a further 2 hours with pre-
blocked Dynabeads M-280 Sheep anti-mouse IgG (Invitrogen 112-01D). Beads were washed 
3x and treated with proteinase K for 30 mins, and the 3 IP samples were pooled before 
purification with MinElute PCR purification kit (Qiagen 28004). IP efficiency was analysed by 
qPCR of known methylated and unmethylated regions. Purified, immunoprecipitated library 
DNA was amplified according to the NEBNext DNA Library Prep Kit instructions, using PE PCR 
primer 1.0, and an iPCR tag primer both at 10nM, to generate indexed MeDIP-sequencing 
libraries. Libraries were purified using QIAquick PCR Purification kit (Qiagen 28104) before 
size selection either by gel extraction or using AMPure beads. For gel extraction, MeDIP 
libraries were run on a 2% agarose gel and cutting a band between 200-500bp before 
purifying using QIAquickGel Extraction kit (Qiagen 28704). For AMPure bead double size 
selection, libraries were incubated for 10 minutes with 0.6x volume of beads, and the 
supernatant retained and incubated with 0.45x total volume of beads for 10 minutes, before 
washing with 80% EtOH and eluting in nuclease free H2O (Qiagen 129114). Libraries were 
quantified and assessed for quality using both the BioAnalyzer 2100 System (Agilent), and 
KAPA Library Quantification Kit (KAPA Biosystems KK4824). Indexed libraries were pooled 
and sequenced on an Illumina HiSeq2500 sequencer, using a 50bp paired-end protocol. Raw 
fastq data were mapped to the Mus musculus GRCm38 genome assembly using Bowtie2. 
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2.8 Native histone chromatin immunoprecipitation sequencing (ChIP) 
 
2.8.1 Chromatin isolation and digestion 
Histone ChIP was performed pellets of 200,00 uterine stromal cells isolated from E3.5 uteri 
from young (n=3) and aged (n=3) mice as described in section 2.11, and snap frozen in 
passage 3-4. Frozen pellets were resuspended in 10mM Tris pH7.5, 10mM NaCl, 3mM MgCl2, 
1mM CaCl2, 0.4% NP-40, before separating into 3 equal fractions. All buffers were treated 
with protease inhibitors (Roche 5056489001) to prevent the degradation of histones. 
Chromatin was digested with MNase (Sigma N5386-200UN) at 1x, 1/2x and 1/4x 
concentration, for 8 minutes at 37oC. The digest was quenched on ice with EDTA to a final 
concentration of 10mM, before centrifuging at 2,500g at 4 oC. The supernatant (S1) was 
isolated, and the pellet resuspended in 10mM Tris pH7.5, 10mM NaCl, 3mM MgCl2, 0.25mM 
EDTA, 0.4% NP-40, and incubated on ice for 15 minutes. The resuspended pellet was passed 
4 times through a 20 gauge needle and 4 times through a 25 gauge needle, before 
centrifuging at 10,000g for 10 minutes a 4oC, and combining the supernatant (S2) with S1. 
NaCl concentration was raised to 150mM before incubating on ice for 20 minutes and 
centrifuging at 10,000g for 15 minutes and retaining the supernatant. 20µl of chromatin was 
taken and DNA was purified using the Qiaquick PCR purification kit (Qiagen 28106) and run 
on the Agilent BioAnalyzer 2500 to confirm the extent of chromatin digestion. Chromatin 
from digests at 1x, 1/2x, and 1/4x concentration were pooled at this point. 
2.8.2 ChIP 
The digested chromatin was diluted to a final volume of 800µl per ChIP. 20µl of Dynabeads 
Protein A for Immunoprecipitation beads (Dynabeads 10001D) per ChIP were washed 3x 
with 10mM Tris pH7.4, 50mM NaCl, 5mM EDTA, and 10µl of beads were added to 800µl of 
chromatin and 1µg of rabbit IgG (Santa Cruz Biotechnology sc-2027X) and rotated for 2 
hours at 4oC to preclear chromatin. Beads were discarded and 10% of chromatin was taken 
for input, before adding 0.25µg of H3K4me3 (Abcam ab1791) or rabbit IgG (Santa Cruz 
Biotechnology sc-2027X) to precleared chromatin, and rotating overnight at 4oc. 10µl of 
prewashed Protein A beads were added to each ChIP, and rotated for 4 hours at 4oC. After 4 
hours beads were washed 5 times in ice cold NChIP buffer, then resuspended in NChIP + 1% 
SDS at room temperature for 15 minutes, and treated with TE buffer pH6.5 and proteinase K 
for 30 minutes at 45oC. Input and ChIP samples were purified using the Qiaquick PCR 
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purification kit. qPCR was performed for regions known to be enriched or depleted for 
H3K4me3 and K3K9me3 to check efficiency of the pull down. 
2.8.3 ChIP-seq library preparation 
DNA libraries were generated from H3K4me3, H3K9me3, and input DNA, using the NEBNext 
Ultra II DNA library prep kit (Illumina E7645), following the manufacturer’s instructions. 
Libraries were purified, and double size selected in the same way as MeDIP libraries using 
Agencourt AMPure XP beads (Beckman Coulter A63881). Size selected libraries were 
amplified using NEBNext Ultra II kit, and Sanger 8 base pair indexed oligos: 10µM PE1.0 
primer and 10µM iPCR tag, using the programme 98oC for 30s, 12-15 cycles of 98oC for 10s, 
65oC for 75s, followed by final extension at 65oC for 5 minutes. ChIP libraries were purified 
with AMPure XP beads. Libraries were quantified and assessed for quality using both the 
BioAnalyzer 2100 System (Agilent), and KAPA Library Quantification Kit (KAPA Biosystems 
KK4824). Indexed libraries were pooled and sequenced on an Illumina HiSeq2500 sequencer, 
using a 50bp paired-end protocol. Raw fastq data were mapped to the Mus musculus 
GRCm38 genome assembly using Bowtie 2. 
2.9 Sequencing of amplicon targets from bisulphite treated DNA 
 
1µg of DNA was bisulphite treated using the EpiTect Bisulphite Kit (Qiagen 59104) according 
to the manufacturer’s instructions. Primers were designed to differentially methylated 
regions identified by MeDIP-seq, and used to amplify 30ng BS treated DNA with HiFi HotStart 
Uracil+ Readymix (Kapa Biosystems KK2801). PCR products were purified with Agencourt 
AMPure XP beads (Beckman Coulter A63881). Multiple products pooled together for each 
sample, and amplified a second time using a Sanger 8 base pair indexed oligos, and HiFi 
Hotstart Readymix (Kapa Biosystems KK2601). Libraries were quantified and assessed for 
quality using both the BioAnalyzer 2100 System (Agilent), and KAPA Library Quantification 
Kit (KAPA Biosystems KK4824). Indexed libraries were pooled and sequenced on an Illumina 
MiSeq sequencer, using a 150bp paired-end protocol. Raw fastq data was mapped to the 
Mus musuclus GRCm38 genome assembly and methylation calls generated using the Bismark 
tool (Babraham Bioinformatics). 
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2.10 Bioinformatic analysis 
 
Raw next generation sequencing data was processed and mapped by the Bioinformatics 
facility at The Babraham Institute. 
2.10.1 RNA-seq analysis 
RNA-seq data was visualised and quantitated at the mRNA level using the RNA-seq 
quantitation pipeline in SeqMonk software (http://www.bioinformatics.babraham.ac.uk), 
and normalised according to total read count (reads per kilobase of transcript per million 
mapped reads, RPKM), and 75% distribution if necessary. Differential expression was 
calculated using DESeq2 (Love et al., 2014) and the intensity difference filter in SeqMonk, 
with a p value threshold of 0.05 and adjusted for multiple testing correction using the 
Benjamini-Hochberg method. Gene lists used for analysis were either stringent with the 
gene called by both methods, or less stringent with differential expressed called by either or 
both methods.  
Heatmaps were generated using Heatmap.2 in R. Principal component analysis was 
performed using DESeq2 rlog-normalised RNA-seq data on read counts using the top 500 
most variable genes, before plotting the principal component analysis using prcomp in R.  
For the analysis of gene proximity to Pgr and Esr1 binding elements, I first 
determined the cohort of differentially expressed genes between young and aged deciduas 
using DESeq2 and intensity difference in SeqMonk. Proximity of these genes to Pgr and Esr1 
binding sites was determined using published data, available in NCBI GEO dataset accession 
numbers GSE34927 and GSE36455 in bed format, using a distance cut-off of 10 kb. 
Differentially expressed genes were split into up-regulated and down-regulated genes, which 
were analysed separately. Statistical significance of the overlap was calculated by Fisher’s 
exact test in R. 
2.10.2 MeDIP-seq analysis 
MeDIP-seq data was visualised using Seqmonk software. Differential methylation was 
determined using the MEDIPS package in R (Lienhard 2014), with a window size of 200bp, 
and a bonferroni adjusted p value cut-off of 0.5 for comparisons between young and aged, 
and 0.01 for comparison between E3.5 and E11.5. Enrichment of 5mC in different genomic 
features was determined by calculating the percentage of reads from each library in each 
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feature and dividing it by the percentage of the genome occupied by that feature. This figure 
was log2 transformed to find the log2 relative enrichment, and plotted using ggplot2 in R. 
2.10.3 ChIP-seq analysis 
Peaks were called on bam files from H3K4me3 ChIP-seq libraries using the MACS2 command 
line tool (Feng et al., 2012; Zhang et al., 2008) in broad peak mode with an FDR cutoff of 
0.05, using data from the input library of one young sample as the reference input for all 
samples. ChIP-seq peak data was analysed using the R package DiffBind (Stark and Brown, 
2011) to examine the correlation between samples, and generate consensus peak lists 
containing either peaks present in all young samples (n=3), peaks present in all aged samples 
(n=3), or peaks present in all young and/or all aged samples. H3K4me3 ChIP-seq data was 
visualised in Seqmonk, and reads under MACS2 peaks were quantified and normalised 
according to total read count (reads per kilobase of transcript per million mapped reads, 
RPKM). Peaks containing significantly different levels of H3K4me3 were found using DESeq2 
p<0.05. Further normalisation at the 20th and 90th percentiles in Seqmonk was required to 
correct for variation in the efficiency of H3K4me3 immunoprecipitation, informed by 
measurement of total protein levels of H3K4me3 by Western blot. For analysis of H3K4me3 
peak breadth, peaks overlapping between the young and aged consensus peak lists were 
found using the intersect function in the BEDtools Suite (Quinlan and Hall, 2010). The 
difference in breadth between matched peaks present in young and aged was calculated and 
plotted in R. 
2.10.4 Amplicon bisulphite-seq analysis 
Percentage methylation at each CpG site analysed was extracted in R from coverage files 
produced by the Bismark aligner 
(https://www.bioinformatics.babraham.ac.uk/projects/bismark/). Only CpGs located in the 
MEDIPS window tested for were included. Average DNA methylation at each CpG was 
calculated by finding the mean % methylation, and plotted using ggplot2 in R. 
2.10.5 Heatmap generation 
Median centred heatmaps were generated in R using the Heatmap.2 package. 
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2.10.6 Gene ontology and enrichment analysis 
For identification of enriched terms in RNA-seq data, enrichment was calculated using The 
Database for Annotation Visualisation and Integrated Discovery (DAVID) (Huang da et al., 
2009) (https://david.ncifcrf.gov/), using all genes containing more than 10 reads in the tissue 
of interest as a background. For analysis of regions of interest in bed format including ChIP-
seq and MeDIP-seq data, the Genomic Regions Enrichment of Annotations Tool (GREAT) 
(McLean et al., 2010) (http://great.stanford.edu/public/html/) was used, with the mm10 
genome as a background. In both cases, terms with a Bonferroni adjusted p value > 0.05 
were considered significantly enriched. 
2.10.7 Principal component analysis 
Principal component analysis was performed using DESeq2 rlog-normalised RNA-seq data on 
read counts using the top 500 most variable genes, before plotting the principal component 
analysis using prcomp in R. 
2.10.8 Generation of cell-type specific gene expression signatures 
Gene expression signatures specific to luminal epithelial (LE) cells and uterine stromal cells 
(USCs) were generated using publicly available RNA-seq data from the GEO database, 
generated from LE isolated by laser capture microdissection on day 4 of pregnancy 
(GSE57680), and RNA-seq data from USCs generated as described in sections 2.11 and 2.6. 
LE fastq data was downloaded from the sequence read archive and remapped to the 
GRCm38 genome using Hisat2, for visualisation and analysis in Seqmonk. RNA-seq data was 
normalised to the 75th percentile, and genes specific to the LE were found by differential 
expression (DE) analysis with DESeq2 p<0.05. Genes DE between LE and USCs with a 
difference >4 were selected. These were filtered further by removing any genes in the LE list 
with >10 reads in USC libraries, and removing genes in the USC list with >10 reads in LE 
libraries. 
2.10.9 Microarray analysis 
Acquisition and analysis of microarray data was kindly performed in Dr Francesco DeMayo’s 
lab, USA. Microarrays of uterine RNA samples from conditional ablation of Bmp2, Wnt4, 
Egfr2 and their respective control groups were performed by Genomic and RNA profiling 
Core of Baylor College of Medicine as described previously (Large et al., 2014). Two-tailed t 
test and fold changes were used to define differentially expressed probes. To obtain a non-
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redundant list of significantly altered genes, multiple probe sets for a given gene (when 
present) were averaged. Genes with an absolute fold change of ≥1.4 and a p value of ≤0.01 
were considered for further analysis.  
The overlap between Pgr, Bmp2, Wnt4, and Egfr2 regulated genes identified by 
microarray, and genes dys-regulated in aged E3.5 uteri was calculated. The significance of 
the pairwise overlap between the datasets was then determined by Fisher’s exact test, 
against a background of all genes detected in both RNA-seq and microarray datasets. 
2.10.10 Analysis of motif enrichment 
Enrichment of transcription factor binding motifs in differentially methylated regions (DMRs) 
was determined using the Analysis of Motif Enrichment (AME) tool (McLeay and Bailey, 
2010) in MEME Suite (http://meme-suite.org/). Fasta sequences were extracted from DMRs 
in bed format, using the UCSC Table Browser (https://genome.ucsc.edu/cgi-bin/hgTables), 
masking repeats to N. Repeat masked sequences were run through AME using the 
HOCOMOCO v11 full motif database, with shuffled versions of the input sequences as a 
control. 
2.11 Uterine stromal cell isolation and culture 
 
Uterine stromal cells were isolated as previously described (Afonso et al., 2002), with a few 
modifications. Briefly, uteri from pregnant mice were dissected at E3.5 and slit 
longitudinally. Uteri were incubated with 2.5% pancreatin (Sigma P3293) and 0.5% trypsin 
type III (Sigma T4799) in Hank’s basic salt solution (HBSS)-calcium/magnesium free (Life 
Technologies 55021C) for 1.5h on ice, and vortexed and washed twice in HBSS to remove 
luminal epithelial cells. Uterine stromal cells were isolated by digestion for 20 mins at 37oC, 
with HBSS containing 0.007% collagenase (ThermoFischer Scientific 17104-019), 0.02% 
DNaseI (Roche 10104159001), and 0.008% protease (Sigma P8811), vortexing every 10 
minutes. Dissociated tissues were triturated and passed through a 70µm cell strainer (BD 
Biosciences) and spun at 1000g for 5 mins at 4oC. Cell pellets were resuspended and cultured 
in phenol-red free Dulbecco’s modified Eagle’s medium: Nutrient Mixture F-12 (DMEM/F-12) 
(ThermoFisher Scientific 21041-025) plus 10% foetal bovine serum, 1mM sodium pyruvate 
(ThermoFisher Scientific 11360-039), 1X antimycotic/antibiotic (ThermoFisher Scientific 
#15240-062) and 50 µM 2-mercaptoethanol (ThermoFisher Scientific #31350-010). 
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2.1.1 Proliferation assay 
For analysis of cell proliferation rates, 10,000 uterine stromal cells from young and aged 
mice were plated in either complete DMEM/F12 medium or complete medium containing 
the decidualisation-inducing cocktail (E2 + P4 + cAMP) and collected every 24 h over 4 days. 
After trypsinisation the number of viable cells was counted using the Muse Count & Viability 
Assay Kit (Merck Millipore MCH100102) and run on the Muse cell analyser (Merck Millipore), 
according to manufacturer’s instructions. Statistical analysis was performed using ANOVA 
followed by Holm-Sidak’s post-hoc test. 
2.11.2 In vitro decidualization 
Decidualisation of cultured uterine stromal cells was induced by incubating the cells with 
complete DMEM/F-12 medium plus 10nM β-estradiol (Sigma #E2758), 1µM 
medroxyprogesterone 17-acetate (Sigma #M1629) and 10 µM 8-bromoadenosine 3ʹ,5ʹ-cyclic 
monophosphate (Sigma #B5386) (E2 + P4 + cAMP). The culture medium was changed every 2 
or 3 days with continuous supplementation with these treatments. 
2.11.3 Generation of USC conditioned media and trophoblast stem (TS) cell 
differentiation 
Conditioned medium (CM) was generated by plating mouse embryonic fibroblasts or uterine 
stromal cells from young or aged mice in a 6cm dish, and culturing for 3 days in TS base 
medium. USCs were supplemented with 10nM β-estradiol (Sigma #E2758), 1µM 
medroxyprogesterone 17-acetate (Sigma #M1629) and 10 µM 8-bromoadenosine 3ʹ,5ʹ-cyclic 
monophosphate (Sigma #B5386) (E2 + P4 + cAMP), to induce decidualization. CM was 
collected after 3 days and filtered through a filter unit to remove any cells (Thermo Scientific 
122-0045). For TS cell culture under stem cells conditions, Rosa26 TS cells in passage 70 
were plated in a 12 well plate, and cultured in complete TS medium, consisting of 3/10 TS 
base and 7/10 CM plus 37.5ng/ml bFgf (Stem Cell Institute) and 1µg/ml heparin (Sigma 
Aldrich H3149). After 2 days RNA was collected from TS cells at sub-confluence using Tri 
reagent as described in section 2.4. For TS differentiation, Rosa26 TS cells in a 12 well plate 
were cultured in TS medium consisting of 3/10 TS base and 7/10 CM, without bFgf and 
Heparin, for 3 days and 5 days. TS cells at sub-confluence were then isolated using Tri 
reagent. 
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2.12 Western blotting 
 
Total cell extracts from deciduas were prepared in radioimmunoprecipitation assay buffer 
(20 mM Tris-HCl, pH 8.0, 137 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 10% glycerol, 1% NP-40, 
0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate), or in the case of uterine stromal 
cells, cells were lysed in a detergent buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM 
KCl, 0.5% Nonidet P-40) containing a protease inhibitor cocktail (Sigma P2714), and 
incubated at 4°C for 1 h, followed by centrifugation (9300 × g, 10 min). For H3K4me3, total 
cells or tissues were lysed in 50mM Tris pH6.8, 100mM DTT, 2% SDS, 0.1% bromophenol 
blue, 10% glycerol, and quantified by eye. Western blotting was performed following a 
standard protocol. Blots were probed with the following antibodies: anti-pStat3 (Tyr705) 
(Cell Signaling Technology #9138S), anti-Stat3 (Cell Signaling Technology #12640S), anti-Pgr 
(Dako #A0098), anti-beta-actin (Abcam ab6276), anti-Bmp2 (Peprotech #500-P195), anti-
H3K4me3 (Abcam ab1791), anti-H3 (Abcam ab1791). Horseradish peroxidase-conjugated 
secondary antibodies were from Bio-Rad. Detection was carried out with enhanced 
chemiluminescence reaction (GE Healthcare RPN2209) using standard X-ray films. Band 
intensities were quantified using ImageJ software. 
2.13 Leukocyte flow cytometry analysis 
 
Preparation of single cell suspensions and FACS analysis were performed by Jens Kieckbusch 
(Colucci lab, Cambridge) as per established protocols. Briefly, mesometrial poles of E10.5 
implantation sites were dissected, pooled and minced and tissue homogenates digested 
with Liberase TM (Sigma 05401119001). Cells were typed with fluorochrome-conjugated 
antibodies for CD45 (30-F11), NK1.1 (PK138), CD11b (M1/70), CD49a (HMα1), CD49b (DX5), 
I-A/I-E (M5/114.15.2), Gr-1 (RB6-8C5), F4/80 (BM8), CD11c (N418), CD3ε (145-2C11), NKp46 
(29A1.4) and Eomes (Dan11mag) purchased from BD PharMingen, BioLegend or eBioscience. 
For intracellular and intra-nuclear antigens, Fix & Perm and Foxp3 staining buffer set (both 
eBioscience) were used, respectively. Cells were acquired on an LSRFortessa. 
2.14 Statistical analysis 
 
Statistical analyses including ANOVA and student’s t-test were carried out using Graphpad 
Prism software, unless otherwise stated. Coefficient of variation data was analysed by one 
way ANOVA followed by Tukey’s post-hoc test (performed by AS-P). QPCR and 5mC 
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distribution experiments were analysed by one-way ANOVA followed by Tukey’s post-hoc 
test when more than 2 groups were compared, and by two-tailed t-test when only 2 groups 
were compared (performed by LW). Deciduoma assay was analysed by two-tailed t-test 
(performed by XW). Proliferation assays were analysed by two-way ANOVA followed by 
Holm-Sidak’s multiple comparisons test (performed by AS-P). Western blot data was 
analysed by one-way ANOVA followed by Holm-Bonferroni’s post-hoc test (performed by AS-
P). The significance of overlaps between RNA-seq and microarray data, and between ChIP-
seq and Pgr/Esr1 binding site data were determined by Fisher’s exact test in R. P-value is 
denoted as follows: p<0.05 (*), p<0.01 (**), p<0.001 (***). 
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3.1 Introduction 
 
Advanced maternal age in humans is associated with infertility, an increase in fetal 
developmental abnormalities including fetal growth restriction, and increased risk of a 
spectrum of pregnancy complications known as the “Great Obstetrical Syndromes”. The 
same pattern has been previously described in ageing mice, where maternal age correlates 
with reduced litter size and decreased post-implantation fetal viability (Holinka et al., 1979; 
Talbert, 1971). Embryos from older mothers are also at a significantly increased risk of 
developmental abnormalities including fetal growth restriction, heart and brain 
malformations, and of undergoing fetal resorption (Holinka et al., 1979; Kidd et al., 1993; 
Lean et al., 2017; Lopes et al., 2009). Therefore, ageing mice reflect similar aspects of the 
effects of maternal age on reproductive outcome as those observed in humans. As such they 
seem an adequate model system in which to investigate the fetal developmental 
abnormalities that arise in pregnancies complicated by advanced maternal age, despite the 
known differences in endometrial cycle between both species.  
The reproductive life-span of C57BL/6 (B6) female mice begins at 5-6 weeks of age, 
when they reach sexual maturity (B. Anne Croy, 2013) and enter the mouse reproductive 
cycle, termed the estrous cycle. The B6 estrous cycle is 4-5 days in length, and consists of 4 
stages; proestrus, estrus, metestrus, and diestrus. Estrous cycles tend to become 
unpredictable and less frequent, and to increase in length after 12 months of age (Nelson et 
al., 1982). The B6 reproductive life span is relatively long, and females can often enter 
estrous and achieve pregnancy beyond 12-15 months of age, however the number of viable 
pups per litter decreases as maternal age increases (Patel et al., 2017; Talbert, 1971). 
As mentioned earlier, maternal age-related abnormalities in embryonic development 
and embryo resorption, could be caused either by age-related defects in the maternal 
oocyte, or the uterus. Oocytes obtained from the ovaries of older mice have a significantly 
higher incidence of aneuploidy which reduces the success of blastocyst formation (Merriman 
et al., 2012; Pan et al., 2008). For example, one study found that the proportion of super-
ovulated oocytes which were aneuploid increased from 2.9% in 1 month old mice, to 37.5% 
in 12 month old mice (Merriman et al., 2012). It is however unlikely that developmental 
defects in the offspring of aged mice are entirely caused by aneuploidy in the oocyte, as 
most aneuploidies are not viable and lead to embryonic death and resorption in the early 
stages of pregnancy. The particular developmental defects associated with advanced 
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maternal age - fetal growth restriction, and cardiac and vascular defects - have also been 
linked to abnormal development and function of the placenta (Linask, 2013; Perez-Garcia et 
al., 2018; Salafia et al., 2006). In line with this, a study in 2009 showed that advanced 
maternal age was accompanied by both embryonic defects – cardiac malformations and 
growth restriction – and abnormal placentation (Lopes et al., 2009). In this study, Lopes et al 
analysed the gross morphology of a small number of implantation sites at mid-gestation by 
Haematoxylin and Eosin staining (H&E), reporting that advanced maternal age was 
associated with increased thickness of the TGC layer, and, in a few cases, impaired labyrinth 
formation. This study remained largely superficial, looking only at gross morphological 
defects of the embryo and placenta in a small number of aged pregnancies. Taking this as 
further evidence of the link between advanced maternal age and placental abnormalities, I 
endeavoured in this PhD project to investigate in depth the effect of maternal ageing on 
placental development, and the mechanism giving rise to pregnancy defects. 
 
3.2 Results 
 
3.2.1 Advanced maternal age is associated with abnormal embryo development 
It has long been known that advanced maternal age is accompanied by a decline in fertility 
(Speroff, 1994), however the precise underlying reasons for this have not been elucidated. 
Oocyte numbers stay unaffected up until at least 1 year of age in the mouse, thus not 
contributing to fewer offspring numbers. Therefore, we set out to systematically investigate 
the reproductive decline that is observed in C57BL/6 (B6) females with advanced age. A total 
of 40 pregnancies were assessed in B6 females ranging from 42-52 weeks of age (Fig 3.1a) 
(Table 1) at E11.5. This time point was chosen because mid-gestation (i.e. ~E10.5) is a 
bottleneck for developmental progression in the mouse due to the necessary switch from 
yolk sac nutrition to requiring a functional placenta by this time point. Thus, E11.5 litters 
would reveal the detrimental effects of placental failure.  
The average number of implantation sites at E11.5 (including resorptions) was not 
affected by maternal age (Fig 3.1b), however, significantly more embryos were 
developmentally abnormal in E11.5 litters from aged mothers (“aged litters”) than in those 
from young mothers (“young litters”) (Fig 3.1a, c). 
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While young litters were relatively homogeneous, we observed significant variability in 
terms of developmental progression in aged litters. We also observed frequent 
developmental abnormalities including growth restriction, cardiac edema, vascular defects, 
and brain and neural tube closure defects (Fig 3.1a). To quantify the developmental 
variability, we used crown-rump length measurements as a proxy. This confirmed that aged 
litters are significantly more variable in their development than young litters (Fig 3.1d). 
While some embryos were normal in size and comparable to the developmental stage of 
embryos from young litters, there was an increase in the number of growth-retarded 
embryos, and embryos undergoing resorption in aged litters (Fig 3.1c). On average, aged 
litters contained fewer normal embryos, with a concomitant increase in embryos which 
were abnormal or undergoing resorption (Fig 3.1c). 93.8% of embryos from young litters 
were normal, compared to only 41.6% of those from aged litters. Only 2.1% of embryos from 
young litters displayed gross abnormalities, whereas 37.8% from aged litters were abnormal, 
and the incidence of resorption increased from 4.1% in young litters to 20.5% in aged litters 
(Fig 3.1c, Table 1). 
Whilst developmentally abnormal embryos and resorption sites were commonly seen in 
matings between aged mothers and young stud males; these defects were extremely 
uncommon when young females were mated either with young males, or old males at 52 
weeks of age (Fig 3.1a). This demonstrates that the root of the developmental abnormalities 
in these embryos can be attributed to the aged maternal reproductive system, whereas the 
aged paternal system does not have a clear effect on gross development of the embryo. 
Table 1 – Developmental outcomes of embryos derived from young females (8-12 weeks), aged 
females (42-52 weeks). Figures in brackets are total number of embryos in each category. 
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Figure 3.1 - Congenital abnormalities in litters from old mothers 
a) Gross morphology of embryos at E11.5 of pregnancy in matings between young females (8-
12 weeks) and young males, young females mated with aged males (52 weeks), and aged 
females (42-52 weeks) with young males. Each row represents one litter. Arrowhead points 
to cardiac malformation in the embryo. Scale bars 1mm. (Matings performed by BSU, 
dissection performed by MH). 
b) Number of implantation sites present at E11.5 in litters from matings between young females 
(F) and young males (M), aged females and young males, and young females and aged males, 
including resorptions. Each point represents one litter. Mean +/- S.E.M.. 
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3.2.2 Advanced maternal age is accompanied by abnormal placentation and 
trophoblast differentiation 
 
Interestingly, many of the developmental abnormalities that were associated with advanced 
maternal age, such as fetal growth restriction, developmental retardation and heart and 
brain defects have been shown to be linked to defects in placentation (Linask, 2013; Perez-
Garcia et al., 2018; Salafia et al., 2006). Therefore, we analysed the morphology of each 
placenta from 3 entire aged litters alongside their accompanying embryos, by haematoxylin 
and eosin (H&E) staining (Fig 3.2a), to investigate whether developmental abnormalities of 
the embryo proper correlated with defects in placental development. In every case assessed 
we found that an abnormal embryo was associated with an abnormal placenta, whereas 
embryos that appeared morphologically normal also had grossly normal placentas (Fig 3.2a).  
The extent of placental abnormality appeared to correlate with the severity of the 
embryonic defect. Embryos which were only slightly growth restricted, or presented with 
minor heart or brain defects had placentas with minor abnormalities in size, shape, or 
orientation of the placenta, or a reduced labyrinth compartment. By contrast, those 
embryos which were severely growth restricted or undergoing resorption exhibited a 
dramatically abnormal placental morphology, in particular a severely reduced expansion, or 
complete lack of the labyrinth layer (Fig 3.2a). In situ hybridisation for the TGC marker Prl2c2 
(Plf) was used to demarcate the boundary between fetal trophoblast and the maternal 
decidua (Fig 3.2a). This staining highlighted the variability in size reduction of the fetal 
labyrinth compartment in conceptuses of varying abnormality, as well as indicating a 
disproportionate overabundance of TGCs in relation to the remaining trophoblast 
c) Pie charts showing the mean percentage of embryos in litters from young mothers and aged 
mothers which are morphologically normal, abnormal, or undergoing resorption at E11.5 of 
pregnancy. 
d) Dot plot showing developmental variability within litters from young and aged mothers at, 
displayed as coefficient of variation. Fully resorbed sites were omitted. Coefficient of 
variation was calculated from crown-rump length measurements of each embryo in a litter at 
E11.5, each point represents the coefficient of variation in one entire litter. Statistical 
analysis was by ANOVA followed by Tukey’s multiple comparisons post-hoc test, performed 
by AS-P. 
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compartment in severely abnormal conceptuses. These age-related defects in trophoblast 
development prompted me to further characterise the progression of differentiation of the 
various trophoblast cell types in the aged placenta by RT-qPCR. Placentas were designated as 
young (Y, n=3), aged normal (An, n=3), or aged abnormal (Aa, n=3), determined by the gross 
morphology of the placenta and associated embryo, and were separated into these groups 
for analysis. Aa placentas showed significantly increased expression of the trophoblast stem 
(TS) cell marker Eomes. Esrrb, and Elf5 were also increased, but did not reach significance 
(Fig 3.2b). This was accompanied by downregulation of the intermediate 
trophoblast/spongiotrophoblast (SpT) and syncytiotrophoblast (SynT) markers Tpbpa and 
Synb. The expression of TGC marker Prl2c2 (Plf) was increased with age although this did not 
reach significance. Overall, the expression of TGC markers was increased and more variable 
in Aa trophoblast (Fig 3.2b). Interestingly, An trophoblast also exhibited differences in 
trophoblast marker expression, albeit to a lesser extent than trophoblast from Aa 
conceptuses (Fig 3.2b). This suggests that all placentas from aged mothers experience some 
level of de-regulated trophoblast differentiation, even if trophoblast abnormalities were not 
overtly obvious by gross morphological appearance.  
As discussed in Chapter 1 (Fig 1.6), trophoblast differentiation can progress down 
two major routes, allowing TS cells to become either SynT which makes up the majority of 
the labyrinth, or towards the SpT and TGC lineages. Differentiation down these routes 
behaves antagonistically. In the case of aged females, preferential differentiation down the 
TGC route comes at the expense of the alternative SynT pathway (Fig 3.2c). This failure of 
SynT differentiation reflects the morphologically clear deficit in labyrinth formation with 
advanced maternal age. Failing labyrinth development likely underpins the observed 
embryonic developmental defects, particularly fetal growth restriction, as the labyrinth layer 
is responsible for all nutrient and gas exchange at the feto-maternal interface. 
Not only were lineage markers differentially expressed in trophoblast from aged 
pregnancies, some were also considerably more variable, indicating that the morphological 
variability in placental development is reflected at the molecular level (Fig 3.2a, b). 
Interestingly, the TS cell markers Eomes, Esrrb, and Elf5 were up-regulated, while another TS 
marker Cdx2 tended to be down-regulated in Aa trophoblast (Fig 3.2b). Cells expressing 
these markers are unlikely to be true TS cells at this time, as TS cells can only 
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be derived from extra-embryonic tissues up to E8.5 of development (Tanaka et al., 1998; Uy 
et al., 2002). However, Eomes-positive cell clusters are retained in the placenta until post-
mid-gestation (Wu et al., 2003). Hence it is possible that the up-regulation of markers 
commonly regarded as “stem cell” genes reflects a failure of trophoblast progenitor cells to 
differentiate at normal rates and in the correct temporal dynamics.  
 I confirmed the dysregulation of trophoblast marker expression in aged placentas by 
RNA-sequencing (RNA-seq) analysis, showing upregulation of TS cell and TGC markers, 
accompanied by downregulation of SpT and SynT markers (Fig 3.2d). There were slight 
differences in expression patterns between the 2 methods, which may be due to differences 
in sample preparation. RNA-seq was performed on RNA extracted from the fetal part of the 
placenta only, with the decidua dissected away, whereas RT-qPCRs were performed on RNA 
from whole placentas consisting of both fetal and maternal portions.  
The RNA-seq data also portrayed a global picture of the trophoblast transcriptome at 
E11.5. Young control trophoblast samples were obtained from 8 week old mothers (n=3). In 
Figure 3.2 - Placental abnormalities in litters from old mothers 
a) Gross morphology of embryos and their accompanying placentas in one entire litter from an 
aged mother at E11.5. Placentas in the LH column were stained with Haemotoxylin and 
Eosin, dotted line demarcates the junction between trophoblast and decidua. Placentas in 
the RH column were stained by immunohistochemistry for Prl2c2 (Plf) mRNA. Arrowhead 
indicates defect in forebrain development. Arrow indicates skewed direction of 
implantation. (Matings performed by BSU, dissection and histology performed by MH, and 
LW). 
b) Boxplots showing relative expression of trophoblast lineage markers in trophoblast from 
young mothers (n=3), aged mothers where the embryo was grossly normal (An, n=6) or 
abnormal (Aa, n=6) (all mated to young males). *p<0.05, **p<0.01, *** p<0.001. Statistical 
analysis was by one-way ANOVA, followed by Tukey’s multiple comparisons post-hoc test. 
Error bars are S.E.M. 
c) Model of trophoblast differentiation defects in aged pregnancies. Colour of boxes indicates 
the direction of gene dysregulation as found by RT-qPCR or RNA-seq, green = up-regulated 
in aged, red = downregulated in aged. 
d) Heatmap showing expression of trophoblast lineage markers in E11.5 trophoblast from 
young, aged normal (An), and aged abnormal (Aa) pregnancies. Colour of gene name 
indicates the trophoblast cell type it is expressed by. An and Aa females were aged between 
43-47 weeks.  
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order to capture the differences between morphologically normal and abnormal 
conceptuses, pairs of samples were taken from 5 pregnancies in 43-47 week old mothers, 
where one littermate was morphologically normal (An, n = 5), and the other abnormal (Aa, n 
= 5). Principal component analysis (PCA) showed that the samples cluster into 2 main 
groups, with young and An trophoblast clustering closely together, while Aa samples lie 
considerably removed along PC1 which represents the largest proportion of the variation 
between the datasets (Fig 3.3a).  
DESeq2 and the intensity difference filter in SeqMonk were applied to identify genes 
which were strongly and consistently differentially expressed in Aa trophoblast. I focussed 
on the differences between young and Aa samples, as PCA analysis suggested that this is 
where the most striking differences would be found. This stringent approach identified 42 
genes that were differentially expressed with age, 21 of which were up-regulated and 21 
down-regulated in trophoblast from aged females (Fig 3.3b) (Appendix, Supplementary table 
1). Notably, this list included a number of placenta specific genes, including those in the 
prolactin family, as well as pregnancy-specific glycoproteins (Psg), carcinoembryonic 
antigen-related cell adhesion molecules (Ceacam), and cathepsins (Cts) (Fig 3.3b). Syncytin b 
(Synb) was significantly down-regulated in trophoblast from aged mothers, confirming the 
RT-qPCR results (Fig 3.3b, Fig 3.2b). Gene ontology (GO) analysis performed on all 
differentially expressed genes (i.e. differentially expressed by either DESeq2 p<0.05, or 
intensity difference p<0.05) showed that maternal age-related genes were enriched for 
terms relating generally to pregnancy, and hormones, as well as several functions and 
properties of TGCs, such as collagen degradation, focal adhesions, and positive regulation of 
angiogenesis (Fig 3.3c) (Hemberger et al., 2003; Katz, 1995; Parast et al., 2001). This list was 
also significantly enriched for genes involved in positive regulation of the Erk signalling 
pathway, which maintains the expression of key transcription factors in TS cells (Latos et al., 
2015) (Fig 3.3c). These results add weight to the finding that trophoblast development is 
perturbed in aged pregnancies, characterised by abnormal gross morphology of the 
trophoblast, and abnormal maintenance of TS marker expression. This is coupled with 
preferential differentiation of the remaining cells to the TGC lineage at the expense of SynT, 
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confirming maternal age-related restriction of the labyrinth on a morphological and 
molecular level (Fig 3.2c). 
Fig 3.3 - RNA-seq analysis of E11.5 trophoblast from young and aged pregnancies 
a) Principal component analysis (PCA) of RNA-seq data from E11.5 trophoblast in young (Y), 
aged normal (An) and aged abnormal (Aa) pregnancies. Each point represents one samples. 
b) Heatmap showing expression of 42 genes which are significantly differentially expressed 
between young and Aa trophoblast. Differentially expressed genes were identified by both 
DESeq2 (p<0.05) and intensity difference (p<0.05). 
c) Gene ontology annotations enriched in genes differentially expressed between young and Aa 
trophoblast (Bonferroni p<0.05). Differentially expressed genes were identified by either 
DESeq2 (p<0.05) and intensity difference (p<0.05). 
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Genes which were differentially expressed between young and Aa trophoblast were 
also dys-regulated - albeit to a lesser extent - in An placentas, despite their grossly normal 
appearance on the morphological level (Fig 3.3b). Interestingly this subtle transcriptional de-
regulation was only seen in trophoblast from mothers aged 45 weeks or more, and not in 
those aged 43 weeks. This suggests that the impact of advanced maternal age on 
trophoblast gene expression in normal conceptuses changes rather dramatically between 
43-45 weeks of age. 
This observation indicates that in pregnancies with females aged 45 weeks and over, 
all conceptuses exhibit perturbations in trophoblast gene expression. However, this only 
leads to developmental abnormalities of the embryo and placenta in a subset of cases when 
analysed by H&E staining and in situ hybridisation for the TGC marker Prl2c2 (Fig 3.2a). It 
may be that some conceptuses are able compensate for the effects of advanced maternal 
age and are therefore less susceptible to developmental abnormalities. Alternatively, it is 
also possible that more subtle defects are present which cannot be detected by gross 
morphological analysis alone, or that embryos which are normal at E11.5 will go on to 
develop abnormalities later in gestation. I next compared An versus Aa trophoblast in order 
to identify differentially expressed genes which may reflect adaptations of the trophoblast 
to pregnancy in advanced maternal age in An trophoblast. This identified 29 differentially 
expressed genes which were dys-regulated in An trophoblast from 45-47 week old mothers, 
compared to young (Fig 3.3d). However, all the genes which were differentially expressed 
between young and An trophoblast were also dys-regulated in Aa samples (Fig 3.3d), 
suggesting these genes are differentially expressed as a result of abnormal trophoblast 
development and not due to adaptations which promote normal development in An 
conceptuses. 
 
 
d) Heatmap showing genes significantly differentially expressed between An and Aa 
trophoblast. Differentially expressed genes were identified by both DESeq2 (p<0.05) and 
intensity difference (p<0.05). 
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3.2.3 The aged maternal environment underlies reproductive decline in 
advanced maternal age 
 
The above results suggested that high levels of developmental abnormalities, growth 
restriction, and resorptions in aged pregnancies are related to defects in placental 
development. As mentioned previously these defects could occur as a result of age-related 
deterioration of either the oocyte, or the maternal reproductive tract. Although most studies 
have focused on oocyte related defects such as aneuploidy and mitochondrial function, 
some have suggested that the ageing uterus may also play a role (Talbert and Krohn, 1966). 
 In mice, most chromosomal aberrations are incompatible with development to term 
and conceptuses die during early pregnancy. Therefore, aneuploid embryos tend to be 
resorbed in the early stages of pregnancy. In aged pregnancies there were relatively few 
empty implantation sites resulting from early embryonic demise compared to the number of 
more developed embryos, suggesting that the majority of conceptuses from aged litters 
developed beyond this period of early pregnancy (Fig 3.1a). Therefore, it is unlikely that the 
gross morphological defects observed in litters from aged females result from age-related 
karyotypic defects in the oocyte and may instead be attributed to the aged uterine 
environment. To confirm the absence of aneuploidies in the conceptuses analysed in section 
3.2.2, I performed an e-karyotyping analysis as described by (Weissbein et al., 2016) on the 
trophoblast RNA-seq data. This technique is able to detect whole chromosome monosomy 
and trisomy which are commonly observed in aged pregnancies. This suggested that all 
conceptuses analysed from aged pregnancies were karyotypically normal, and therefore any 
observed defects were not due to large scale chromosomal aberrations in the oocyte. This 
analysis may not however detect small scale chromosomal abnormalities, genetic mutations, 
or DNA damage which may affect the offspring of older mothers. 
 We then performed embryo transfer experiments in order to delineate whether the 
maternal age-related defects in embryo and placental development were intrinsic to the 
oocyte, or related to the ability of the aged uterus to support pregnancy. Preimplantation 
blastocysts were isolated from aged mothers at E2.5 and transferred to pseudo pregnant 8-
10 week old ‘young’ recipients (A->Y). Embryos from young mothers were transferred into 
young recipients in parallel, as a control (Y->Y). The A->Y transfer rescued a large proportion 
of the maternal age associated embryonic defects (Fig 3.4a), with striking reductions in the 
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incidence of embryonic defects from 37.8% to 12.2%, and embryo resorption from 20.5% to 
14.6% (Fig 3.4b, Table 2). Placental development also largely returned to normal in A->Y 
transfer conceptuses when compared with the clear variability and gross abnormalities 
observed in those which developed in the uterine environment of aged mothers (Fig 3.4c, 
3.2a). In line with this visual appearance of developmental rescue, the variability in crown-
rump length within each litter was significantly reduced in A->Y transfers compared to aged 
litters, and indeed was not significantly different from Y->Y transfers or young controls (Fig 
3.4d). 
 In 1966, Talbert and Krohn performed similar experiments, transferring embryos 
derived from aged mothers into young recipients, and in line with our findings saw that 
embryos from aged donors were able to successfully develop in a young host uterus. 
However, this study did not analyse placental development in the resulting conceptuses. It 
also failed to take into account the effect of parity, which can impact on embryo survival, 
and fetal and placental weight (Gosden, 1979; Hetherington, 1972), as a number of donor 
and recipient mice had undergone previous pregnancies. The results I have presented build 
on this study, confirming that advanced age of the donor does not preclude successful 
development of the embryo in a young primiparous recipient. My findings provide evidence 
that placental abnormalities in litters from aged mothers are induced by an age-related 
decline of the maternal uterus and not the oocyte. 
Talbert and Krohn also performed the reciprocal experiment transferring young 
donor embryos into aged recipients (Y->A) and found that this induced embryonic defects in 
the resulting litters (Talbert and Krohn, 1966). We did not perform Y->A transfers, as the  
Table 2 – Developmental outcomes of embryos derived from young females (8-12 weeks), 
aged females (42-52 weeks), and embryo transfers. Y->Y, embryos derived from young females 
and transferred to young surrogates. A->Y, embryos derived from aged females and 
transferred to young surrogates. Figures in brackets are total number of embryos in each 
category. 
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 Figure 3.4 - Embryo transfer to a young surrogate rescues embryonic and placental defects 
of embryos from aged mothers. 
a) Gross morphology of embryos at E10.5 after embryo transfer. Embryos were either 
isolated from a young mother and transferred to a young surrogate,or isolated from an 
aged mother and transferred to a young surrogate. Each row represents one litter. 
(Embryo transfer performed by BSU, dissection performed by MH). 
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timing of mating and hence formation of the vaginal plug is extremely unpredictable in aged 
females. Therefore, it is difficult to successfully induce pseudopregnancy in a sufficient 
number of aged females on a given day, which needs to be synchronised with young 
pregnant females, in order to perform embryo transfers. Due to this significant technical 
difficulty, the number of animals required to obtain an appropriate sample size was deemed 
too large to justify this experiment, in light of the principles of the 3Rs (Prescott and Lidster, 
2017). A more recent study by Schulkey et al in 2015 showed convincing evidence that 
transplant of ovarian tissue from young donors to aged recipients led to cardiac 
malformations in the offspring. As mentioned previously, such cardiac defects may in fact be 
secondary to abnormal placental development. This adds further weight to the hypothesis 
that these defects are caused by uterine ageing and not defects in the oocyte (Schulkey et 
al., 2015). 
 In addition to rescuing embryonic development, placental development was also 
grossly normal in conceptuses from A->Y transfer pregnancies (Fig 3.4c). When analysed by 
RT-qPCR and RNA-seq, the trophoblast compartment of A->Y transfers was 
transcriptomically indistinguishable from Y->Y transfers (Fig 3.5a, b). The 42 genes that were 
identified by RNA-seq as dys-regulated in aged trophoblast were not differentially expressed 
between A->Y and Y->Y trophoblast (Fig 3.5c, d). 
b) Pie charts showing the mean proportion of embryos in litters from Y->Y and A->Y transfer 
pregnancies which are morphologically normal, abnormal, or undergoing resorption at E10.5 
of pregnancy. 
c) Gross morphology of embryos and their accompanying placentas from Y->Y and A->Y 
transfer pregnancies. Placentas in the LH column were stained with Haemotoxylin and Eosin, 
dotted line indicates the junction between trophoblast and decidua. Placentas in the RH 
column were stained by IHC for Prl2c2 (Plf) mRNA. (Dissection and histology performed by 
MH and LW). 
d) Dot plot showing developmental variability within litters from young and aged mothers, and 
Y->Y and A->Y transfer pregnancies, fully resorbed sites were omitted. Coefficient of 
variation was calculated from crown-rump length measurements of each embryo in a litter 
at E11.5, each point represents the coefficient of variation in one entire litter. Statistical 
analysis was by ANOVA followed by Tukey’s multiple comparisons post-hoc test, performed 
by AS-P. n.s. = not significant. 
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Figure 3.5 - Trophoblast differentiation defects are rescued in placentas from A->Y transfer 
pregnancies. 
a) Boxplots showing relative expression of trophoblast lineage markers in trophoblast from Y-
>Y (n=4) and A->Y (n=4) transfer pregnancies. Statistical analysis is by two-tailed t-test 
(p<0.05). 
b) PCA analysis of RNA-seq data from Y->Y and A->Y trophoblast at E10.5. 
c) Heatmap showing expression of 42 genes differentially expressed between young and Aa 
trophoblast, in Y->Y and A->Y transfer trophoblast. 
d) Scatter plot showing the expression of all genes in Y->Y and A->Y trophoblast. 42 genes 
differentially expressed between young and Aa trophoblast are highlighted in blue. R = 
Pearson correlation coefficient 
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In addition, no genes were identified as differentially expressed between trophoblast from 
Y->Y and A->Y transfer pregnancies by DESeq2. These results show that blastocysts from 
aged mothers are able to develop into grossly normal conceptuses, with transcriptomically 
normal placentas when allowed to develop in a young maternal environment. Therefore, the 
aged oocyte is not the main cause of gross embryonic and placental defects and 
developmental variability in the offspring of aged female mice. Instead, these data suggest 
that the abnormalities in embryonic and placental development in aged murine pregnancies 
are due to age-related changes in the maternal uterine environment. 
 
3.2.4 Characterisation of aged decidua  
 
Embryo transfer experiments showed that maternal age-related abnormalities in embryonic 
and placental development are not due to the oocyte, but are instead related to the quality 
of the maternal uterine environment. This prompted me to investigate gene expression in 
the decidua, the maternal portion of the placenta which is derived from the pregnant uterus. 
The decidua lies at the feto-maternal interface and is in direct contact with the trophoblast, 
with which it communicates extensively. Therefore, maternal age-related defects in 
trophoblast development may be a result of abnormal decidual function. In order to 
investigate this on a transcriptomic level, RNA-seq libraries were generated from the 
decidua of the same conceptuses analysed by RNA-seq in section 3.2.2. This includes 
deciduas from young mothers (n=6; 3 from the same conceptuses analysed in section 3.2.2 
plus 3 additional controls), and from aged mothers where the accompanying embryo was 
grossly normal (An, n = 5), or abnormal (Aa, n=5). PCA analysis separated deciduas from aged 
pregnancies away from young along PC1, suggesting that they are transcriptomically distinct 
from each other (Fig 3.6a). Some aged samples, however, were more similar to young along 
PC1. These corresponded to deciduas from grossly normal conceptuses developed in aged 
mothers that were 43 weeks of age as opposed to 45 weeks or greater, suggesting that gene 
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expression in the decidua becomes considerably more dys-regulated as the mother gets 
older, similar to observations on the trophoblast side (Fig 3.6a).  
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This is supported by differential expression (DE) analysis, which identified 162 genes 
that were differentially expressed between young and Aa deciduas (Fig 3.6b) (Appendix, 
Supplementary table 2). 78 genes were up-regulated, and 84 genes down-regulated in 
deciduas from older mothers. Gene ontology analysis showed that these genes are related 
to pregnancy and hormones, and are involved in processes important during decidualization 
such as cell proliferation, cell adhesion, collagen binding, heparin binding, and PI3K-Akt 
signalling (Fig 3.6c) (Covarrubias et al., 2015; Fabi et al., 2017; Fluhr et al., 2010; Wang et al., 
2013). Interestingly, dys-regulated genes were also significantly enriched for the terms heart 
development and hypertrophic cardiomyopathy, suggesting that pathways involved in 
cardiac development are shared with decidual genes and may form an underlying basis for 
the link with heart defects in embryos from aged pregnancies. This pattern of gene 
expression was confirmed by RT-qPCR for genes known to be involved in 
Figure 3.6 - Gene expression abnormalities in the decidua during pregnancy in aged females. 
a) PCA analysis of RNA-seq data from deciduas from young and aged pregnancies at E11.5, and 
deciduas in a time-course of development from E9.5-E12.5. 
b) Heatmap showing expression of 162 genes differentially expressed between young and Aa 
deciduas at E11.5. An = aged normal, Aa = aged normal. Young mothers were aged between 
9-11 weeks, and aged mothers between 43-47 weeks. Differentially expressed genes were 
identified by both DESeq (p>0.05), and intensity difference (p<0.05). 
c) Gene ontology annotations enriched in genes differentially expressed between young and 
Aa decidua. Differentially expressed genes were identified by either DESeq2 (p<0.05) and 
intensity difference (p<0.05). 
d) Independent validation of differential expression of key decidualization genes in deciduas 
from young (n=6), An (n=5), and Aa (n=5) pregnancies. Statistical analysis is by one way 
ANOVA followed by Tukey’s post-hoc test. *p<0.05, **p<0.01, ***p<0.001, error bars are 
S.E.M. 
e) Confirmation of higher Bmp2 levels in deciduas from aged females. Protein levels of Bmp2 
in 3 independent replicates of E11.5 deciduas from young, An, and Aa pregnancies by 
western blot. Level of Bmp2 was quantified relative to actin. Statistical analysis was by 
ANOVA with Holm-Bonferroni’s post-hoc test, **p<0.01. (Western blot performed by V P-G, 
statistics performed by A S-P) 
f) Closest neighbour analysis of global transcriptomes generated by RNA-seq, from E11.5 
deciduas from An, and Aa pregnancies from mothers aged 43 weeks, or 45-47 weeks, and 
deciduas from young control females in a time-course of development from E9.5-E12.5 
(red). 
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decidualization and/or expressed in the decidua (Fig 3.6d), such as Bmp2 (Lee et al., 2007; Li 
et al., 2007; Paria et al., 2001), which was also confirmed at the protein level (Fig 3.6e). 
In a similar way to the trophoblast, all deciduas from aged pregnancies that were tested 
exhibited an altered gene expression profile to some extent, even when the associated 
embryo was grossly normal (Fig 3.6a-b). Interestingly, and also similar to the picture in 
trophoblast, An embryos from 43 week old mothers had a less severely abnormal 
transcriptional signature, which lies in between that of young and An 45-47 week/Aa 
deciduas (Fig 3.6b). This suggests that the extent of decidual dysfunction varies between 
implantation sites from the same pregnancy, mirroring the variability that is observed in 
embryo development and trophoblast gene expression. The observation that the 
transcriptomes of decidua and trophoblast associated with normal embryos from 43 week 
old mothers were more similar to young controls, whereas those from 45-47 week old 
mothers were far more abnormal, is interesting. This observation raises the question of 
when in maternal ageing the decline in uterine function begins, and whether it progresses 
gradually or drops off suddenly between 43-45 weeks of age.  
On closer inspection, the transcriptional signature of deciduas from aged pregnancies 
appeared to be reminiscent of an earlier stage of development. For example, in normal 
placentation, Bmp2 expression peaks before mid-gestation and subsequently decreases, 
however its expression is increased in aged decidua compared to that in young samples (Fig 
3.6d-e). A number of genes follow a similar pattern, suggesting that decidual development 
may be delayed in aged females. To explore this further, RNA-seq libraries were generated 
from normal, young deciduas in a time course of development from E9.5-E12.5. The 
expression profiles from E11.5 deciduas developed in young females correlate highly with 
the E11.5 time-course samples by PCA analysis, hierarchical clustering, and in their 
expression of the 162 age-related genes, whereas E11.5 deciduas from aged females 
corresponded more closely to E9.5 and E10.5 time-course samples (Fig 3.6a, f) (Appendix, 
Supplementary figure 1). This suggests that developmental progression of the decidua is 
delayed with advanced maternal age, causing deciduas from aged females to be 
developmentally up to 2 days behind those from young females at E11.5 of pregnancy.  
Interestingly, a number of genes which were differentially expressed with age are 
involved in implantation and endometrial decidualization, processes required for 
development to proceed normally. For example, Bmp2, a critical regulator of decidualization 
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(Lee et al., 2007; Li et al., 2007), was up-regulated in aged deciduas (Fig 3.6d-e). In addition, 
expression of Il15 and its receptor Il15ra which are recruitment factors for uterine natural 
killer (uNK) cells (Ashkar et al., 2003; Barber and Pollard, 2003; Croy et al., 2003) was 
significantly increased (Fig 3.6d), while expression of Csf1, a marker and recruitment factor 
of dendritic cells in the uterus, was decreased (Tagliani et al., 2011) (Fig 3.8d). 
The maternal immune system is thought to play a significant role at the feto-maternal 
interface, and the perturbation of decidual immune cells can affect pregnancy. uNK cells are 
particularly important during mouse pregnancy, although their precise function is 
controversial as knockout models show variable phenotypes (Croy et al., 2003). Most 
consistently, uNK deficient models show that their absence leads to a deficit in the decidual 
bed characterized by hypocellularity and edema, and deficient spiral artery remodelling 
(Ashkar et al., 2000; Guimond et al., 1997). When analysed by Dolichos Biflorus Agglutinin 
(DBA) staining which marks uNK cells, there was no appreciable difference in the number 
and distribution of uNK cells in the young and aged decidua (Appendix, Supplementary 
figure 2).  
To investigate this specialized immune cell type further, we utilised flow cytometry as a 
more sensitive and quantitative method to measure the composition of the immune cell 
population in the decidua at E10.5. Gating strategies separated decidual immune cells into 
the myeloid and lymphoid lineages, followed by further delineation into macrophages and 
dendritic cells, and into conventional CD49- and tissue resident CD49+ uNK cell subsets 
respectively (Fig 3.7 a, e). The absolute number of leukocytes per implantation site was 
significantly decreased in aged pregnancies, due to a decrease in the numbers of dendritic 
cells and macrophages, accompanied by decreased expression of the dendritic cell 
recruitment factor Csf1 in aged deciduas (Fig 3.7b-d). In line with previous reports, the 
absolute number of NK cells, and the proportion of mature CD11b+ NK cells in the spleen of 
aged pregnant females was significantly decreased (Fig 3.7g) (Guo et al., 2014). However, 
this effect was not present in the uterus where the absolute number of uNK cells per 
implantation site was not significantly different between young and aged pregnancies (Fig 
3.7f). The maturation of uNK cells was similarly unaffected, as was the proportion of uNK 
cells falling into the tissue-resident CD49a+ and conventional CD49a- subsets (Fig 3.7f). 
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These results showed that uNK cells, the largest immune cell population in the decidua, were 
unaffected by advanced maternal age, whereas, dendritic cells and macrophages were 
decreased in number 
 
3.3 Discussion 
 
In this chapter, I have characterised the defects that occur during pregnancy in aged B6 
females, and show that the majority of these defects arise as a result of abnormal 
placentation, mediated by an aged maternal uterine environment. A previous study by Lopes 
et al reported that advanced age in B6 females correlates with the development of gross 
morphological abnormalities of the embryo and placenta (Lopes et al., 2009), although this 
study lacked in-depth characterisation of placental defects. The data I have presented 
corroborate the observation that advanced maternal age is accompanied by defective 
embryonic and placental development, and for the first time characterized age-related 
abnormalities in the placenta in detail, at the transcriptomic level.  
Figure 3.7 - Altered leukocyte composition in the aged decidua at mid-gestation.  
Flow cytometry and analysis performed by JK (Colucci lab, Cambridge) 
a) Flow cytometry analysis of decidual leukocytes: gating strategy showing delineation 
of decidual cells into macrophages and dendritic cells. DC, dendritic cells. 
b) Absolute number of leukocytes measured per implantation site. 
c) Absolute numbers of DCs and macrophages per implantation site. 
d) Expression levels of Csf1, a cytokine involved in DC maturation, determined by RNA-
seq. Displayed by normalised read counts of young (Y, n = 9) and aged (A, n = 10) 
independent replicates. 
e) Gating strategy used to delineate uNK (uterine natural killer) cells into resident 
CD49a+ and conventional CD49a- subsets. 
f) Absolute number of uNK cells per implantation site, and relative abundance of tissue-
resident and conventional subsets, as well as frequency of mature CD11b+ uNK cells. 
g) Numbers and maturation of peripheral splenic NK cells in pregnant females. Each 
data point in b, c, f, and g represents an entire litter of one pregnant mouse, values in 
f) are means +/- SEM. 
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While maternal age dramatically affected gross embryonic and placental 
development, I found that there was no clear impact of paternal age in matings between 
young females and 12 month old males. This is in line with previous reports that advanced 
paternal age in rodents does not contribute to congenital malformations in the offspring 
(Parkening et al., 1988; Serre and Robaire, 1998). However, these studies found that 
paternal age of 24 months was associated with poor semen and sperm quality in C57BL/6 
males, and pre-implantation loss, decreased fetal weight, and neonatal death in litters sired 
by male Brown Norway rats, suggesting that while 12 month old fathers do not adversely 
affect embryo development, there may be an effect when even older males are used. 
In line with Lopes and colleagues, I found that embryonic defects were associated 
with abnormal placental development in pregnancies from aged females, as shown by the 
co-occurrence of embryonic and placental abnormalities. The observation that the severity 
of embryonic defects is paralleled by the severity in placental abnormalities also supports 
this idea, i.e. the most severe embryonic phenotypes were accompanied by very abnormal 
placentas. Less severely abnormal embryos had mild placental defects, and normal embryos 
were accompanied by grossly normal placentas. The main placental abnormality observed 
was a restriction of the labyrinth trophoblast compartment, and an relative overabundance 
of TGCs, as suggested previously by Lopes et al., 2009. I have confirmed this observation on 
the transcriptional level by both RT-qPCR and RNA-seq, showing that differentiation to the 
various trophoblast lineages is altered in placentas from aged pregnancies. This analysis 
shows that key TS cell markers Esrrb, Eomes, and Elf5 are up-regulated in aged placentas at 
E11.5. Expression of these markers rapidly decreases on TS cell differentiation in vitro. 
Therefore, their persistence in aged placentas may reflect the continued presence of a 
population of trophoblast progenitor cells, although they are unlikely to be true TS cells at 
this stage of pregnancy (Tanaka et al., 1998; Uy et al., 2002). Maintenance of TS marker 
expression in aged trophoblast suggests a failure to properly exit the stem cell state and 
specify the various trophoblast lineages. Indeed, trophoblast from aged females expressed 
low levels of SynT and SpT markers at mid-gestation, indicating poor differentiation to these 
cell types. This is accompanied by over-representation of TGC lineage markers, and relative 
overabundance of TGCs themselves in the trophoblast compartment. 
 Trophoblast developing from the aged blastocyst is intrinsically normal, and 
indistinguishable from young counterparts when allowed to develop in a young maternal 
environment. It would be interesting to confirm this by derivation of TS cells from the aged 
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blastocyst to establish whether any changes that originate in the older oocyte, either genetic 
or epigenetic, have some minor impact on trophoblast proliferation or differentiation. It is 
also interesting to note that I detected gene expression changes in all aged samples 
including those in which the placenta and the embryo were seemingly normal, albeit these 
changes were much less pronounced in the An compared to the Aa group. This finding may 
be explained by (a) minor abnormalities that were not obvious by assessment of gross 
morphology and histology, (b) the possibility that sub-threshold mRNA expression changes 
have no overt effect on protein levels and/or on instructing trophoblast differentiation, or 
(c) that these placentas are prone to more obvious failure later on during development. This 
latter point is indeed supported by a recent study which shows that late fetal death up to 
E17.5 occurs more commonly in aged pregnancies, although this does not occur in every 
case as a number of fetuses remain viable at E17.5 (Lean et al., 2017). 
One of the most interesting observations originating from this work is the striking 
developmental variability that exists within aged litters. Within a single litter the entire 
range of developmental outcomes was present, from normality, through mild to severe 
growth restriction, brain defects, and cardiac malformations, to complete embryo 
resorption. How is it that within a single litter, this entire range of abnormalities can be 
found? As I have shown, aged blastocysts are able to develop normally when transferred to 
a young surrogate mother, and therefore these defects must occur from a deficiency of the 
maternal environment during pregnancy. It does not seem likely that circulating steroid 
hormone levels are to blame - although ageing is accompanied by altered hormone levels - 
as they would be similar across all implantation sites, and a previous study found no 
correlation between plasma progesterone and the number of viable fetuses in litters from 
aged females (Holinka et al., 1979). It is possible that there are positional variations in the 
quality of the aged endometrium which may affect placentation at those sites, and this will 
be further investigated in Chapter 4. Another possibility is that some embryos are better 
able to adapt to age-related changes in decidual function than others, allowing the most 
adaptable to flourish whilst those that cannot adapt are resorbed, or develop abnormalities 
due to impaired placental development. If this was the case, then An trophoblast may 
exhibit beneficial adaptations in gene expression, which may be attributed to genes which 
are differentially expressed between An and Aa trophoblast and not between young and An. 
I could find no evidence of this in my RNA-seq data, however this hypothesis could be tested 
by co-culturing individual blastocysts in vitro with uterine stromal cells isolated from aged 
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females to measure the variation in their response to the aged uterine environment, as 
described by Teklenburg et al., in the context of recurrent pregnancy loss (Teklenburg et al., 
2010). 
However, the key data presented in this chapter highlight that the core failure in 
reproductive success in older female B6 mice resides with the mother, not the oocyte. This 
observation is strongly supported by several previous studies even if they did not investigate 
at the time how this comes to pass. Studies in the 1960s and ‘70s showed that the 
development of uterine deciduoma in response to mechanical stimulation of the 
endometrium is impaired in aged mice. This was one of the first suggestions that ageing of 
the uterus contributes to reproductive decline with advanced maternal age (Finn, 1966; 
Holinka and Finch, 1977; Shapiro and Talbert, 1974). Building on this, embryo transfer 
experiments showed that whilst the young uterus is able to support development of 
embryos from old donors (which my data confirm), transplants of young embryos to old 
recipient mothers are less successful (Talbert and Krohn, 1966). This study did not take into 
account the effect of parity on reproductive ageing, and both primiparous and multiparous 
mothers were used, potentially confounding the effect of maternal age (Baser et al., 2013; 
Gosden, 1979; Kalogiannidis et al., 2011). Although these studies highlighted the role of the 
uterus in reproductive ageing, no effort has since been made to fully characterise, and 
mechanistically unravel the basis of uterine ageing. 
My data show that maternal ageing leads to major disturbances in the decidual 
compartment, which derives from the maternal endometrium and is instrumental in 
supporting normal placental development. Hence, I hypothesise that maternal age-related 
defects in placentation stem from a deficiency in the decidua, affecting cell communication 
at the feto-maternal interface. I have shown that development of the trophoblast is 
abnormal in the context of an aged maternal system, and, given the extensive 
communication at the feto-maternal interface, it is likely that ageing disrupts signalling 
between the maternal decidua and fetal trophoblast. This may lead to the disruption of 
appropriate trophoblast differentiation in aged pregnancies. It would be desirable to 
delineate the precise mechanisms by which the aged maternal environment perturbs the 
normal development of the trophoblast, as this may highlight pathways which could be 
modulated pharmacologically to improve trophoblast differentiation in aged pregnancies. 
This will be investigated further in Chapter 4. 
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My data show major disturbances in the decidual compartment, which is 
instrumental in supporting normal placental development (Bilinski et al., 1998; Mori et al., 
2016). These findings lead me to hypothesise that the placental abnormalities stem from a 
defect in the maternal decidual compartment, without major contributions by uNK cell 
differentiation which remains largely unaltered in aged females. Hence, I focused on 
studying decidualization, the process by which the endometrium differentiates and develops 
into the decidua, in more detail in Chapter 4. 
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Chapter IV 
Advanced maternal age perturbs the 
progression of early pregnancy 
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4.1 Introduction 
 
In the previous chapter, I showed that placental development is abnormal in older B6 
mothers as a result of as yet undefined age-related changes in the uterus. The 
developmental delay that was obvious in the decidual compartment may result in defective 
trophoblast differentiation, and consequentially abnormal development of the embryo. 
At the RNA level, development of the maternal E11.5 decidua in aged females was 
delayed by up to 2 days when compared to those of young females, and was characterised 
by de-regulation of genes known to be important in decidualization. Decidualization is the 
process by which the stromal cells that make up much of the uterine bed undergo 
proliferation and differentiation in response to steroid hormones. This process facilitates 
implantation of the blastocyst into the uterine wall, and is critical for the formation of the 
decidual portion of the placenta. As this transformation of uterine stromal cells is initiated in 
the peri-implantation window, abnormalities in the decidual compartment in aged mothers 
are likely to be rooted in defects of the uterus at an earlier stage of pregnancy (Cha et al., 
2012).  
The detrimental effects of imbalances in the tightly orchestrated timing of 
decidualization events have been shown by the study of uterine-specific mouse gene 
knockouts. For example, uterine deletion of the muscle segment homeobox gene Msx1 
causes implantation to be delayed until after the normal window of implantation, and 
severely reduces the decidualization response. This leads to abnormal embryo spacing and 
increased rates of resorption (Daikoku et al., 2011). Similarly, a study from Zhang et al in 
2014 showed that uterine expression of Rbpj, a transducer of Notch signalling, is required for 
proper orientation of the embryo during implantation and remodelling of the decidua during 
post-implantation development (Zhang et al., 2014). Perturbation of these events by 
deletion of Rbpj in the uterus leads to embryo resorption at mid-gestation. These, and other 
studies (Peng et al., 2015; Plaks et al., 2013) show that function of the uterus during 
pregnancy is vital for proper development of the embryo and placenta. Hence, in this 
chapter, I will investigate in detail the effect of advanced maternal age on uterine function 
during early pregnancy.  
The literature suggests that uterine ageing is a determinant of fertility in advanced 
maternal age (Nelson et al., 2013), however the biology underlying this association remains 
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largely unexplored. Previous studies have reported age-related changes in uterine histology, 
including increased collagen deposition reminiscent of fibrosis (Blaha and Leavitt, 1974; 
Gosden, 1979; Ohta, 1987), lipofuscin deposits in the cytoplasm of USCs, and reduced 
numbers of microvilli present on LE cells (Craig, 1981). However, these histological defects 
have so far not been related to any functional disturbance in aged pregnancies. Most 
significantly, the artificial decidualization response is severely impaired in older mice (Finn, 
1966; Holinka and Finch, 1977; Shapiro and Talbert, 1974). This could reflect either a 
deficiency in the levels of maternal steroid hormones - mainly progesterone (P4) and 
estrogen (E2) - or a decline in the ability of aged tissues to respond to hormonal cues. 
Indeed, P4 levels do vary between young and aged mothers during early pregnancy (Holinka 
et al., 1979), however even after P4 supplementation age-related differences in uterine 
weight and decidualization still persist (Finch and Holinka, 1982; Holinka and Finch, 1977). 
Additionally, P4 levels in older mice during pregnancy do not correlate with embryo viability 
or resorption (Holinka et al., 1979), which - as I have shown in Chapter 1 - are the major 
consequences of advanced maternal age. Also, the artificial decidualization response is 
routinely triggered in ovariectomized females after timed injections with E2 and P4, thus 
arguing against systemic age-related changes in hormone levels as the cause of these 
defects. Hence, I here specifically assessed the capacity of USCs from aged females, 
compared to young controls, to initiate the decidualization response. 
 
4.2 Results 
 
4.2.1 Decidualization is impaired in aged uteri 
 
To investigate uterine function during early pregnancy, I performed RNA-seq analysis on 
uterus fragments of about 5mm in length from young (8-22 weeks) and aged (41-49 weeks) 
pseudo-pregnant females at E3.5. From each mouse, two fragments were taken that were 
located adjacent to the ovary and distal from it, close to the joining point of the uterine 
horns. There were no significant differences in gene expression between these proximal and 
distal uterine segments, and therefore sequencing reads from both samples were pooled  
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 Figure 4.1 - Abnormal expression of decidualization genes in the pre-receptive 
uterus. 
a) Heatmap showing 75 genes significantly differentially expressed between E3.5 
uteri from young (8-22 weeks) and aged (41-49 weeks) females after mating with 
vasectomised males. Two independent samples of uterus were dissected from 
corresponding regions per uterus, which were pooled after sequencing resulting in 
a total of 3 independent replicates in each group. Differentially expressed genes 
were identified by both DESeq (p>0.05), and intensity difference (p<0.05). 
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prior to analysis. Analysis with DESeq2 and the intensity difference filter identified 75 genes 
which were significantly differentially expressed between young (n=3) and aged (n=3) uteri, 
with 53 genes up-regulated and 22 down-regulated (Fig 4.1a) Appendix, Supplementary 
table 3). This was at E3.5, during the period of hormonal priming, suggesting that priming of 
the endometrium is delayed, or incomplete in aged females. One out of the three aged 
samples showed a milder defect, with a gene expression pattern in between that of uteri 
from young females, and the remaining aged samples (Fig 4.1a, b). This did not correlate 
with the age of the female within this group, indicating that there is interindividual 
variability in the effect of maternal ageing on gene expression in the uterus during early 
pregnancy. It would be desirable to investigate this further with a larger number of samples 
at multiple ages to investigate the interindividual variability in, and age of onset of uterine 
deterioration with maternal ageing. 
Gene ontology analysis of differentially expressed genes shows enrichment for 
annotations relevant to early pregnancy and decidualization, such as cell adhesion, 
extracellular matrix and collagen, developmental protein, growth factor activity, and heparin 
and platelet-derived growth factor binding (Fig 4.1c). Enrichment of the term glycoprotein 
may reflect the secretory function of USCs and uterine glands during decidualization, as 
secreted proteins such as growth factors and extracellular matrix components are often 
glycosylated. 
A number of genes dys-regulated in uteri from aged females play important roles 
during early pregnancy, including Follistatin (Fst) which is required for the acquisition of 
b) Principal component analysis on RNA-seq data from E3.5 uteri from young (8-22 
weeks) and aged (41-49 weeks) females. 
c) Gene ontology annotations enriched in genes differentially expressed between young 
and aged uteri (Bonferroni p<0.05). Differentially expressed genes were identified by 
either DESeq2 (p<0.05) and intensity difference (p<0.05). 
d) Venn diagrams showing genes which were commonly differentially expressed in aged 
uteri, and in the E3.5 uteri of gene knockout (KO) mice. Differentially expressed genes 
were split into those which were up-regulated and down-regulated. Dotted line 
indicates groups overlapping with aged uteri. P values indicate the significance of the 
overlap (Fischer’s exact test) between genes differentially expressed in the indicated 
gene KO, and in aged uteri. 
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uterine receptivity and subsequent decidualization (Fullerton 2017), and Hoxa10 and Hand2  
 
Figure 4.2 – Abnormal expression of LE and USC markers in aged E3.5 uteri. 
a) Expression levels of genes specific to the luminal epithelium (Ltf, Fst) and uterine 
stroma (Hand2, Hoxa10) E3.5 uteri from young (n=3) and aged (n=3) females as 
determined by RNA-seq. Genes were identified as differentially expressed by 
DESeq2 (p<0.05) or intensity difference (p<0.05) in RNA-seq data. 
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which are necessary for USC proliferation and differentiation (Benson et al., 1996; Lim et al., 
1999; Mestre-Citrinovitz et al., 2015; Yu et al., 2017) (Fig 4.1a). Decidualization is driven by 
key signalling pathways, most notably these are regulated by the progesterone receptor 
(Pgr), which activates the Egfr, Bmp2, and Wnt4 pathways (Large et al., 2014; Lee et al., 
2007; Li et al., 2007; Lydon et al., 1995). I investigated the perturbation of these pathways in 
aged pregnancies using microarray data generated by our collaborators (Professor F. 
DeMayo’s lab, USA), which identified targets of these signalling pathways in a uterine 
context, using uterus-specific knockout mice. I found that genes up-regulated in aged uteri 
were significantly enriched for genes up-regulated in the uterus of Bmp2, Pgr, Egfr, and 
Wnt4 KO mice, and vice versa, suggesting that these key pathways of decidualization and 
early pregnancy are disturbed in aged uteri (Fig 4.1d) (Appendix, Supplementary table 4). 
The uterus is a heterogeneous tissue comprised of multiple cells types, including 
USCs, LE, and GE, as well as immune cells such as uNK cells. uNK cells were not taken into 
account any further, as no differences were observed in their number or maturation state 
(Chapter 3, Fig 3.8f). During early pregnancy, the LE becomes receptive for implantation on 
the evening of day 4, in response to Lif secreted by the uterine glands (Pawar et al., 2015). 
The receptive LE enables blastocyst attachment and invasion into the uterine stroma, which 
stimulates decidualization of the stromal cell compartment. RNA-seq analysis of E3.5 uteri 
suggested that both the LE and USC compartments are affected by maternal ageing, 
revealing age-related changes in the expression of genes involved in both, epithelial 
receptivity (e.g., Ltf, Fst) and stromal cell decidualization (e.g. Hand2, Hoxa10) (Fig 4.2a). In 
order to elucidate which cell type in the uterus is most affected by maternal ageing, I 
bioinformatically defined gene expression profiles specific to USCs and LE in the uterus. I 
generated RNA-seq data from young USCs isolated from the uterus at E3.5 and used RNA-
b) Examples of aligned sequencing reads from RNA-seq datasets of luminal epithelial 
(LE), and uterine stromal cells (USC), at LE specific gene Ltf, and USC specific gene 
Des, in seqmonk. Very few reads align to Ltf in the USC dataset, and to Des in the LE 
dataset, as expected. USC data is opposing strand specific, whilst LE data from 
GSE57680 is non-strand specific. 
c) Heatmaps showing expression of genes specific to LE cells or USCs in E3.5 uteri from 
young and aged females, determined by RNA-seq. 
 
 
  83 
seq data available in the GEO repository from LE obtained by laser capture micro-dissection 
(GSE57680). Each signature was generated by first identifying all genes expressed in the cell 
type of interest, and then excluding genes also expressed in the other cell type. This 
produced a signature of 666 and 811 genes representing the USC and LE respectively. The LE 
signature included the well-known LE marker Lactotransferrin (Ltf) and excluded Desmin 
(Des) which is specific to the uterine stroma, whilst the USC signature included Des and 
excluded Ltf, suggesting the signatures are representative of each individual cell type (Fig 
4.2b). 
I used these cell type specific signatures to interrogate the RNA-seq data from E3.5 
uteri, to determine which compartment is most affected by maternal ageing. Both USC and 
LE specific genes were abnormally expressed in aged uteri. USC specific genes were mostly 
down-regulated, whereas LE genes were mainly up-regulated (Fig 4.2c), which may reflect 
the disruption of hormone responses in aged uteri. In the first 2 days of pregnancy, signalling 
is dominated by estrogen (E2) which stimulates proliferation of the LE. This signal is then 
antagonised from E2.5 by the action of progesterone (P4), which causes the LE to cease 
proliferation in preparation of embryo attachment and implantation. Meanwhile, 
progesterone stimulates USCs to proliferate and differentiate into decidual cells (Kurihara et 
al., 2007). It may be that the aged LE fails to down-regulate E2 controlled genes in response 
to P4, leading to increased expression of LE specific genes. Similarly, aged USCs may be 
unable to adequately activate decidualization genes in response to P4, leading to decreased 
expression of USC marker genes compared with young cells. These results suggest that both 
the LE and stroma are defective in the aged endometrium, and may exhibit resistance to the 
action of P4. However, as the number of implantation sites was not significantly different 
between young and aged mothers (Chapter 3, Fig 3.1a), as has been noted in previous 
studies (Lopes et al., 2009), implantation success per se does not appear to be affected by 
maternal age. This suggests that the major failure leading to embryo and placenta 
abnormalities lies within the stromal compartment. Therefore, I focused my attention on 
age-related changes in the function of USCs during early pregnancy. 
The data shown above led me to hypothesise that defects in steroid hormone 
signalling, primarily through P4, may be responsible for the age-associated transcriptional 
defects observed in E3.5 uteri. It is possible that aged females fail to mount an adequate 
uterine response during early pregnancy either due to fluctuations in plasma levels of P4, or 
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because of an inability to adequately respond to pregnancy hormones. Although aged 
females do exhibit fluctuations in P4 levels during early pregnancy, this does not appear to 
be linked with embryo viability or resorption (Holinka et al., 1979), suggesting that the 
defect lies in hormone responsiveness rather than in maternal hormone levels. The ability of 
the aged endometrium to respond to a decidualization stimulus was studied by performing a 
deciduoma assay on hormonally primed ovariectomized (OVX) mice. This work was 
performed by our collaborators Dr Xiaoqiu Wang and Professor Francesco DeMayo (DeMayo 
lab, USA). The deciduoma assay allows us to study the extent and progression of 
decidualization in controlled hormone conditions, and in the absence of an implanting 
embryo. In confirmation of previous reports (Finn, 1966; Holinka and Finch, 1977), whilst 
young OVX females produced large deciduoma swellings in the stimulated uterine horn, 
aged OVX females exhibited much smaller swellings (Fig 4.3a), showing that decidualization 
was impaired in aged females. This suggests that a cell-intrinsic defect renders aged females 
unable to respond adequately to decidualization stimuli, as opposed to age-related changes 
in levels of maternal hormones.  
Failure to mount a deciduoma response, coupled with the dysregulation of numerous 
genes involved in decidualization at E3.5 and E11.5, suggests a failure in the decidualization 
response of USCs from aged females. This hypothesis was investigated in vitro using USCs 
isolated at E3.5 of pregnancy. USCs were cultured in the presence of a decidualization 
cocktail comprised of E2, P4, and cyclic AMP (cAMP) to induce decidualization. USCs from 
young females responded to hormone treatment by up-regulating the expression of 
decidualization markers, as expected. However, aged USCs failed to upregulate the key 
marker Dtprp (Prl8a2) to the same extent as young USCs, and entirely failed to upregulate 
other important markers such as Bmp2 and Hoxa10 (Fig 4.3b). Taken together, these results 
suggest an intrinsic failure of USCs from aged females to undergo decidualization in 
response to hormonal stimulation. 
To investigate the defective decidualization response of aged USCs in further detail, I 
generated RNA-seq libraries from USCs derived from one young and one aged female prior 
to, and after 4 days of in vitro decidualization. USCs from aged females were 
transcriptomically distinct from their young counterparts, both prior to and post 
decidualization (Fig 4.3c). PCA analysis defines 2 main clusters consisting of young and aged  
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Figure 4.3 - The decidualization response is blunted in aged females. 
a) Deciduoma assay showing the extent of the decidualization reaction in response to 
mechanical stimulation in hormonally primed young and aged mice. The ratio of 
weight of the stimulated horn (right) compared to the control (left) is also displayed. 
Statistical analysis is by two-tailed t-test, ** p<0.01. Deciduoma assay performed by 
XW (DeMayo lab, USA). 
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b) RT-qPCR analysis of decidualization markers in USCs stimulated for 2 and 4 days 
(mean +/- S.E.M., n=3). *p<0.05 two-tailed t-test. (USC isolation and in vitro 
decidualization performed jointly by LW and V P-G). 
c) Closest neighbour analysis of RNA-seq datasets from USCs isolated from young, or 
aged females prior to in vitro decidualization, or after 4 days of treatment. Each group 
consisted of one independent biological sample, on which three technical replicates 
were performed. 
d) Principal component analysis of the samples shown in c). 
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samples which separate along PC1. Each group is sub- divided along PC2 into 2 groups 
representing USCs pre- and post-decidualization (Fig 4.3d). 
e) Scatter plot showing the expression (RPKM) of all genes in young USCs after 0 days 
and 4 days of in vitro decidualization. Genes which were significantly differentially 
expressed (DESeq2 p<0.05 and Intensity difference p<0.05) between 0d and 4d of 
treatment. Genes significantly upregulated at 4d are highlighted in blue, those 
downregulated are highlighted in red. A selection of genes are labelled for reference 
to f). 
f) Scatter plot showing the expression (RPKM) of all genes in aged USCs after 0 days and 
4 days of decidualization. Highlighted genes indicate those differentially expressed in 
young USCs between 0d and 4d of stimulation f) to compare the expression change in 
decidualization response genes between young and aged cells. A selection of genes 
are labelled for reference to e). 
g) Venn diagram showing the genes which change in response to in vitro decidualization, 
which are common between young and aged USCs (DESeq2 p<0.05 and Intensity 
difference p<0.05). i.e. the which change significantly between young 0d vs 4d AND 
aged 0d vs 4d. 
h) Proliferation curve of uterine stromal cells in vitro. Cells were isolated and counted on 
4 consecutive days after plating. Cells from aged females display significant defects in 
proliferation (mean +/- S.E.M.). Statistical analysis by two-way ANOVA with Holm-
Sidak’s multiple comparisons test. (Proliferation assay performed by V P-G, statistics 
performed by A S-P). 
i) Proliferation curve of uterine stromal cells in vitro from young and aged females. Cells 
were either unstimulated, or subjected to in vitro decidualization. Two-way ANOVA 
with Holm-Sidak’s multiple comparisons test. (Proliferation assay performed by V. P-
G, statistics performed by A. S-P). 
j) Ki67 staining of uteri from young and aged pseudopregnant females at E3.5. Arrows 
indicate luminal epithelium. STR, stromal compartment. LE, luminal epithelium. Scale 
bar: 200μm. 
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Initially, I characterised the decidualization response of young USCs by identifying 
genes which were differentially expressed between pre- and post-decidualization. 124 genes 
were differentially expressed in response to the decidualization cocktail, 112 of which were 
up-regulated, and only 12 down-regulated (Fig 4.3e) (Appendix, Supplementary table 5). 
Genes that were up-regulated after 4 days of in vitro decidualization included well known 
decidualization markers including Dtprp (Prl8a2). Also up-regulated were the genes encoding 
nuclear receptor coactivator 4 (Ncoa4) which acts as a co-receptor for a number of steroid 
hormone receptors including Esr1 and Pgr (Kollara and Brown, 2012), and Hsd11b1 which is 
induced by P4 in decidualizing human endometrial stromal cells (Kuroda et al., 2013) 
(Appendix, Supplementary table 5). The small group of only 12 genes that were significantly 
down-regulated by decidualization included regulators of G protein signalling Rgs4 and Rgs5, 
and gap junction component Connexin 26 (Gjb2) (Appendix, Supplementary table 5). 
Analysis of USCs from aged females undergoing in vitro decidualization revealed that, 
as expected, they did not respond to hormonal stimulation as strongly as young USCs (Fig 
4.3f). Only 17 of the 124 young decidualization response genes were differentially expressed 
in aged USCs after 4 days of in vitro decidualization (Fig 4.3g). These all fell into the up-
regulated group. For example, decidualization marker Prl8a2 was significantly up-regulated 
in aged USCs, but to a lesser extent than in young counterparts, as was the Wnt3 regulated 
cell adhesion molecule Periostin (Postn) (Haertel-Wiesmann et al., 2000) (Fig 3e-f). No 
significantly down-regulated genes were shared between young and aged USCs. This further 
corroborates my previous data that USCs from aged females are less able to respond to 
decidualization cues than their young counterparts. Even those genes that do respond do so 
to a reduced extent. These findings lend further support to the hypothesis that maternal 
ageing leads to cell intrinsic changes in USCs, attenuating the hormonal responsiveness of 
the stromal compartment, which may perturb the early stages of extra-embryonic 
development and placentation in aged pregnancies. As these experiments were performed 
using only one independent biological replicate for each group, they should be replicated in 
the future to confirm the reproducibility of these results. 
Endometrial decidualization is characterised by extensive proliferation and 
differentiation of USCs, which are vital for the establishment and maintenance of pregnancy 
(Lee et al., 2007; Wang et al., 2013). The regulation of USC proliferation during 
decidualization is not well understood, however the Wnt signalling pathway, and in 
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particular Wnt4, is a key player (Franco et al., 2011). As expression of Wnt4 targets was 
perturbed in the uteri of aged females (Fig 4.1d) and GO analysis of E3.5 uteri showed that 
age-related genes were enriched for positive regulators of proliferation (Fig 4.1c), we next 
investigated the proliferative capacity of aged USCs. USCs isolated from aged females 
exhibited significantly reduced proliferation in vitro (Fig 4.3h). Aged USCs were also unable 
to modulate their rate of proliferation in response to the decidualization cocktail, whereas 
this led to a reduction in proliferation in young USCs (Fig 4.3i).  
Corroborating the reduced proliferative capacity of aged USCs in vitro, the spatial 
distribution of proliferative cells was also clearly perturbed in vivo. At E3.5, the action of P4 
on an E2 primed uterus normally inhibits the proliferation of the LE and stimulates 
proliferation in the stroma (Kurihara et al., 2007). On examination of uteri from young 
females by Ki67 staining we found that very few LE cells were positive for Ki67, whereas 
large numbers of USCs in the stromal compartment were actively dividing, as expected at 
this time-point (Fig 4.3j). In the majority of uteri from aged females however, the LE was still 
undergoing extensive proliferation, with minimal proliferation in the stroma (Fig 4.3j). This 
suggests that the switch from LE to stromal cell proliferation, brought about by the action of 
P4 on an E2 primed uterus, either does not occur adequately, or is delayed in uteri from 
aged females. This is likely to be another reflection of the impaired hormonal 
responsiveness, and specifically the P4-resistant phenotype that appears to interfere with 
the normal progression of pregnancy in aged females.  
4.2.2 Effectors of progesterone signalling in the uterus are affected by maternal 
ageing 
 
As uteri from aged females displayed a blunted response to decidualization hormones, I 
went on to investigate the expression and distribution of the steroid hormone receptors in 
the aged uterus. Immunohistochemical (IHC) staining at E3.5 showed that Esr1 levels were 
increased in some areas of the LE in aged females compared to young, with pEsr1 staining 
indicating it is in the transcriptionally active state (Fig 4.4a). However, the most striking 
differences were observed for Pgr distribution. In young females Pgr was strongly and 
homogeneously expressed in all cells of the LE, with some expression in the underlying 
stroma. By contrast, in aged females Pgr expression was patchy and highly variable in the LE. 
Some regions expressed reduced levels or completely lacked Pgr staining, whereas others 
showed largely normal expression at E3.5 (Fig 4.4b). At the RNA level, Pgr and Esr1 were not 
  90 
appreciably abnormal in whole uteri from aged females at E3.5, however both were 
significantly down-regulated in aged USCs both prior to and after 4d of decidualization (Fig 
4.4c). At E6.5, Pgr expression has progressed from the primary decidual zone (PDZ) to the 
secondary decidual zone (SDZ) in young pregnancies, whereas in aged pregnancies it is still 
restricted to the PDZ at this time (Fig 4.4b). These differences in distribution are indicative of 
a slower progression of the decidualization wave across the stromal cell compartment (Tan 
et al., 1999). Pgr expression is still perturbed at E11.5, when protein levels of Pgr isoforms 
Pgr-A and Pgr-B are significantly decreased in An decidua (Fig 4.4d). Aa deciduas also 
displayed altered levels of Pgr-A and -B, however this did not reach statistical significance as 
Pgr levels were more variable within this group. Taken together, these data lend further 
support to the idea that the progression of decidualization is delayed in aged pregnancies. 
This may be due to the development of P4 resistance related to reduced expression of Pgr, 
likely causing a “ripple effect” interfering with the progression of placentation and embryo 
development that manifests as developmental delay and other abnormalities at later time 
points (Cha et al., 2012). Interestingly, one aged female displayed normal Pgr staining at E3.5 
and was also transcriptomically more normal by RNA-seq (Fig 4.1a), showing that there is 
considerable inter-individual variability to the rate/onset of age-related reproductive 
decline. It is also tempting to speculate that the variability in Pgr expression observed in 
aged uteri may underlie the variability in embryo development at E11.5, perhaps with 
normal embryos implanting in regions expressing Pgr, and abnormal embryos implanting at 
regions depleted for Pgr (Fig 4.4b).  
In the pregnant uterus Pgr interacts directly with phosphorylated Stat3 (pStat3), 
which acts as a Pgr co-activator. Ablation of Stat3 in Pgr expressing cells of the uterus leads 
to defective decidualization and implantation (Liu and Ogle, 2002; Proietti et al., 2011), and 
diminishes the ability of Pgr to induce the expression of target genes (Lee et al., 2013). Thus, 
in addition to reduced Pgr expression, disturbances in pStat3 availability could contribute to 
the impaired P4 responsiveness. We therefore investigated the expression and localisation 
of pStat3 in aged pregnancies. pStat3 levels were significantly decreased in aged compared 
to young USCs undergoing in vitro decidualization (Fig 4.5a). Furthermore, IHC analysis 
showed that levels of pStat3 were also drastically reduced in vivo in the LE and GE of aged 
females at E3.5, and pStat3 was restricted to the cytoplasm and appeared to be 
conspicuously excluded from the nucleus (Fig 4.5b). 
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Figure 4.4 - Steroid hormone receptors are abnormally expressed in uteri from aged females. 
a) E3.5 uteri from young and aged females, stained for Estrogen receptor (Esr1) and pEsr1 
(brown). Arrows highlight intense patches of staining in the luminal epithelium of aged uteri. 
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This defect persisted at E6.5 (Fig 4.5c). These data suggest, that in vivo, the ability of pStat3 
to localise to the nucleus where it interacts with Pgr is severely reduced, thereby preventing 
its function as a Pgr co-activator. Prevention of this vital interaction may interfere with the 
transcriptional responses of Pgr target genes, which could underlie the dampened response 
of Pgr target genes to P4 treatment in the aged uterus. Therefore, abnormal expression of 
Pgr in the aged uterus, combined with reduced expression and mis-localisation of pStat3, 
may explain the attenuation of uterine responses to P4, and the blunted decidualization 
reaction that is observed in aged females. Stat3 is phosphorylated as a result of Lif signalling. 
Lif is secreted from the uterine glands at E3.5 in response to E2 (Bhatt et al., 1991), and is 
required to initiate embryo implantation (Stewart et al., 1992); it also plays a role in stromal 
cell decidualization (Fouladi-Nashta et al., 2005; Shuya et al., 2011). As I found no 
implantation defect per se in aged pregnancies, and Lif expression was comparable in E3.5 
uteri from young and aged pregnancies, I hypothesised that Lif deficiency was not the cause 
of reduced Stat3 phosphorylation. I confirmed this by Lif supplementation of USCs during in 
vitro decidualization, which failed to rescue the decidualization response of USCs from aged 
females (Fig 4.5d). 
(Stainings performed by XW in the FD lab). 
b) E3.5 uteri (a-b) and E6.5 implantation sites (c-f) from young and aged females, stained for 
Progesterone receptor (Pgr). a-b) White arrows point to uniform staining in the luminal 
epithelium, red lined arrows highlight the mosaic staining of Pgr in the age luminal 
epithelium. LE, luminal epithelium. STR, stromal compartment. c-f) Dotted lines demarcate 
the boundary between the primary (PDZ) and secondary (SDZ) decidual zones. Red asterisks 
indicate autofluorescence from red blood cells. MD, mesometrial decidua. AM, anti-
mesometrial decidua. Scale bar: 500μm. 
c) Differential expression of Esr1 and Pgr in uterine stromal cells from young and aged females 
before (0d) and after 4d (4d) of in vitro decidualization, determined by RNA-seq. DESeq2 
p<0.05. 
d) Expression levels of Progesterone receptor isoform -A and -B in deciduas isolated from young 
and aged pregnant females at E11.5. Aged samples were either associated to a grossly 
normal embryo (Aged normal), or an abnormal one (Aged abnormal). Graphs show Pgr 
protein levels normalised to actin, and relative to young mice (mean +/- S.E.M, n=3). 
(Western blot performed by V P-G). 
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Figure 4.5 - Expression and activation of Stat3 is abnormal in aged pregnancies. 
a) Western blot showing protein levels of Stat3 and pStat3 in uterine stromal cells from young 
and aged females, undergoing in vitro decidualization for 2-4 days. Graph shows the ratio of 
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Interestingly, expression of the Lif receptor (Lifr) was increased in aged USCs (Fig 4.5e), 
despite a reduction in Stat3 phosphorylation in aged cells. Upregulation of Lifr may reflect an 
attempt to compensate for impaired Stat3 activation in aged USCs. This adds to the 
mounting evidence that an intrinsic defect in USCs from aged females, and not altered levels 
of maternal hormones and growth factor signals per se, prevents proper responses to P4, 
and underlies the decidualization and placentation defects. 
 
4.2.3 Altered USC secretome in aged females impacts trophoblast 
differentiation 
 
In Chapter 3 I showed that aged pregnancies exhibit abnormal differentiation of the 
trophoblast compartment, characterised by increased expression of TS cell markers, 
increased differentiation to the TGC lineage, and decreased differentiation to a labyrinth 
fate. A distinctive characteristic of USCs is that they acquire a unique secretory phenotype 
during decidualization. Gene ontology analysis of E3.5 uteri from young and aged females 
pStat3/Stat3, normalised to 2 day young cells (mean +/- S.E.M., n=6). *p<0.05, **p<0.01 
(ANOVA with Holm-Bonferroni’s post-hoc test). (Western blot performed by V P-G). 
b) IHC for pStat3 in E3.5 uteri from young and aged females. Dotted line demarcates the 
boundary between the luminal epithelium and uterine stroma. Small arrows indicate nuclear 
localisation of pStat3 in the stroma of young uteri, large arrows indicate the cytoplasmic 
localisation of pStat3 in the stroma of aged uteri. LE, luminal epithelium. GE, glandular 
epithelium. Scale bar: 100μm. 
c) pStat3 staining in E6.5 implantation sites from young and aged females. Insets show an 
overview of the implantation site and yellow rectangles the location of the magnified image. 
In young females pStat3 is localised to the nucleus of uterine stromal cells (USCs), wheres in 
aged females only a few USCs show nuclear localisation (white arrows), and many show 
exclusion of pStat3 from the nucleus (red outlines arrows). Scale bar: 100μm. 
d) Expression of decidualization markers Prl8a2 and Hand2 in uterine stromal cells undergoing 
in vitro decidualization in response to a decidualization cocktail of estrogen (E2), 
progesterone (P4), and cAMP, or the decidualization cocktail supplemented with 10ng/ml Lif 
for 2 days and 4 days (mean +/- S.E.M, n=3). Two-tailed t-test *p<0.05. 
e) Expression of Lifr in E3.5 uteri from young and aged females, from RNA-seq data. Mean +/- 
S.E.M., DESeq2 *p<0.05 
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shows that many secreted factors are differentially expressed as a function of age (Fig 4.1c). 
Many previous studies have highlighted the importance of highly orchestrated paracrine 
signalling between the LE, GE, uterine stroma, and trophoblast (Bany and Cross, 2006; Hess 
et al., 2007; Lee et al., 2006; Paria et al., 2002; Pawar et al., 2015). In 2017 Menkhorst and 
colleagues showed that invasive trophoblast cells signal to USCs to promote their 
decidualization (Menkhorst et al., 2017). In turn, the main function of the decidua is to limit 
trophoblast invasion; when placed at ectopic sites, trophoblast invades in an unrestricted 
manner. Decidual components such as tissue inhibitors of metalloproteases (TIMPs) function 
as a barrier to provide a “safe” environment for trophoblast invasion to occur. Thus, 
trophoblast invasion and likely trophoblast differentiation are also affected by the decidua. 
as a barrier to provide a “safe” environment for trophoblast invasion to occur.  
I hypothesised that paracrine factors secreted by USCs during decidualization may 
direct trophoblast differentiation, and that age-related changes in the secretome of USCs 
would affect this process. To investigate this, I generated conditioned medium from 
decidualizing young USCs (yUSC-CM) and aged USCs (aUSC-CM), and analysed the stem cell 
capacity and differentiation dynamics of TS cells in vitro in the presence of these conditioned 
media (Fig 4.6a). Commonly, the stem cell potential of TS cells in vitro is maintained by 
supplementing the medium with mouse embryonic fibroblast conditioned medium (MEF-
CM), Fgf, and Heparin. Differentiation is promoted by the withdrawal of MEF-CM, Fgf, and 
Heparin (Tanaka, 2006). As I wanted to investigate the effect of young- and aged-CM on 
differentiation, I promoted TS differentiation in the presence of USC-CM by withdrawal of 
only Fgf and Heparin for 3 and 5 days (Fig 4.6a). Despite the continued presence of CM, 
Fgf/Heparin withdrawal caused a rapid downregulation of TS cell markers at 3d, and 
upregulation of SpT, SynT, and TGC markers by 3d and 5d (Fig 4.6b), as expected from the 
dominant role of Fgf in maintaining the TS cell state. Therefore, differentiation in the 
presence of USC-CM would allow me to investigate the effect of the aged USC secretome on 
trophoblast differentiation. The first observation from these experiments is that USC-CM 
(irrespective of young versus aged) affects the TS cell state differently than MEF-CM. This 
was evident from the globally elevated levels of TS cell and TGC marker gene expression, and 
in particular a reduction of Gcm1. Whether or not these effects are due to USC-secreted 
factors, or instead due to the presence of E2, P4 and cAMP in the USC-CM but not the MEF-
CM remains to be explored in the future. 
  96 
 
  
  97 
More importantly in the context of my project, I focussed on the differences between yUSC-
CM and aUSC-CM.  In the presence of aUSC-CM, TS cells under stem cell conditions exhibited 
slight increases in the expression of the TS markers Eomes, Elf5, and Esrrb, and decreased 
expression of Cdx2 compared to yUSC-CM, although these differences did not reach 
statistical significance (Fig 4.6b). Under differentiation conditions, TS cell markers were 
significantly more rapidly down-regulated in the presence of aUSC-CM than yUSC-CM. 
Expression of the intermediate/SpT markers Ascl2 and Tpbpa was increased with aUSC-CM, 
at 3d and 5d respectively, although only the difference in Ascl2 expression was significant 
(Fig 4.6b). Differentiation in the presence of aUSC-CM also resulted in significantly increased 
expression of the TGC marker Plf and increased expression of Pl2 and Ctsq after 5d of 
differentiation. The SynT markers Syna and Synb were not significantly affected, however 
expression of the labyrinth progenitor marker Gcm1 was slightly decreased in aged cells at 
3d and 5d of differentiation (Fig 4.6b).  
These results suggest that CM from aged USCs promotes the expression of TS cell 
factors under stem cell conditions, and causes differentiation to progress more rapidly on 
Figure 4.6 - Factors secreted by aged uterine stromal cells affect the differentiation of 
trophoblast stem cells. 
a) Uterine stromal cells were cultured in TS base medium with the decidualization 
cocktail for 3 days to generate young- and aged-conditioned medium (CM). 
Trophoblast stem (TS) cells were either maintained undifferentiated in culture for 2 
days in the presence on young- or aged-CM plus Fgf and Heparin, or differentiated in 
the presence of young- or aged-CM by withdrawal of Fgf and Hepain for 3 days and 5 
days. 
b) Expression of trophoblast lineage markers in trophoblast stem cells either under 
stem cell conditions (stem), and after 3 days (3d diff) or 5 days (5d diff) of 
differentiation. TS cells were cultured either in the presence of MEF conditioned 
medium, young-CM (Young USC), or aged-CM (aged USCs) as described in Fig 4.6a. 
Mean +/- S.E.M., n=3. Statistical analysis was by two-tailed t-test *p<0.05, **p<0.01, 
***p<0.001. 
c) Schematic showing suggested model of trophoblast differentiation in the presence of 
conditioned medium from aged uterine stromal cells, compared to young-CM. 
Intermed. trophoblast, intermediate trophoblast. 
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withdrawal of Fgf and Heparin. Differentiation with aUSC-CM was characterised by 
promotion of the TGC and SpT fates (Fig 4.6b-c). These in vitro findings partially recapitulate 
the phenotype observed in the trophoblast compartment in aged pregnancies. In vivo, 
expression of TS cell markers is aberrantly maintained at mid-gestation, accompanied by 
over-expression of TGC markers. These results show that factors secreted by young and aged 
USCs differentially affect the trophoblast differentiation programme. Aged UCSs interfere 
with this differentiation programme, either because they produce more and/or different 
factors than young USCs, or because they secrete reduced amounts of critical factors. The 
precise nature of these secretions will need to be determined in future experiments. 
However, these conditioned media experiments provide further striking evidence for my 
reasoning that declining uterine function with maternal ageing impacts on development of 
the fetal trophoblast compartment, thereby causing developmental abnormalities in the 
placenta and embryo. 
4.3 Discussion 
 
The successful establishment of pregnancy requires a highly orchestrated series of events 
which render the endometrium receptive to a blastocyst, synchronised with the presence of 
a competent blastocyst which subsequently implants into the uterine wall. Thus, gene 
expression in the uterus must be tightly controlled at this time. I have found that maternal 
ageing leads to a decline in the ability of the uterine stromal compartment to respond to P4, 
which plays a role in regulating gene expression in the endometrium during early pregnancy. 
Reduced hormonal responsiveness affects the expression of key genes, including Bmp2, 
Hoxa10, and Hand2 which are indispensable for decidualization (Benson et al., 1996; 
Godbole and Modi, 2010; Lee et al., 2007; Li et al., 2007; Yu et al., 2017). Abnormalities in 
the progression of decidualization can lead to a “ripple effect”, leading to abnormal 
trophoblast differentiation and resulting in the abnormal placental and embryonic 
development observed at mid-gestation in aged pregnancies. 
In mice, USC decidualization is triggered by the presence of an implanting blastocyst 
in a hormonally primed endometrium. Hormonal priming takes place in the preimplantation 
stage of pregnancy, under the influence of E2 on days 0-2, and P4 from E2.5 onwards. This 
priming is necessary for successful implantation and decidualization, and for the induction of 
artificial decidualization. My results suggest that hormonal priming is delayed, or incomplete 
in the uteri of pseudo-pregnant aged females at E3.5. This leads to altered expression of Pgr 
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target genes such as Hand2, and downstream signalling pathways including the Egfr, Bmp2, 
and Wnt4 pathways in aged females, even in the absence of an implanting blastocyst. 
Estrogen responsiveness appears to be less severely affected, as Ltf, a gene regulated by E2 
in the uterine epithelium (Jefferson et al., 2000) is highly expressed in aged females, and E2-
directed proliferation of the LE occurs robustly. Interestingly, expression Ihh, which acts as a 
paracrine signal from the LE to the stroma is reduced in E3.5 uteri from aged females 
(Appendix, Supplementary figure 3), suggesting that the ability or timing of communication 
between the LE and USCs is affected by maternal ageing. 
 The most severe defect appears to be in the progesterone responsiveness of uteri 
from aged females. This is supported by the persistence of proliferating cells in the LE, and 
robust expression of E2 response genes in aged E3.5 uteri, which suggests a failure of P4 to 
antagonise the E2-directed epithelial proliferation and gene expression. This may be a result 
of insufficient expression of the P4 regulated gene Hand2. Hand2 expression in the uterine 
stroma promotes production of members of the Fgf family, which mediate the mitogenic 
effect of E2 on the LE (Li et al., 2011). Indeed, the expression of Hand2, and multiple 
members of the Fgf family including Fgf2, Fgf5, and Fgf10 are decreased in USCs isolated 
from aged females (Appendix, Supplementary figure 3). The absence of proliferating cells in 
the uterine stroma, the reduced expression of P4 target genes and the severely reduced 
decidualization response in aged females provides further evidence of a defect in P4 
responsiveness. 
 Impaired uterine responses to P4 in aged USCs may be a result of reduced expression 
of Pgr itself. The variability in Pgr expression between cells of the same type, i.e. within the 
LE compartment and also within the stromal cell compartment, was intriguing. As I alluded 
to above, these differences may explain why some embryos develop seemingly normally – 
perhaps because they implanted at sites of largely adequate Pgr expression – while others 
fail to thrive, possibly because they implanted at sites of low/absent Pgr expression. The 
cause of this variability needs to be addressed in future studies that should include single 
cell approaches, to elucidate the full extent of this cellular heterogeneity. It is possible that 
regional variations in uterine blood flow or levels of hormones or metabolites causes this 
variability. RNA-seq analysis of upper and lower portions of the uterus did not show any 
gene expression differences, however microenvironmental variations may be present which 
would be not be detected by this analysis. Additionally, inter-individual variations may 
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explain why some of the age-associated defects I described exhibit a substantial amount of 
variability between samples, expressed as sometimes rather large standard deviations/error 
(e.g. Pgr levels in E11.5 decidua).  
The effect of decreased Pgr expression is likely to be compounded by the blunted 
expression, activation, and aberrant subcellular localisation of the Pgr co-activator Stat3 in 
aged USCs. Once ligand bound, Pgr translocates to the nucleus where the Pgr-A isoform 
physically interacts with activated, nuclear pStat3 (Lee et al., 2013). However, the impaired 
activation and unusual subcellular localisation of pStat3 in aged females suggests that this 
interaction may be severely impaired in the aged endometrium. These results could be 
verified in co-IP experiments from nuclear extracts in the future. Deletion of Stat3 in the LE 
leads to implantation failure (Pawar et al., 2013), a defect which is not apparent in aged 
pregnancies. However, mice with a stromal cell-specific Stat3 deletion exhibit a reproductive 
phenotype remarkably similar to that seen in aged pregnancies (Robker et al., 2014). The 
Stat3 stromal cell-specific conditional KO has no effect on the total number of implantation 
sites, but results in reduced embryo viability at E18, placentation defects, and a significantly 
increased incidence of resorption. In Chapter 3 I showed that conceptuses from pregnancies 
in aged mothers show a strikingly similar phenotype. This strongly suggests that age-related 
disturbances in Stat3 expression, phosphorylation, and localisation in USCs contributes to 
impaired P4 responsiveness, leading to placental defects with detrimental downstream 
effects on embryo development. This should be studied in more detail to increase our 
understanding of Stat3 regulation during decidualization, and the intricacies of its 
interaction with Pgr. Future studies should also survey the effect of Pgr-pStat3 interaction on 
the repertoire and transcriptional activation of Pgr target genes.  
Also of importance is the mechanism by which pStat3 is excluded from the nucleus in 
the uterine stroma of aged pregnancies. Studies suggest that Lif mediated phosphorylation 
of Stat3 occurs via the Jak/Stat pathway, where ligand bound Lifr induces Stat3 
phosphorylation at the plasma membrane, mediated by Janus tyrosine kinases. Activated 
pStat3 is internalised by receptor-mediated endocytosis, and transits to the perinuclear 
region where it can translocate to the nucleus. Disruption of the endocytic machinery blocks 
the translocation of pStat3 to the perinuclear region, resulting in its retention at the plasma 
membrane in a pattern similar to that in the stromal compartment of aged females (Bild et 
al., 2002). Elucidation of the mechanism underlying pStat3 nuclear exclusion may allow us to 
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improve pStat3 activation and translocation, and thereby improve decidualization in aged 
females. 
In the previous chapter, I showed that advanced maternal age perturbs development 
of the trophoblast compartment, with alterations in the normal differentiation programme 
from a trophoblast stem/progenitor cell to the various differentiated cell types. Maternal 
age-related defects in trophoblast differentiation are not due to intrinsic defects inherited 
from the oocyte of aged mothers, and instead ageing of the maternal uterine environment 
induces developmental defects in the trophoblast compartment. In this chapter, I have 
shown that USCs isolated from aged females exhibit a blunted decidualization response, 
which appears to be accompanied by alterations in the expression of secreted factors during 
decidualization. Culture and differentiation of TS cells in the presence of conditioned 
medium from aged USCs alters their differentiation programme, seemingly by increasing the 
rate of differentiation allowing more rapid downregulation of stem cell factors, and 
promoting differentiation to the TGC fate. This remarkably closely resembles abnormal 
differentiation of the trophoblast compartment which is associated with maternal ageing in 
vivo, suggesting that paracrine signals from the uterine stroma to the fetal trophoblast play a 
role in directing trophoblast differentiation in vivo, and this is perturbed in advanced 
maternal age.  
 These results prompt the question of what are the paracrine factors produced by 
USCs which modulate TS cell differentiation, and out of these which are the key mediators of 
abnormal TS differentiation in older females? In 2014 Ohinata and Tsukiyama derived TS 
cells from the mouse blastocyst under defined culture conditions, which included Fgf2, 
Activin A, and inhibitors of p160ROCK and Wnt signalling (Ohinata and Tsukiyama, 2014). A 
number of Fgf and Wnt family signalling molecules including Fgf2, Fgf10, Wnt4, and Wnt9a 
are significantly down-regulated in decidualizing USCs from aged females (Appendix, 
Supplementary figure 3), which may influence maintenance of the TS cell state in aged 
pregnancies. Another possible explanation lies in the ability of USCs to promote 
sequestration of Fgf and heparin, which would promote the maintenance of TS cell identity 
through the continued supply of these factors. Expression of Heparin binding epidermal 
growth factor (Hbegf) and glypicans which are able to sequester heparin and Fgfs, 
respectively, are de-regulated in in vitro decidualizing aged USCs (Appendix, Supplementary 
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figure 3). This may affect the availability of growth factors in the culture medium and thus 
alter the dynamics of TS cell differentiation. 
Excitingly, this experiment could equally be performed on human TS cells which were 
successfully derived for the first time by Okae and colleagues in January 2018 (Okae et al., 
2018). The identification of paracrine factors affecting trophoblast differentiation in human 
pregnancy could lead a to deeper understanding of the mechanisms underlying various 
placental pathologies, and may facilitate the development of treatments to combat them. 
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Chapter V 
Epigenetic mechanisms of uterine ageing 
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5.1 Introduction 
 
Traditionally, epigenetics has been defined as the study of heritable modifications to the 
genome which occur without any change to the underlying DNA sequence. Epigenetic 
modifications are responsible for the regulation of genetic material in terms of its functional 
use and stability, such that they represent the link between genotype and phenotype. The 
epigenetic landscape changes measurably with advancing age, with global changes to DNA 
methylation and histone modifications observed in ageing organisms and tissues (Pal and 
Tyler, 2016). As age increases chromatin becomes globally more open and accessible, a 
phenomenon known as the heterochromatin loss model of ageing which is conserved in all 
eukaryotes from yeast to humans (Tsurumi and Li, 2012; Villeponteau, 1997). This model 
suggests that loss of heterochromatin due to age-related changes in the epigenetic 
landscape alters global nuclear architecture, resulting in aberrant expression of genes in 
affected regions. 
As well as global changes in chromatin structure, ageing is also associated with 
epigenetic drift at specific loci. Over the lifespan of an organism epigenetic modifications are 
imperfectly maintained, leading to stochastic changes mainly in DNA methylation which 
reflects a gradual drift away from the baseline (Issa, 2014). Although many studies looking 
into epigenetic mechanisms of ageing have yielded contradictory results, it is clear that 
ageing is accompanied by changes to DNA methylation and histone modifications which may 
be associated with the functional changes that can be observed during the ageing process. 
DNA methylation is subject to epigenetic drift, where environmental factors and stochastic 
errors leads to gradual divergence of the DNA methylation landscape. DNA methylation also 
exhibits specific, directional changes with ageing including hypermethylation of some 
promoter-associated CpG islands (Issa, 2014; Pal and Tyler, 2016), and hypomethylation at 
CpG-poor promoters, intergenic regions and gene bodies (Issa, 2014; Winnefeld and Lyko, 
2012). 
 Epigenetic changes during ageing have not been thoroughly studied in a reproductive 
context, and most studies that have been published focus on age-related changes in oocytes. 
One study showed that the expression of DNA methyltransferases (DNMTs) is reduced in 
oocytes from aged females, accompanied by decreased levels of DNA methylation (Yue et 
al., 2012), and suggested that this could be the mechanism underlying the maternal-age-
associated increase in fetal malformations. However, in Chapter 3 I showed through embryo 
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transfer experiments that the effect of ageing on the maternal reproductive tract underlies 
developmental abnormalities in the conceptus, with little effect from the ageing oocyte. 
 Age-related epigenetic changes have not previously been studied in the mouse 
uterus. However, maintenance of proper epigenetic regulation in mouse reproductive 
tissues is functionally important, as highlighted by one study which showed that the CBA/J x 
DBA/2 mouse model of pregnancy failure is characterised by disturbance of DNA 
methylation in the decidua (Brown et al., 2013), whilst methylation in the trophoblast 
portion remained normal. It is likely that DNA methylation in the endometrium is dynamic. 
Specifically, steroid hormone responsive gene promoters appear to rapidly methylate and 
demethylate at promoter CpG sites to regulate the transcription of target genes (Métivier et 
al., 2008), and could thereby cyclically regulate the transcriptome through the 
estrous/menstrual cycle. Indeed, in humans DNA methylation changes have been linked to 
reproductive disease states including endometriosis and endometrial cancers (Dyson et al., 
2014; Ji et al., 2017; Jones et al., 2013; Tao and Freudenheim, 2010), and it has been 
suggested that DNMT expression is regulated throughout the menstrual cycle and correlates 
with cycle stage specific fluctuations in DNA methylation (Ghabreau et al., 2004; Houshdaran 
et al., 2014; Yamagata et al., 2009). 
 Decidualization itself may be regulated epigenetically through the action of steroid 
hormones on USCs. Research in this area is in its infancy. One study found that expression of 
Dnmt1 and Dnmt3a is up-regulated during murine decidualization in vivo, and inhibition of 
DNA methylation with 5-azacytidine perturbs the decidualization response (Gao et al., 2012), 
thus demonstrating that DNA methylation is required for normal decidualization. Research 
into decidualization of human endometrial stromal cells similarly shows that the expression 
of DNMTs is regulated in response to in vitro decidualization (Grimaldi et al., 2012; Logan et 
al., 2013; Vincent et al., 2011; Yamagata et al., 2009), suggesting that the importance of DNA 
methylation in decidualization is conserved in humans. 
 In the previous chapter, I showed that aged mice have an altered uterine 
transcriptome during early pregnancy. This is characterised by a blunted response to P4, and 
dys-regulation of key genes involved in decidualization. As the epigenome changes as a 
function of age, and this can lead to age-related changes in gene expression and tissue 
function, this brought about the hypothesis that alterations in the uterine epigenetic 
landscape may underlie, or at least contribute to, the defects observed during pregnancy in 
aged females, which I will investigate in this chapter. 
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5.2 Results 
 
5.2.1 Histone modifications in uterine stromal cells 
 
In Chapter 4, I showed that in aged females the uterine stromal compartment is unable to 
mount a robust decidualization response, due to reduced hormone responsiveness 
associated with abnormal expression of Pgr and its co-activator pStat3. Hence, I proceeded 
to investigate the epigenetic regulation of transcription in aged USCs to shed light on the 
potential underlying mechanism. I focused on USCs as they appeared the cellular 
compartment exhibiting the most profound and physiologically relevant defects. To 
investigate the distribution of histone modifications in USCs from young and aged females, I 
performed chromatin immunoprecipitation sequencing (ChIP-seq) for the activating mark 
histone 3 lysine 4 trimethylation (H3K4me3). Peaks were called on each sample (n=3) using 
the Macs2 package (Feng et al., 2012; Zhang et al., 2008), and a consensus peak list was 
generated using the R package DiffBind (Stark and Brown, 2011) to find peaks present in 
young and/or aged samples. For H3K4me3, Macs2 peaks defined 2 groups containing young 
and aged samples respectively (Fig 5.1a). 19,419 peaks were called in young samples, and 
13,178 in aged, with 12,426 peaks present in both young and aged (Fig 5.1b). H3K4me3 
peaks were mainly located in promoter regions as expected, with similar proportions of 
peaks called in young and aged falling in promoters (Fig 5.1c) (Appendix, Supplementary 
figure 5). After correction for library size, the data showed higher enrichment under peaks in 
young USCs than aged, suggesting there may be a global decrease in H3K4me3 with ageing 
(Fig 5.1d), as has been shown in studies on Drosophila (Wood et al., 2010). To address this 
possibility, I measured total levels of H3K4me3 by western blot, which showed there was no 
difference in total H3K4me3 between young and aged USCs (Fig 5.1e). This led me to 
conclude that the differential enrichment intensity must have been due to technical 
variability in the efficiency of the IP between different samples, not absolute differences in 
H3K4me3 levels. Therefore, I normalised the ChIP-seq data using enrichment normalization 
quantitation at the 20th and 90th percentiles in Seqmonk to correct for the variability in 
enrichment. I then applied DESeq2 (p<0.05) to test for differential enrichment of H3K4me3 
at consensus peaks in USCs from young and aged females. This resulted in 3318 differential 
peaks, 1963 of which were enriched and 1355 depleted for H3K4me3 in aged USCs (Fig 5.1f). 
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 Figure 5.1 - The pattern of H3K4me3 is altered in aged USCs. 
a)  Correlation heatmap showing the correlation in H3K4me3 in young (Y) and aged (A) 
uterine stromal cells (n=3). Correlation is based on the read count under consensus 
peaks from ChIP-seq data. Plot was generated using the R package DiffBind. 
b) Venn diagram showing the overlap between H3K4me3 peaks called in young and aged 
USCs. 
c) Pie chart showing the distribution of H3K4me3 consensus peaks in genomic features. 
d) Scatter plot showing the amount of H3K4me3 (RPKM) under consensus peaks in 
young and aged USCs (n=3), from ChIP-seq data, before normalisation in Seqmonk. 
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e) Western blot showing protein levels of H3K4me3 and H3 in uterine stromal cells (USC, 
n=2) from young and aged females. 
f) Scatter plot showing the amount of H3K4me3 (RPKM) under consensus peaks in 
young and aged USCs (n=3), from ChIP-seq data, after normalisation to the 20th and 
90th percentile in Seqmonk. Peaks with significantly increased levels of H3K4me3 in 
aged USCs are highlighted in blue, those with significantly decreased levels are 
highlighted in red (DESeq2 p<0.05). 
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Expression of genes with significantly different levels of H3K4me3 peak enrichment in their 
promoter shows that those with increased H3K4me3 in aged samples generally exhibited 
increased expression, and those with decreased H3K4me3 showed decreased expression (Fig 
5.1g-h). This is in line with current knowledge on the function of H3K4me3, indicating that 
the normalisation yielded reliable results that accurately reflected the true biological 
situation.  
Functional annotation of differentially modified regions using GREAT (McLean et al., 
2010) showed their relevance to USCs, with significant enrichment of terms such as 
regulation of cell proliferation, angiogenesis, and cell adhesion, all of which were also 
enriched in RNA-seq data from aged USCs (Fig 5.1i) (Appendix, Supplementary figure 4). 
Interestingly, differentially modified peaks were also associated with pre-eclampsia, a 
condition of pregnancy characterised by shallow trophoblast invasion of the decidual bed 
(Kanasaki and Kalluri, 2009), and mouse phenotypes such as abnormal reproductive system 
morphology, partial lethality throughout fetal growth and development, and heart 
development (Fig 5.1i).  
A significant proportion of peaks with differential enrichment of H3K4me3 in aged 
USCs overlapped with Pgr binding sites in the uterus (Fig 5.1j). As I showed in Chapter 4, 
transcriptional regulation of Pgr target genes is abnormal in aged uteri. Taken together, 
g) Heatmap showing the expression (RPKM, RNA-seq data) of genes in young and aged 
USCs (n=3), which are within 2kb of a peak with significantly decreased levels of 
H3K4me3 in aged USCs, after normalisation of ChIP-seq data. 
h) Heatmap showing the expression (RPKM, RNA-seq data) of genes in young and aged 
USCs (n=3), within 2kb of a peak with significantly increased levels of H3K4me3 in 
aged USCs, after normalisation of ChIP-seq data. 
i) Gene ontology annotations which are significantly enriched in genes within 2kb of a 
peak with significantly increased/decreased levels of H3K4me3 in aged USCs. 
Bonferroni p<0.05 
j) Venn diagram showing the number of H3K4me3 peaks with significantly 
increased/decreased levels of H3K4me3 in aged USCs which are within 2kb of a 
Progesterone receptor (Pgr), or Estrogen receptor (Esr1) binding site. Statistical 
analysis by Fischer’s exact test. 
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these results suggest that Pgr fails to correctly modulate the expression of its target genes in 
aged uteri, and therefore H3K4me3 is not deposited and/or erased at these genes, in line 
with their transcriptional de-regulation. 
This could be a result of reduced interaction between Pgr and its target genes, 
reduced competence of the Pgr to regulate its targets due to abnormal expression of Pgr 
coactivators, or an abnormal response of the histone methylation machinery. The 
enrichment of Esr1 binding sites in H3K4me3 peaks perturbed by ageing did not reach 
significance (Fig 5.1j). This may reflect the greater importance of Pgr signalling in USCs, 
compared to Esr1 signalling as suggested in the previous chapter. As this experiment was 
performed on USCs isolated at E3.5 of pregnancy during the period of hormonal priming, my 
results suggest that the remodelling of H3K4me3 at Pgr target genes in this priming period is 
incomplete or perturbed in aged females. This may contribute to the impaired 
decidualization response which I have shown occurs in aged females in both deciduoma 
assays and in vitro decidualization. 
 Interestingly, besides age-related differences in H3K4me3 peak location and 
intensity, H3K4me3 peaks also tended to be significantly shorter in aged USCs (Fig 5.2a-b). 
Most strikingly, in particular regions exhibiting the broadest peaks in young USCs of up to 
50kb in length, were marked by much shorter stretches of H3K4me3 in USCs from aged 
females. For example, the Hox gene cluster containing Hoxa10, a gene necessary for stromal 
cell decidualization, is marked by a broad domain of H3K4me3 spanning 48.3kb in USCs from 
young females. This peak spans only 32.1kb in USCs from aged females, and the peak 
intensity is also reduced in magnitude (Fig 5.2c). The Pgr promoter is overlapped by a peak 
of 10.2kb in young USCs, however this was drastically reduced in both breadth and intensity 
in aged USCs (Fig 5.2d). In some cases, e.g. at Hand2, a very broad peak of 18kb spanned the 
entire gene in young USCs, but this was completely absent in aged USCs. This pattern of 
reduced peak breadth and the absence of very broad peaks in aged USCs is conserved over a 
number of genes that are of pivotal importance for decidualization. In general, these data 
are in line with a previous observation that genes essential for cell identity and cell type-
specific function are marked by very broad regions of H3K4me3 (Benayoun et al., 2014). 
Benayoun et al., showed that genes in such regions are characterised by enhanced 
chromatin accessibility and increased occupancy of paused PolII at their promoters. 
Importantly, these broad H3K4me3 domains have been associated with enhanced 
transcriptional stability at the single cell level. 
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Figure 5.2 - The breadth of H3K4me3 peaks is decreased in aged USCs. 
a) Heatmap showing the position and breadth of H3K4me3 peaks relative to the 
transcription start site. Peaks were called individually on 3 independent biological 
replicates of USCs from young and aged females. 
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The authors suggested that broad H3K4me3 domains confer precise transcriptional 
regulation at key cell identity genes. In young USCs, genes marked by the top 5% broadest 
peaks included the P4 and E2 nuclear receptors Pgr and Esr1, and a number of genes 
associated with decidualization such as Hand2 and Wnt5a (Fig 5.2d). Gene ontology analysis 
confirms that the affected genes are involved in decidualization, with terms such as 
differentiation, regulation of proliferation, PI3K signalling, and Wnt signalling (Appendix, 
supplementary figure 6). The breadth of these peaks was reduced in aged USCs in 79% of 
cases, by 2.7kb on average, and in 8% of cases the peak was completely absent in aged USCs 
(Fig 5.2d). These results suggest that changes in the pattern of H3K4me3 in USCs from aged 
females may affect the reinforcement of cell identity and function, potentially by reduced 
chromatin accessibility and paused PolII occupancy of key hormone responsive genes, 
although this would require further investigation. 
Although my data suggest that H3K4me3 peak breadth at key decidualization genes 
is decreased in aged USCs, it is technically possible that this is due to a reduced ability to 
isolate chromatin, or immunoprecipitate H3K4me3 from aged cells, although the reasons for 
that would be difficult to explain. An inefficient H3K4me3 enrichment would result in 
increased background levels in the sequencing data, which may affect peak calling by Macs2. 
The fact that peak breadth is shorter overall, even at loci that have no obvious association 
with decidualization suggests this may indeed be a potential issue that has to be addressed 
in future experiments. However, the observation that very broad H3K4me3 domains at some 
b) Violin plot showing the difference in breadth of H3K4me3 peaks called independently 
in young and aged USCs (n=3). Plot has been cut-off at 20,000kb to better show the 
difference in mean. Black diamond indicates the mean of each group, two-tailed t-
test ***p<0.001. 
c) Plots showing the breadth of H3K4me3 peaks called independently on young (green 
bars) and aged (blue bars) USCs and their associated gene (arrow indicates the 
direction of transcription). Wiggle plots below indicate the read count of H3K4me3 
ChIP-seq datasets (normalised to largest dataset) in young and aged USCs. Peaks 
within 2kb were merged. 
d) Pie chart showing the direction of change when comparing the breadth of H3K4me3 
peaks overlapping promoters in both young and aged USCs. Direction of change is 
relative to young USCs. 
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key decidualization genes including Hand2 are not only shorter but in some cases absent in 
aged USCs, is likely to be a true biological age-related change that may reflect the impaired 
decidualization response of aged USCs. Reduced breadth of H3K27me3 domains has been 
previously described in ageing muscle stem cells (Liu et al., 2013). These changes may 
constitute either a cause, or a consequence, of the failing gene activation. 
 
5.2.2 DNA methylation in young and aged E3.5 uteri 
 
 I next went on to study the DNA methylation landscape of the uterus during pregnancy in 
aged females. DNA methylation is perturbed in multiple ageing tissues, and such 
perturbations can lead to functional alterations and disease (Johnson et al., 2012). 
I performed methylated DNA immunoprecipitation sequencing (MeDIP-seq) on DNA 
extracted from the same samples of pseudo-pregnant uteri as those analysed by RNA-seq in 
Chapter 4, to reveal any correlations between DNA methylation and gene expression. 
MeDIP-seq analysis shows that the young and aged uteri are overall highly similar in their 
pattern of 5-methylcytosine (5mC) deposition (Fig 5.3a). However, analysis of the 
enrichment of 5mC in various genomic features shows that there is a small, but significant 
increase in 5mC enrichment in CpG islands (CGIs) and at promoters – the latter probably 
reflecting the presence of CGIs in a subset of gene promoters (Fig 5.3b). This is in line with 
previous reports that promoter associated CGIs become hypermethylated with age in a 
tissue specific manner (Zampieri et al., 2015). 
 Closer interrogation of CGIs suggests that whilst globally they become slightly 
hypermethylated in aged uteri (Fig 5.3b), only 3 individual CGIs showed a significant change 
in 5mC when analysed using the MEDIPS package (Lienhard et al., 2014) (Fig 5.3c). The CGI 
spanning exon 2 of C2 calcium dependent domain containing 4d (C2cd4d) was significantly 
hypermethylated in aged uteri, however RNA-seq data shows this gene is not expressed in 
the maternal uterus at E3.5, nor in the decidua at E11.5 of pregnancy, and the C2cd4d 
knockout mouse displays no reproductive phenotype (Omori et al., 2016). Therefore, it is 
unlikely that this gene plays an important role in aged pregnancies. The remaining two 
differentially methylated CpG islands were located intergenically, one of which became 
hypermethylated with age, and the other hypomethylated (Fig 5.3c). I then scanned the 
genome in an unbiased manner to identify specific loci which were differentially methylated  
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between young and aged uteri, using MEDIPS with a window size of 200bp. This identified 
only 1 region, located on chromosome 11 at Sfi1 homolog, spindle assembly associated 
(yeast) (Sfi1), however, this region was excluded from further analysis, as multiple loci in this 
Figure 5.3 - DNA methylation in E3.5 uteri from aged females. 
a) Scatter plot showing similar levels of 5-methylcytosine (5mC) (RPKM) as measured by 
MeDIP-seq, in E3.5 uteri from young (n=3) and aged (n=5) females, in 2kb windows running 
consecutively along the genome. 
b) The relative enrichment (log2 transformed) of 5mC in different genomic features in E3.5 
uteri from young (n=3) and aged (n=5) females, as measured by MeDIP-seq. Two-tailed t-
test *p<0.05, **p<0.01. 
c) Scatter plot showing the levels of 5mC at CpG islands in E3.5 uteri from young (n=3) and 
aged (n=5) females, as measured by MeDIP-seq. Three CpG islands with significantly 
different levels of 5mC as detected by MEDIPS analysis (p<0.05) in r are highlighted in blue. 
d) IHC staining for 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) in E3.5 uteri 
from young and aged females. Arrows indicate higher levels of 5hmC in the glandular 
epithelium of young uteri. Scale bar: 100μm. 
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gene have been identified as ‘blacklist’ regions 
(http://mitra.stanford.edu/kundaje/akundaje/release/blacklists/). In addition, since RNA-seq 
data show that Sfi1 is not expressed in E3.5 uteri it is unlikely to play a role in uterine 
function either. 
These data suggest that ageing in the mouse uterus follows the generally accepted 
patterns of DNA methylation changes in terms of the acquisition of 5mC at CGIs. No changes 
were seen in gene body methylation. The age-related differences in DNA methylation that I 
have shown are of relatively small magnitude, and do not appear to affect gene expression 
at this stage of pregnancy. It is therefore unlikely that changes in DNA methylation are the 
primary mechanism underlying abnormal uterine function in advanced maternal age. 
Immunohistochemical (IHC) staining suggests there are small cell-type specific 
differences in 5mC in the uterus, with enrichment of 5mC in the GE of uteri from young 
females which is not apparent in those from aged mice (Fig 5.3d). Interestingly, differences 
in the levels of 5-hydroxymethylcytosine (5hmC) are also apparent, showing a similar pattern 
of GE enrichment in young females. This would be interesting to investigate in detail in 
future studies, as 5hmC has been implicated in ageing in other tissues such as the 
cerebellum (Chen et al., 2012). So far 5hmC remains largely unstudied in the context of 
uterine function, however this topic was outside of the scope of my PhD thesis work.  
 
5.2.3 DNA methylation in young and aged E11.5 decidual tissue 
 
Although I observed only slight changes in 5mC in the uteri of aged females at E3.5, a study 
by Gao and colleagues in 2012 showed that in normal pregnancy the DNA 
methyltransferases Dnmt1 and Dnmt3a are up-regulated at implantation sites from day 7, 
and were induced by artificial decidualization. Inhibition of DNA methylation by 5-
azacytidine exposure strongly inhibited decidualization, affecting USC proliferation and 
expression of decidualization markers (Gao et al., 2012). This is similar to the age-related 
perturbation in decidualization I showed in Chapter 4, suggesting that DNA methylation may 
have a role in decidualization after the priming period, i.e. after E3.5. Hence, I went on to 
investigate DNA methylation in the E11.5 decidual samples that I had previously analysed by 
RNA-seq in Chapter 3. Analysis with MEDIPS identified 214 differentially methylated regions 
(DMRs) between E11.5 deciduas from young and aged females. Intriguingly, all these sites 
exhibited lower DNA methylation levels with age (Fig 5.4a). Differential methylation was 
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confirmed at base pair resolution for the promoter region of Pou2f1, by amplicon 
sequencing of bisulphite-treated DNA. This showed that DNA methylation was decreased in 
aged samples at some CpGs, although total DNA methylation was low at these regions even 
in young samples (Fig 5.4b).  
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Overall, the majority of the 214 decidua DMRs were confined to intergenic and intronic 
regions, but a substantial proportion (~18%) were also located at promoters defined as 
immediately upstream (≤3kb) of the transcriptional start site (Appendix, Supplementary 
figure 7). 38 of the 214 DMRs overlapped CGIs, 16 of which were within the promoter group 
(Appendix, Supplementary figure 8). I hypothesised that loss of methylation may result in 
increased expression of the associated gene, and analysed the expression of genes 
associated with decidua DMRs in the corresponding RNA-seq datasets (Chapter 3). 93 DMRs 
were associated with a gene (i.e. within 2kb), and only 15/93 were significantly differentially 
expressed (Fig 5.4c). Moreover, similar fractions of these genes were up- as well as down-
regulated, i.e. there was no consistent effect of differential methylation on the direction of 
gene expression changes (Fig 5.4d). However, when I used the 214 decidual DMRs for 
analysis with the Gene Regions Enrichment of Annotations tool (GREAT) (McLean et al., 
Figure 5.4 - DNA methylation is abnormal in E11.5 deciduas from aged females. 
a) Heatmap showing significantly reduced DNA methylation at 214 differentially methylated 
regions (DMRs, identified by MEDIPS p>0.05) in E11.5 deciduas from aged females. DNA 
methylation is affected both in deciduas associated with grossly normal, and abnormal 
embryos. 
b) Wiggle plot showing the relative amount of 5-methylcytosine near the promoter of the 
Pou2f1 gene, which was identified as having significantly decreased 5mC in aged deciduas. 
Grey bars indicate location of Pou2f1 gene. Blue rectangle indicates the location of the 
MEDIPS window identified as being differentially methylated in MeDIP-seq data. The bar plot 
below shows the %DNA methylation at CpGs within the MEDIPS window as measured by 
amplicon sequencing of bisulphite converted DNA from young and aged E11.5 deciduas. 
c) Venn diagram showing the overlap between genes that were differentially expressed (DE, 
RNA-seq data), and regions that were differentially methylated (DM, MeDIP-seq data) in 
E11.5 deciduas from aged pregnancies. 
d) Heatmap showing the relative expression (RNA-seq data) of genes associated with a DMR in 
aged E11.5 decidua. Gene expression changes are relatively small and inconsistent in 
direction. 
e) Enrichment of biological annotations by Genomic regions enrichment of annotations tool 
(GREAT) analysis in the 214 DMRs in E11.5 deciduas from aged pregnancies. 
f) The relative enrichment (log2 transformed) of 5-methylcytosine in genomic features in E3.5 
uteri and E11.5 deciduas from young and aged pregnancies, as determined by MeDIP-seq. 
Statistical analysis by two-tailed t-test *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
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2010), two terms were significantly associated with these sites, notably the term “absent 
ectoplacental cone” (Fig 5.4e). This per se was surprising as the DMRs were identified in 
decidual tissue. However, these findings suggested that the genes regulated by these sites 
may be involved in placental development, and/or that these same genes have a function in 
trophoblast as well as decidual development, but that the latter is less well annotated. I 
performed motif analysis of the 214 DMRs, using the Analysis of Motif Enrichment (AME) 
tool in the MEME Suite package (McLeay and Bailey, 2010) to find known transcription factor 
binding motifs which were enriched in decidua DMRs. The only significantly enriched motif 
identified was specific to the binding site for the transcription factor Ets2 (adjusted p-value = 
1.28e-02) (Appendix, Supplementary table 6), which has been postulated to play an  
important role in decidualization as well as placentation (Georgiades et al., 2002; 
Salamonsen et al., 2003). 
As region-specific alterations in DNA methylation were not detected in the uterus at 
E3.5, but had developed by E11.5, I hypothesised that 5mC is either lost, or fails to be 
deposited, at specific genomic regions during pregnancy in aged females. Globally, I found 
significantly reduced methylation at exons, CGIs, and promoters in E11.5 deciduas from aged 
versus young mothers (Fig 5.4f), suggesting this may indeed be the case. Interestingly, this is 
the opposite pattern to that observed at E3.5 of pregnancy. Focussing on young females, my 
data shows that the enrichment of 5mC at genomic features changes significantly between 
E3.5-E11.5. 5mC becomes more enriched at all features studied, apart from introns where it 
was depleted at E11.5 compared to E3.5 (Fig 5.4f). Most strikingly, 5mC was dramatically 
increased at exons, CGIs, and promoters at E11.5. 
 
5.2.4 DNA methylation in the uterus is remodelled during pregnancy 
 
 This data, combined with the findings from Gao et al., 2012 that DNMT expression 
increases in the decidua at E7, suggest that DNA methylation may be remodelled as 
pregnancy progresses. Focussing on the young control samples only, a chromosome wide 
view of DNA methylation at E3.5 and E11.5 clearly shows that 5mC is globally altered 
between the two time-points, with significantly higher enrichment of 5mC across a large 
number of sites at E11.5 compared to E3.5 (Fig. 5.5a). This global pattern of 5mC acquisition 
with gestational progression is conserved in aged females.  
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To further investigate the behaviour of these dynamically changing 5mC sites, I 
analysed the MeDIP data for differential methylation, comparing uteri from young mothers 
at E3.5 with “young” decidua at E11.5. This identified 89,685 regions which were 
differentially methylated between the two stages, the bulk of which exhibited increased 
5mC at E11.5 (Fig 5.5b). The majority of changes occurred at intergenic regions, 
approximately 10% were at promoter regions, 15% in exons, and 29% at introns (Appendix, 
Supplementary figure 7). 5356 differentially methylated windows overlapped with CGIs, with 
1463 of these at promoter CGIs. The methylome dynamics in uteri and deciduas from aged 
females showed that these DNA methylation changes were globally similar to those 
observed in young females, when interrogated at the same loci (Fig 5.5c). This suggested 
that the acquisition of DNA methylation across these features occurs largely normally in 
aged pregnancies.  
However, when assessing the DNA methylation dynamics between gestational stages 
between young and aged females, exons, CGIs, and promoter regions exhibited a 
significantly less pronounced enrichment of 5mC at E11.5 (Fig 5.5f). Strikingly, whilst 5mC 
became enriched at promoter regions in young females, there was no change at promoters 
in aged samples. These data suggest that DNA methylation remodelling at exons, CGIs, and 
promoters during decidual development is abnormal with advanced maternal age. Adding to 
this, on closer inspection of the 89,685 regions that gained DNA methylation between E3.5-
E11.5 in young deciduas, I found that a subset of them remained hypomethylated in aged 
females compared to young. Using a differential methylation cut-off of 2 RPKM, I identified 
331 regions which gained 5mC in deciduas from young mothers but failed to do so in 
deciduas from aged females (Fig 5.5d-e, g). This suggests that during pregnancy in aged 
females, although uterine methylome remodelling is largely successful, a small number of 
regions are resistant to methylation gain. I termed these sites “refractory DMRs”.  
The genomic distribution of these refractory DMRs was vastly different from the 
previously analysed sets of differentially methylated sites, with almost 50% located in 
promoters (Fig 5.5h), and a large proportion in CGIs (Appendix, Supplementary figure 7-8), in 
line with the genomic feature enrichment analysis (Fig 5.5f). This in itself suggested a 
potentially important role of these sites in uterine function and decidualization. However, 
enrichment analysis of refractory DMRs with GREAT did not reveal any terms relevant and 
specific to placentation (Fig 5.5i). Expression of genes overlapping refractory DMRs was 
altered in “aged” deciduas, with approximately half up-regulated and half down-regulated in 
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aged samples (Fig 5.5j). This suggests that the failure of refractory DMRs to gain methylation 
Figure 5.5 – DNA methylation remodelling in the decidua is incomplete in aged pregnancies. 
a) Overview of the relative levels of 5-methylcytosine across the entirety of chromosome 19 in 
E3.5 uteri and E11.5 deciduas from young and aged females, as measured by MeDIP-seq. 
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in aged pregnancies does not systematically affect gene expression and decidual function at 
b) DNA methylation changes in young pregnancies. Scatterplot showing the relative levels 
(RPKM) of 5mC in regions found to be differentially methylated between young E3.5 uteri and 
E11.5 deciduas, by MEDIPS analysis of MeDIP-seq data. The overwhelming majority of regions 
gain methylation between E3.5-E11.5. 
c) DNA methylation changes in aged pregnancies. Scatterplot showing the relative levels of DNA 
methylation in aged E3.5 uteri and E11.5 deciduas, at regions which are differentially 
methylated during pregnancy in young deciduas (Fig5.5b). 
d) Repeat of scatterplot in Fig 5.5b, with refractory DMRs highlighted in blue. These regions gain 
methylation in young pregnancies between E3.5-E115. 
e) Repeat of scatterplot in Fig5.5c, with refractory DMRs highlighted in blue. These regions do 
not change in terms of methylation level in aged deciduas between E3.5-E11.5. 
f) The relative enrichment (log2 transformed) of 5-methylcytosine in genomic features in E3.5 
uteri and E11.5 deciduas from young and aged pregnancies, as determined by MeDIP-seq. 
Statistical analysis by two-tailed t-test*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Repeat 
of plot shown in Fig 5.4f. 
g) Heatmap showing the relative levels of DNA methylation at refractory DMRs in young and 
aged pregnancies, between E3.5-E11.5. Refractory DMRs gain methylation in young 
pregnancies,but fail to do so in aged pregnancies. 
h) Pie chart showing the distribution of refractory DMRs in genomic features. 3’ UTR, 3’ 
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E11.5 of pregnancy, however this does not rule out the possibility that gene expression 
could be affected at earlier or later stages. 
The 331 refractory DMRs did not overlap with DMRs found by directly comparing 
deciduas from young and aged females (Appendix, Supplementary figure 9), however 
decidual DMRs showed the same characteristics as refractory DMRs, gaining methylation 
during young pregnancies, and failing to gain methylation in aged pregnancies (Appendix, 
Supplementary figure 10). As mentioned earlier, decidual DMRs were enriched for the Ets2 
transcription factor binding motif. Interestingly, refractory DMRs were also enriched for the 
Ets2 motif, as well as for a number of binding motifs specific for other TFs (Appendix, 
Supplementary table 6). These include members of the Klf family which are implicated in 
endometrial receptivity and female reproductive system pathologies (Simmen et al., 2015; 
Sun et al., 2012). These observations suggest that altered activity or availability of these TFs 
may prevent the acquisition of DNA methylation at refractory DMRs. Previous studies have  
found that TF binding to DNA can prevent DNA methylation (Marchal and Miotto, 2015), 
potentially by excluding the DNA methylation machinery. This suggests that increased DNA 
occupancy of Ets2 and Klf TFs in aged pregnancies may block the acquisition of DNA 
methylation at refractory DMRs. While this possibility will require further investigation to 
confirm, it is strongly corroborated by the fact that expression levels of Ets2 and some Klf 
family members are indeed increased in aged deciduas (Appendix, Supplementary figure 3). 
 
5.2.5 DNA methylation in aged E11.5 trophoblast 
 
DNA methylation plays a critical role during intra-uterine development, including in the 
development of extra embryonic tissues such as the trophoblast (Branco et al., 2016; Li et 
al., 1992; Okano et al., 1999; Tanaka et al., 2014), and is an important regulator of cell 
lineage decisions in the early embryo. Therefore, I analysed DNA methylation in trophoblast 
untranslated region. 
i) GREAT analysis of refractory DMRs, showing the enrichment of biological functional 
annotations at these regions. 
j) Heatmap showing the expression of genes within 2kb of a refractory DMR in young and 
aged deciduas at E11.5. Note that gene expression changes are relatively small in magnitude 
and inconsistent in direction. 
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from young and aged pregnancies at E11.5 by MeDIP-seq, using DNA isolated from the same 
samples on which RNA-seq was performed in Chapter 3. This analysis showed that although 
the distribution of methylation across the genome was overall very similar between young 
and aged trophoblast, there was a small but significant decrease in enrichment of 5mC at 
Figure 5.6 – Trophoblast from aged pregnancies loses DNA methylation at specific loci. 
a) The relative enrichment (log2 transformed) of 5-methylcytosine in genomic features in E11.5 
trophoblast from young (n=3) and aged (n=4) pregnancies, as determined by MeDIP-seq. 
Statistical analysis by one-way ANOVA followed by Tukey’s post-hoc test *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001. 
b) Heatmap showing the relative levels of 5mC in trophoblast from young (n=3) and aged (n=5) 
pregnancies at E11.5. 
c) The relative enrichment (log2 transformed) of 5-methylcytosine in genomic features in 
trophoblast from Y->Y (n=4) and A->Y (n=4) transfers, as determined by MeDIP-seq. 
Statistical analysis by two-tailed t-test *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
d) Heatmap showing the relative levels of 5mC in trophoblast from Y->Y (n=4) and A->Y  (n=4) 
transfers. 
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gene bodies, and in both introns and exons (Fig 5.6a). Trophoblast from aged females was 
also significantly depleted for 5mC in a set of differentially methylated regions (DMRs) 
inherited from the oocyte (Smallwood et al., 2011) (Fig 5.6a). Using MEDIPS, I identified 344 
DMRs in trophoblast from aged mothers (excluding sex chromosomes), almost all of which 
showed depletion of 5mC in aged samples (Fig 5.6b). These DMRs should be confirmed by 
amplicon sequencing of bisulphite treated DNA. Trophoblast DMRs were enriched for genes 
with relevance to trophoblast development, including regulation of biosynthetic processes, 
genes based on mouse models with female fertility defects and negative regulation of stem 
cell differentiation (Appendix, Supplementary figure 13), suggesting these loci may be 
involved in abnormal trophoblast development in aged females. In a similar way to that 
described for genes associated with refractory DMRs, genes associated with trophoblast 
DMRs were not robustly or consistently differentially expressed in aged trophoblast 
(Appendix, supplementary figure 11). 
As I showed in Chapter 3, transfer of embryos from aged females to young surrogate 
mothers rescued placental development on a gross morphological and transcriptional level. 
To investigate the effect of A->Y embryo transfer - compared to Y->Y transfer - on the DNA 
methylation landscape, I performed MeDIP-seq on DNA isolated from the same trophoblast 
samples which were analysed by RNA-seq. The methylomes of trophoblast from Y->Y and A-
>Y transfers were indistinguishable, both in terms of enrichment of 5mC in genomic 
features, and at the 344 trophoblast DMRs (Fig 5.6d-e). This lends further support to the 
hypothesis I put forward in Chapter 3, that the trophoblast compartment of embryos from 
aged mothers is intrinsically normal but develops abnormally when exposed to an aged 
maternal environment due to age-related defects in uterine function. 
Trophoblast DMRs did not overlap with the DMRs identified in decidua from aged 
females, or “refractory DMRs” (Appendix, Supplementary figure 9), confirming there is no 
confounding effect of contamination with the other placental compartment. Intriguingly, 
however, the Ets2 TF binding motif was also significantly enriched in trophoblast DMRs 
(adjusted p value = 4.70e-02) (Appendix, Supplementary table 6), similar to its enrichment in 
refractory DMRs in the decidua (Fig 5.5k). This suggests that there may be a common 
mechanism underlying the failing acquisition of DNA methylation at these DMRs in the 
trophoblast and decidua in aged pregnancies. 
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5.3 Discussion 
 
In this chapter I have shown that advanced maternal age is associated with robust changes 
in the epigenetic landscape of uterine and placental tissues, with disturbances in both DNA 
methylation, and H3K4me3 histone modification. As ageing is clearly accompanied by 
changes to the epigenetic landscape in many contexts, impacting on cellular function, I 
hypothesised that age-related epigenetic changes may contribute to the decidualisation 
defects observed in aged uteri. 
 In Chapter 4 I showed that USCs from aged females were unable to adequately 
undergo in vitro decidualization, partially due to impaired up-regulation of the progesterone 
receptor. As activating histone modifications such as H3K4me3 mark promoters of actively 
transcribed genes (Gu and Lee, 2013; Santos-Rosa et al., 2002), I hypothesised that 
alterations in H3K4me3 deposition may disrupt the regulation of gene expression in aged 
USCs. H3K4me3 was indeed perturbed in aged USCs, with significant enrichment and 
depletion of H3K4me3 in aged cells at a large number of promoters associated with 
decidualization, such as Hand2 and the Hoxa10/11 cluster. In line with my findings that 
genes regulated by Pgr are abnormally expressed in uteri from aged females, I found that 
genes associated with a Pgr binding site in the aged uterus are also associated with 
abnormal levels of H3K4me3 (and show differences in gene expression). There are a number 
of possibilities for the mechanism behind this observation. Firstly, abnormal levels of 
H3K4me3 in aged USCs may alter the accessibility of the chromatin, thereby preventing Pgr 
binding at its target genes, or allowing binding at ectopic sites. Consequently, this may 
perturb transcriptional regulation by Pgr. Alternatively, perturbation of Pgr target gene 
regulation – possibly due to its reduced expression and/or impaired interaction with co-
activators – may affect the deposition of H3K4me3, resulting in the abnormal H3K4me3 and 
transcriptional landscapes I have shown in aged USCs. It is unclear whether the abnormal 
distribution of H3K4me3 leads to the abnormal gene expression profile in aged USCs, or if 
H3K4me3 is a readout of expression. This is an area of active discussion in the field of 
epigenetics, and efforts to tease apart the relationship between H3K4me3 and transcription 
are ongoing (Cano-Rodriguez et al., 2016; Howe et al., 2017). It is also possible that the 
histone methyltransferase machinery is perturbed by ageing. For example, expression of the 
H3K9 methyltransferase Suv39h1 decreases with age in mouse and human hematopoietic 
stem cells (HSCs), with a concomitant global decrease in H3K9me3 and altered HSC 
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differentiation (Djeghloul et al., 2016). This explanation is less likely in the case of ageing 
USCs, as global levels of H3K4me3 are unchanged, and expression of the H3K4me3 
methyltransferases Prdm9, Kmt2a, Kmt2b, and Kdm5b, and demethylase Jarid1b is not 
altered in aged USCs (Appendix, Supplementary figure 12). 
However, the most striking finding was the discovery of very broad regions of 
H3K4me3 marking USC identity genes, as observed in a variety of other cell types where they 
are associated with cell identity and transcriptional consistency with increased paused PolII 
occupancy (Benayoun et al., 2014). Interestingly, in aged USCs H3K4me3 peaks were 
significantly less broad at these regions, suggesting that the maintenance of open chromatin 
and transcriptional consistency at key USC identity genes is disrupted with advanced 
maternal age. I could not show this directly with the data available, but this could easily be 
investigated by ATAC-seq and single-cell RNA-seq as a measure of chromatin accessibility 
and transcriptional consistency, respectively. 
The DNA methylome of uterine tissues during pregnancy has remained largely 
unstudied. Hence, I focused on DNA methylation in the uterus and decidua through the 
progression of pregnancy, to gain some insight into the role of DNA methylation in normal 
pregnancy, before attempting to delineate the effects of ageing. Through MeDIP-seq 
analysis, I observed a dramatic remodelling of the DNA methylome in the uterus/decidua 
between E3.5-E11.5 of pregnancy. This is characterised by enrichment of 5mC throughout 
the genome, especially at CGIs, with the exception of intergenic regions at which 5mC is 
depleted. From my data I cannot show whether global 5mC levels are altered during 
pregnancy, however my findings suggest that DNA methylation levels may increase in the 
decidua as pregnancy progresses. This should be investigated in the future by mass 
spectrometry. A previous study by Gao et al., 2012 supports these observations, showing 
that expression of both Dnmt1 and Dnmt3a is induced in the uterus during decidualization. 
Inhibition of DNA methylation disrupts the decidualization response of uterine stromal cells, 
leading to embryonic demise. Taken together, this suggests that the deposition of DNA 
methylation in the uterus is of major importance during pregnancy, and disruption of this 
can affect decidualization, placentation, and embryo development. 
 Although my data suggest that uterine DNA methylation remodelling does take place 
during pregnancy, the MeDIP libraries were sequenced in 2 batches separating E3.5 and 
E11.5 samples. Therefore, these results may be confounded by batch effects during 
sequencing and the libraries should be re-sequenced in a single lane to control for this 
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effect. However, the pregnancy-stage related changes that are observed are robust and 
consistent across all replicates, suggesting they reflect true biological changes. This finding 
should be followed by analysis of uterine/decidual DNA methylation at multiple stages of 
pregnancy to more intricately assess the timing and effects of DNA methylome remodelling 
during pregnancy. Although previous studies have suggested a role for dynamic DNA 
methylation in the uterus across the estrous cycle in mice and menstrual cycle in humans 
(Guo, 2012; Houshdaran et al., 2014), this is the first direct evidence that DNA methylation 
in the pregnant uterus is highly dynamic. DNA methylation remodelling may be regulated 
through the activity of pregnancy hormones (Ghabreau et al., 2004; Logan et al., 2013; 
Yamagata et al., 2009), and could reflect the need for tightly regulated transcriptional 
responses that are required for successful decidualization and placentation. 
After characterising the dynamic changes in DNA methylation during early 
pregnancy, I was able to investigate the effect of advanced maternal age on this process. As 
mentioned earlier, a previous study showed that inhibition of DNA methyltransferase 
activity during early pregnancy disrupted the decidualization response of USCs (Gao et al., 
2012), leading to a remarkably similar phenotype to that seen in pregnancies from aged 
females. This suggested that aberrant DNA methylation may play a role in reproductive 
decline with advanced maternal age, and warrants further investigation. Prior to 
decidualization, uterine tissues from aged females exhibited very few perturbations in 5mC 
at specific loci, suggesting they are largely normal in terms of DNA methylation. Aged 
pregnancies displayed DNA methylome remodelling similar to that observed in young 
pregnancies, however a small number of regions remained refractory to this gain in 
methylation. This suggests that the acquisition of DNA methylation remains incomplete at 
specific sites in aged pregnancies, leading to the emergence of refractory decidual DMRs in 
aged pregnancies. Although I could not equate differential methylation at refractory DMRs 
with consistent changes in gene expression, reduced DNA methylation levels may render 
these sites permissive for transcriptional activation. Indeed, E11.5 decidua DMRs were 
associated with pregnancy related genes, suggesting they may have functional 
consequences at earlier or later time points during gestation. 
Refractory DMRs in the deciduas of aged females may represent a delay in the 
acquisition of 5mC, similar to the delayed transcriptomic signature shown in Chapter 4. 
Alternatively, they may reflect a context specific inability to methylate these regions in aged 
pregnancies. It may be that refractory DMRs are rendered inaccessible to the DNA 
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methylation machinery, potentially by abnormal transcription factor binding activity as has 
been suggested in other contexts (Blattler and Farnham, 2013; Hervouet et al., 2010; 
Marchal and Miotto, 2015). Indeed, refractory DMRs are enriched for transcription factor 
binding motifs specific to a number of Klf family TFs, as well as Ets2. These TFs have known 
roles in decidualization (Salamonsen et al., 2003; Simmen et al., 2015; Sun et al., 2012), and 
are also more highly expressed in aged E3.5 uteri. Thus, it is likely that increased TF 
abundance leads to stronger or temporally prolonged genomic occupancy of their target 
sites, preventing these sites from becoming methylated in a timely manner. Alternatively, 
physical interactions between these TFs and the DNA methyltransferase machinery may 
alter DNMT catalytic activity. This is less likely, as DNA methylation was globally largely as 
normal in aged pregnancies, and the DNMTs were expressed at comparable levels in young 
and aged tissues (Appendix, Supplementary figure 12). Another possibility is that physical 
interaction between TFs and DNMTs could alter the targeting of DNMTs to genomic sites. 
This is possible, as Ets2 has indeed been shown to interact with Dnmt1 (Hervouet et al., 
2010), however Ets2 expression is increased in uteri from aged females (Appendix, 
Supplementary figure 3) which would be expected to promote DNA methylation targeting to 
its binding sites. 
The importance of DNA methylation in the trophoblast compartment is well known, 
with most studies focusing on the maintenance of monoallelic expression at imprinted 
regions, where one parental allele is expressed and the other repressed, often by DNA 
methylation. I did not see any clear impact of advanced maternal age on DNA methylation in 
classical imprinted regions, however 5mC was significantly depleted in trophoblast from 
aged females at a set of DMRs carried over from the oocyte, as identified by Smallwood et 
al., 2011. MeDIP-seq analysis also revealed the presence of age-related hypomethylated 
DMRs in the trophoblast compartment at other sites, unrelated to oocyte-inherited DNA 
methylation.  
Interestingly, the presence of trophoblast DMRs was similar to the situation observed 
in decidua from aged females where 5mC was reduced at a number of specific loci. Both 
E11.5 decidua and trophoblast DMRs were enriched for the Ets2 TF binding motif, suggesting 
there may be a common mechanism involved in the emergence of maternal-age-associated 
DMRs in the trophoblast and decidua. Hypothetically, dys-regulation of a paracrine signal 
originating from the aged uterus/decidua may affect the activity of Ets2 and other TFs in 
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both the decidua and trophoblast. This could lead to the loss of, or failure to gain 5mC at 
specific regions by a number of potential mechanisms, as discussed above. 
Perhaps one of the most compelling observations of this analysis was that this site-
specific depletion of DNA methylation was not evident in trophoblast from A->Y transfer 
conceptuses, i.e. upon development of embryos from aged mothers in a young maternal 
environment. Thus, these DMRs do not originate from epigenetic changes in the ageing 
oocyte or from defects in the protection of maternal methylation marks during 
preimplantation development. Instead, these findings demonstrate that the embryo’s 
epigenome can be affected by the uterine environment. In the future this should be 
confirmed by direct analysis of the identified DMRs by pyrosequencing, and ideally the 
putative paracrine signals identified, for example by comparative mass spectrometric 
analysis of the secretomes of young and aged decidual tissues.  
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6.1 Age-associated developmental defects in the embryo and 
placenta 
 
Maternal age is a significant risk factor for obstetric complications, and fetal developmental 
abnormalities in pregnancy. A significant proportion of pregnancy failure in older mothers 
can be attributed to aneuploidy and other age-related changes in the oocyte. However, 
some clinical studies have recognised that euploid pregnancies also fare significantly worse 
in older mothers, with increased risk of developing the “Great Obstetrical Syndromes”. The 
ageing oocyte is unlikely to be the source of these particular pregnancy complications. 
Instead, this spectrum of complications is most frequently attributable to abnormal function 
of the placenta in pregnancies uncomplicated by advanced maternal age (Brosens et al., 
2011). Development of the placenta is reliant on proper implantation of the conceptus into 
the uterine wall, and remodelling of the endometrium and maternal vasculature to support 
growth and development of the placenta and embryo. Thus, this implicates ageing of the 
uterus in the genesis of such developmental defects and obstetric complications in advanced 
maternal age.  
 Analysis of the gross morphology of conceptuses from B6 females between 48-52 
weeks of age showed that the offspring of aged female mice are significantly more 
developmentally variable than those from young mothers. They are also affected by fetal 
growth restriction ranging from mild to severe, an increased resorption rate, and heart and 
brain defects, confirming and building on findings from previous studies (Lopes et al., 2009; 
Talbert and Krohn, 1966). These outcomes closely resemble the developmental 
abnormalities that are part of the “Great Obstetrical Syndromes” which are prevalent in 
older women, including fetal growth restriction, miscarriage, and pre-eclampsia. The 
similarities in maternal age-associated complications of pregnancy suggest that the B6 
mouse can be used as model to mechanistically study uterine ageing, which may be 
conserved in humans. Aside from the morbidity directly associated with fetal growth 
restriction, offspring affected by low birth weight are subject to the long-lasting 
consequences of the pre-natal environment throughout their adult life. Fetuses affected by 
growth restriction due to an adverse in utero environment are thought to develop 
adaptations to cope with the pre-natal milieu, adapting them also to a thrifty, deprived 
environment after birth. This becomes deleterious in adult life if nutritional supply is 
plentiful, i.e. if there is a drastic imbalance between resource supply during pre- and 
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postnatal environment. For this reason, low birth weight and ‘catch-up growth’ postnatally 
are associated with an increased risk of hypertension, ischemic heart disease, diabetes, and 
kidney disease in adults (Barker, 1990, 1992; Ojeda et al., 2008). This hypothesis of fetal 
programming was first put forward by Dr David Barker, who suggested that the genesis of 
adult disease was programmed during gestation, with poor nutrition in prenatal life 
increasing susceptibility to the effects of an affluent diet during adulthood (Barker, 1990, 
1992). Maternal age has been shown to increase the susceptibility of offspring from older 
females to cardiovascular disease as adults (Cooke et al., 2018). This highlights the 
importance of my work to not only address the immediate maternal and fetal morbidity and 
mortality associated with pregnancy in advanced maternal age, but also the effects of fetal 
programming on the offspring of older mothers into the future.  
 The embryonic defects which I have shown to commonly occur in older mice (growth 
restriction, resorption, and heart and brain defects), can be causally linked with abnormal 
development of the placenta (Linask, 2013; Perez-Garcia et al., 2018). In line with this, and 
previous gross histological findings from Lopes et al 2009., I found that although 
morphologically normal embryos exhibited largely normal placental development, abnormal 
embryos were accompanied by abnormal placentas. Abnormal placentas were characterised 
by underdevelopment of the labyrinth compartment and overabundance of TGCs. I 
performed in depth transcriptomic analysis which showed that the trophoblast 
differentiation program was perturbed by advanced maternal age, with increased expression 
of TS cell and TGC markers at the expense of SpT and SynT. Interestingly, a subset of 
placentas from older pregnancies exhibited trophoblast defects on the transcriptomic level, 
even when the placenta and embryo appeared grossly normal at E11.5. This suggests that all 
offspring of aged mothers may be subject to an adverse in utero environment. It is possible 
that grossly normal placentas (and embryos) exhibit more subtle developmental defects that 
were not detected, or that some defects will only manifest, or become more severe, later in 
gestation. Indeed, a recent study by the group of Rebecca Jones (Lean et al., 2017) – in a 
design very similar to ours – analysed the placentas of conceptuses developed in aged B6 
females at E18.5, and found that they exhibit a diminished nutrient transport capacity. They 
further link this placental dysfunction to fetal growth restriction and stillbirth in women of 
advanced maternal age. This study showed there are similarities in placental phenotype with 
increased placental weight and decreased efficiency, as well as altered uteroplacental 
vascular function, although the phenotype is more severe in the mouse than in humans. 
  139
These findings strongly corroborate my own – my data focuses on the effects of maternal 
age in early pregnancy up to mid-gestation, whereas theirs focuses on late pregnancy events 
which would affect conceptuses that appear normal at E11.5. 
 My data indicate that the extent of maternal ageing has an effect on the severity of 
trophoblast abnormalities. The gene expression profiles of E11.5 deciduas associated with 
grossly normal embryos from 43-week old females were globally more similar to those from 
young mothers compared to those from 45-47 week old females. This prompts the question 
of when in maternal ageing these transcriptomic changes associated with reproductive 
decline begin to appear, if their onset is abrupt or gradual, and how rapidly they progress. 
My results suggest that there is a surprisingly rapid decline in placental development 
between 43 and 45 weeks of age in B6 mice. These questions should be further investigated 
by analysis of decidual and trophoblast development in females across a wider range of 
ages. 
 
6.2 Uterine ageing is the dominant cause of reproductive decline in 
mice 
 
Developmental defects in the offspring of older females may occur due to either 
deterioration in the quality of oocytes, or due to a decreasing ability of the uterus to support 
pregnancy (Kong et al., 2012; Nelson et al., 2013). In a study from 1966, Talbert and Krohn 
performed reciprocal embryo transfer between young and old mice. This showed that whilst 
the young uterus is able to support development of embryos from aged females, embryos 
from young females transferred to an older surrogate mother did not survive to term 
(Talbert and Krohn, 1966). Similarly, Schulkey et al 2015 showed that ovarian transplantation 
from young to aged females did not reduce the incidence of cardiac defects in the offspring 
of aged females, and vice versa transplants of aged ovarian tissue into young females did not 
affect fetal cardiac development. If assuming that these cardiac defects are caused by 
placental abnormalities, this study further supports the data from Talbert and Krohn, as well 
as my own. My findings confirm these results, as embryonic development was rescued by 
transfer of embryos from aged donors to young females. Furthermore, I found that placental 
development was also rescued by embryo transfer both at the gross morphological and 
transcriptional level, providing strong evidence that embryonic and placental defects in 
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advanced maternal age occur as a result of age-related changes in the uterus, and not the 
oocyte. This does not rule out the possibility that embryos are programmed during transit 
through the fallopian tubes in the aged donor as noted by Talbert and Krohn in 1966, 
however we saw no clear effect of donor age on the outcome of the transfer process. 
 During my studies, we did not perform the reciprocal transfer of embryos from young 
females into aged recipients, to follow up the Talbert and Krohn data on the molecular level. 
This was because it is very difficult to synchronise aged females and obtain vaginal plugs at a 
reasonable rate, in concert with having ‘young’ embryos ready for transfer on a given day. 
The inefficiency of plug rates of aged females, and the presumptive lower pregnancy rates 
one would obtain, prohibited this experiment from being feasible within the constraints of 
mouse numbers, expert technical help available (i.e. limited time availability of the 
technician performing embryo transfers for these experiments) and last but not least, cost. 
 Having shown that the source of embryonic and placental defects resides with the 
mother, I went on to perform the first in depth characterisation of the maternal decidua at 
mid-gestation in aged females. I identified a number of genes which are affected by 
maternal age in the E11.5 decidua, some of which were confirmed by RT-qPCR and western 
blot. A number of genes involved in decidualization, including Bmp2, Il15ra, Gdf10, and 
Itgb8, as well as placenta specific genes such as Pregnancy-specific Glycoproteins and 
members of the Prolactin family were expressed abnormally in aged deciduas. This 
suggested that decidualization and subsequent development of the decidua proceeds 
abnormally in aged females. Dys-regulated genes were also enriched for gene annotations 
such as hormone, secreted, and ECM-receptor interaction, suggesting that communication 
between the maternal decidua and fetal trophoblast is disrupted in aged pregnancies. 
Comparison of E11.5 deciduas from aged females with a time course of decidual 
development from E9.5-E12.5 indicated that development of the decidua in aged 
pregnancies was delayed by up to 2 days. On the strength of my data I therefore suggest 
that the delay in the progression of decidualization is the root cause of the placental defects 
that ensue. Abnormal development of the decidua can indeed lead to failure in placental 
and embryonic development. One study found that maternal deletion of Il11ra allows 
implantation and decidualization to occur, but causes the decidua to subsequently 
degenerate. This leads to embryonic death and an abnormal placenta with reduced SpT and 
SynT, and large numbers of TGCs (Bilinski et al., 1998), a strikingly similar phenotype to aged 
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pregnancies. Other studies have similarly found that defects in decidualization disturb 
development of the placenta, with deleterious effects on the embryo (Gehin et al., 2002; 
Hirota et al., 2010; Jeong et al., 2007). Taken together, this suggests that developmental 
delay of the decidua in aged pregnancies may disturb communication at the feto-maternal 
interface, thus perturbing trophoblast differentiation and function with a knock-on effect on 
embryo development.  
 
6.3 Immune cell ageing is likely not involved in the etiology of 
placentation defects of aged females 
 
The maternal immune system has been proposed to play an important role in development 
of the decidua during pregnancy. Immune cells are abundant in the pregnant decidua, a 
large proportion of which are uNK cells, with smaller numbers of DCs and macrophages. 
Their role in the decidua is not well understood, however uNK cells and DCs may interact 
with each other and play a role in mediating trophoblast invasion, spiral artery remodelling, 
and decidual angiogenesis (Ashkar et al., 2000; Blois et al., 2008; Croy et al., 2003; Guimond 
et al., 1997). Despite a reduction in the numbers of peripheral NK that we saw in aged 
females and that are in line with previous reports (Guo et al., 2014), my results show that 
the abundance and maturation of uNK cells in the decidua is unaffected. Aged pregnancies 
do show slight reductions in the number of DCs and macrophages in the decidua. DC cells 
have been shown to be important in decidualization, although these results have remained 
controversial (Plaks et al., 2008). Thus, decreased DC numbers may possibly contribute to 
the retardation of decidual development, but is unlikely to be the primary cause as the 
changes are minimal. I hence focused in more detail on effects of maternal ageing unrelated 
to immune cells. 
 
6.4 Trophoblast differentiation defects can be recapitulated in vitro 
using conditioned medium from aged decidual stromal cells 
 
The decidua plays a key role in regulating invasion and differentiation of the trophoblast to 
form a functional placenta (King and Loke, 1994). It is thought the decidua acts to limit the 
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invasive properties of the trophoblast, as trophoblast tissue appears to invade unimpeded 
when decidual tissue is absent, as in ectopic pregnancies. Conversely, in pre-eclampsia, 
trophoblast invasion into the uterine wall is too shallow and remodelling of the maternal 
spiral arteries remains inadequate. This results in placental under-perfusion, and fetal 
growth restriction (Bibeau et al., 2016; Cartwright et al., 2010; Krishna and Bhalerao, 2011; 
Mandala and Osol, 2012).  
 The decidua produces large quantities of signalling molecules including cytokines, 
which provide cues to the trophoblast regulating its invasion and differentiation (Menkhorst 
et al., 2012). Notable examples of stromal cell-produced cytokines that affect trophoblast 
development and/or invasion are prolactin-related factors such as Prl8a2 in the mouse 
(Alam et al., 2007) and LIF, PRL, and IGFBP1 in human pregnancy (Garrido-Gomez et al., 
2017; Kojima et al., 1995). The cross-talk between decidual stromal and trophoblast cells 
works in both directions with multiple feedback mechanisms. For example, proinflammatory 
cytokines and chemokines, as well as angiogenic/static factors are induced in decidualized 
endometrial stromal cells in response to trophoblast-secreted products (Hess et al., 2007). 
These decidual functions constitute a mechanism of how the decidua can impact on 
development of the trophoblast. This prompted me to investigate the effect of maternal age 
on paracrine signals from the uterine stroma to the trophoblast. I found that differentiation 
of TS cells, in the presence of conditioned media from aged USCs promoted rapid 
downregulation of TS cell markers in vitro. Trophoblast differentiation was skewed towards 
the TGC lineage, at the expense of other lineages. This recapitulated some of the 
characteristics of trophoblast differentiation in aged pregnancies in vivo remarkably closely. 
Differentiation to SynT was however, unaffected. This is unsurprising as it is difficult to 
differentiate TS cells to SynT in vitro, perhaps suggesting the absence of an important factor 
such as physical contact with maternal cells, or reciprocal communication between the 
decidua and trophoblast. 
 Overall, my data suggest that retarded decidual development disrupts 
communication at the feto-maternal interface. What precisely constitutes the change in the 
secretome of aged versus young uterine stromal cells remains to be determined in the 
future, for example by SILAC (Stable Isotope Labelling using Amino acids in Cell culture) 
experiments in which the proteins produced by the two cell populations are labelled by 
different isotopes followed by mass spectrometric identification of significant differences in 
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proteome composition. What seems to be the case, however, is that an altered 
communication signal that originates from aged uterine stromal cells impacts on trophoblast 
differentiation and disturbs the formation of a functionally normal placenta. 
 
6.5 Endometrial decidualization is perturbed in aged females due to 
cell intrinsic defects 
 
Embryos derived from aged females are able to develop into normal conceptuses when 
provided with a young uterine environment during gestation. This suggests that blastocysts 
derived from aged females are competent and able to give rise to a normal embryo and 
placenta. As I have shown, this implicates abnormal function of the maternal uterus during 
aged pregnancies as the root cause of embryo and placenta developmental defects in older 
mothers. Therefore, I next focused on studying maternal age-related changes in the 
endometrium during pregnancy. 
 In the mouse, the first physical contact between embryo and uterus occurs during 
implantation, beginning on the morning of day 4 when the uterus acquires receptivity. The 
success of this interaction relies on steroid hormone induced priming of the uterus in the 
preceding days. Days 1-2 of pregnancy are dominated by E2 signalling, which strongly 
stimulates proliferation of the LE. Corpora lutea form from the post-ovulation follicles, and 
begin to produce large quantities of P4 at E2.5 which antagonises the E2 mediated 
proliferation of the LE, and stimulates proliferation of the underlying stroma in a process 
referred to as endometrial priming. My data from RNA-seq and IHC analyses of the uterus at 
E3.5 provide evidence which suggests that this priming process is abnormal in uteri from 
aged females. In the majority of cases, proliferating cells can still be seen in the LE of aged 
uteri at E3.5, whereas there are many fewer proliferating cells in the stroma. Additionally, 
epithelial specific genes such as Ltf and Areg (Campbell et al., 2006) are up-regulated in uteri 
from aged females at E3.5, whereas markers of the uterine stroma such as Des and Hand2 
are less highly expressed. This suggests that hormonal priming of the uterus and the 
acquisition of uterine receptivity is abnormal or delayed in aged females. Data from a recent 
study indicates that implantation may also be delayed in aged females, as Chicago blue 
staining which indicates vascular permeability at implantation sites is severely reduced in 
aged uteri on E5 of pregnancy, suggesting that implantation has not yet occurred in aged 
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females at this time (Li et al., 2017). This priming defect may be a result of the progesterone 
resistance I have demonstrated in the age endometrium, as well as insufficient luteal 
support as has been suggested previously in aged females (Harman and Talbert, 1970). 
 Advanced maternal age does not appear to affect the ability of the endometrium to 
become receptive, or facilitate implantation per se, as there is no significant reduction in the 
total number of implantation sites in aged pregnancies. However, implantation may be 
delayed until uterine receptivity is acquired, potentially causing a shift in timing of the 
window of implantation in aged females. Mice and many other mammals are able to 
physiologically delay implantation to avoid pregnancy in times of stress, in a process known 
as diapause (Fenelon et al., 2014). However delayed implantation in other contexts can lead 
to developmental defects later in pregnancy in both the mouse and human (Cha and Dey, 
2014; Macklon et al., 2002; Song et al., 2002; Wang and Dey, 2006). This may occur due to 
disruption of the synchronised communication between the blastocyst and uterus that is 
required for successful pregnancy. 
 A number of studies in the 1950s and ‘60s showed that aged ovariectomized (OVX) 
females undergo a severely reduced decidualization reaction when subjected to artificial 
decidualization involving treatment with exogenous hormones and physical stimulation of 
the endometrium (Holinka and Finch, 1977; Ohta, 1987; Shapiro and Talbert, 1974). In this 
thesis I have also found that aged females fail to mount a robust response to artificial 
decidualization. Additionally, I have shown that USCs isolated from aged mice at E3.5 of 
pregnancy are unable to upregulate markers of decidualization upon in vitro decidualization, 
despite supplementation with steroid hormones. In fact, USCs from aged females 
undergoing in vitro decidualization show very few transcriptional changes in response to 
hormonal treatment, and those changes in gene expression that do occur are severely 
reduced in magnitude compared to USCs from young females. These results indicate that the 
decidualization defect in aged females is due to an intrinsic defect in aged USCs, and not 
simply the effect - for example - of reduced maternal hormone levels. 
Furthermore, I have shown that levels of pStat3, a critical mediator of Pgr 
transcriptional activation, are significantly reduced in aged USCs. Importantly, the in vitro 
decidualization defect could not be rescued by supplementation with Lif during in vitro 
decidualization, showing this is not a result of reduced Lif production by the uterine glands. 
There is some evidence that pStat3 in the stroma is regulated by Hbegf, which acts via the 
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Egfr/Erk axis to phosphorylate Stat3 (Zhang et al., 2013). However, my data show that pStat3 
levels are decreased, despite increased expression of Hbegf in aged pregnancies. This further 
supports the idea of a cell intrinsic defect in the ability of aged USCs to respond to hormones 
and growth factor signals. 
 These results led me to conclude that the endometrium becomes resistant to the 
action of steroid hormones during female ageing, leading to an attenuation and/or delay of 
the decidualization response in early pregnancy. The effects of this delay can still be 
detected in aged pregnancies at E11.5, when the decidua exhibits a transcriptomic signature 
very similar to that of earlier stages of pregnancy at E9.5-E10.5, indicating that its 
development is delayed by up to 2 days. This delay in differentiation of the endometrium 
and development of the decidual compartment is likely to disrupt the highly orchestrated 
and synchronised signalling between the maternal and fetal tissues at the feto-maternal 
interface. This is critical for successful pregnancy, and thus may lead to the abnormal 
placental development that I have shown is prevalent in pregnancies in aged females. 
 It is however unclear how closely the decidualization response induced 
experimentally in vitro and in vivo reflects the physiological situation during pregnancy. 
Specifically, the decidualization failure observed in vitro and in deciduomas may be more 
pronounced than that in vivo. Decidualization during pregnancy in aged females clearly 
occurs to an extent which can support adequate implantation of the embryo, and to some 
extent placental development, and it is also noteworthy that some pups within litters of 
aged females develop entirely normally. A number of previous studies have found that 
decidual swellings during pregnancy are of a similar size in pregnancies from young and aged 
mice (Blaha and Leavitt, 1974; Finch and Holinka, 1982; Holinka et al., 1979; Maibenco and 
Krehbiel, 1973), whereas deciduoma swellings are severely impaired in aged females 
(Holinka and Finch, 1977; Shapiro and Talbert, 1974). This may be due to differences in the 
response of the uterus to artificial decidualization and physiological pregnancy. The 
deciduoma assay induces a decidualization response that reflects decidualization in vivo in 
terms of induction of stromal proliferation and differentiation. However, the artificial 
decidualization response occurs throughout the entirety of the uterine horn and the overall 
size of deciduomas is far greater than that of a localized decidual reaction, and also entails 
differences in gene expression (Herington et al., 2009). Pregnancy occurs in the presence of 
paracrine signals produced by the embryo, which affect, but are not required for normal 
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decidualization (Herington et al., 2009). Therefore, embryo derived signals during early 
pregnancy may improve the decidualization response in aged females compared to artificial 
decidualization. However, the presence of developmental abnormalities in the embryo and 
placenta at mid-gestation show that a placentation defect does occur which may be a result 
of abnormal endometrial decidualization, caused by a cell intrinsic defect as I have 
described. 
  
6.6 Progesterone responsiveness in the uterus declines with age 
 
As discussed above, events during early pregnancy, including hormonal priming of the 
endometrium, and the decidualization reaction are abnormal and/or delayed in aged 
females. These events are regulated mainly by the steroid hormones E2 and P4. The serum 
concentration of E2 and P4 has been shown to fluctuate in the estrous cycle and during 
pregnancy in aged females (Holinka et al., 1979; Lu et al., 1979), suggesting that 
reproductive decline could be a by-product of declining hormone levels with age. However, 
in this thesis I have shown evidence of an intrinsic defect in the responsiveness of the uterus 
- and USCs in particular - to steroid hormones, as discussed in the previous section. 
Decreased hormone responses may be mediated by reduced levels or activity of the 
estrogen and progesterone receptors, Esr1 and Pgr. Studies in other contexts have indeed 
found that tissue responses to hormones are decreased during ageing, accompanied by 
reduced expression of hormone receptors (Roth, 1995; Thakur, 1988).  
 In the ageing reproductive system, Esr1/2 expression in the rodent uterus declines 
with age (Hsueh et al., 1979; Saiduddin and Zassenhaus, 1979), and interaction between E2 
and Esr1/2 in the nucleus is diminished (Belisle et al., 1985; Gesell and Roth, 1981). Declining 
expression of Esr1/2 could itself be a result of decreased E2 levels, as Esr1/2 expression is 
regulated by binding to its own promoter (Clark et al., 1974; Mester et al., 1974; Pavlik and 
Coulson, 1976). However, one study found that whilst supplementation with E2 induced 
expression of Esr1/2 in the uterus of young females, this did not occur to the same extent in 
aged mice (Belisle et al., 1985). Impaired uterine responsiveness to P4 in advanced maternal 
age has not been widely reported in rodents, however one study found that administration 
of P4 failed to downregulate the expression of Esr1/2 in the LE of aged rats (Saiduddin and 
Zassenhaus, 1979) that occurs on day 3 of pregnancy. My IHC data also suggests that the 
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attenuation of Esr1 signalling by Pgr may disrupted with age, as E2 mediated proliferation of 
the LE persisted at E3.5 in aged females. These data suggest that the ability of the LE to 
respond to P4 declines with age. 
 My results show that the expression and distribution of both Esr1 and Pgr are 
abnormal in the LE of aged females during early pregnancy. Their expression is also reduced 
in USCs isolated from the E3.5 uterus, suggesting impaired hormone responsiveness may be 
linked to reduced expression of the steroid hormone receptors. Uterine responses to E2 are 
not dramatically affected by maternal ageing as E2 mediated stimulation of proliferation in 
the LE occurs robustly in aged females. However, P4 responses are severely affected, as 
shown by the sustained proliferation and expression of E2 response genes observed in the 
LE at E3.5, and failure to stimulate the proliferation and decidualization of USCs both in vitro 
and in vivo. The effects of this P4 resistance persist throughout pregnancy leading to 
developmental delay in the decidua, as can be seen at E6.5 when the wave of 
decidualization and Pgr expression expands to the secondary decidual zone in young 
pregnancies, but is restricted to the primary decidual zone in aged pregnancies. Decidual 
angiogenesis may also be affected in aged pregnancies, as Pgr expressing USCs secrete large 
quantities of angiogenic factors in response to P4 (Kim et al., 2013). This may impair blood 
flow to the uterus thus reducing perfusion of the placenta and the supply of nutrient rich 
blood to the fetus. 
 As well as decreased expression of the progesterone receptor, the expression and 
activation of Pgr co-activators are also affected in aged pregnancies. Expression of Ncoa4, a 
Pgr coactivator, fails to be induced in USCs on in vitro decidualization, which may affect the 
ability of Pgr to effect transcriptional responses (Kollara and Brown, 2012). Most strikingly, 
the expression, activation and localisation of pStat3 is abnormal in aged pregnancies. pStat3 
is an important coactivator of Pgr in the uterus and is essential for implantation and 
decidualization (Lee et al., 2013; Sun et al., 2013). I have shown pStat3 levels are decreased 
in the LE and USCs of aged females during early pregnancy, and that pStat3 appears to be 
confined to the cytoplasm in the uterine stroma of aged pregnant females. Reduced 
expression of pStat3 in the LE at E3.5 as can be seen by IHC may contribute to the 
failure/delay in counteracting E2 stimulated proliferation and gene expression in the LE, 
which is mediated by Pgr. The exclusion of pStat3 from the nucleus in the stromal 
compartment suggests that the interaction between Pgr and pStat3 in USCs is reduced. This 
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may contribute to the impaired P4 responses observed in aged pregnancies, due to reduced 
transcriptional activation of Pgr target genes. The interaction between Pgr and its co-
activators in aged USCs should be investigated in more detail in future studies to confirm the 
disruption of this interaction, and to study the effect on Pgr target genes. 
 The unusual subcellular localisation of pStat3 in the uterine stroma of aged females is 
intriguing. After Stat3 phosphorylation by JAK at the plasma membrane, pStat3 is 
translocated to the nucleus in a process that requires receptor-mediated endocytosis (Bild et 
al., 2002). The abnormal localisation of pStat3 in the uterine stroma in aged pregnancies is 
reminiscent of that observed when receptor-mediated endocytosis is inhibited (Bild et al., 
2002), suggesting that this process may be reduced or blocked in aged pregnancies. As 
abnormalities in receptor-mediated endocytosis have been implicated in ageing in the 
context of liver sinusoidal epithelial cells in the rat (Simon-Santamaria et al., 2010), it would 
be interesting to explore this mechanism in detail in future studies. 
 
6.7 Acquisition of a P4-resistant phenotype is reminiscent of human 
endometrial pathologies that increase with age 
 
Intriguingly, the finding that the diminished and delayed decidualization response in aged 
female mice exhibits key features of a blunted P4 responsiveness is remarkably similar to the 
P4-resistant phenotype seen in a spectrum of endometrial pathologies in women. 
Intriguingly, many if not most of these, notably fibroids, adenomyosis and endometriosis, 
become markedly more prevalent with age and are also associated with fertility and 
pregnancy problems in the affected women (Benagiano et al., 2012; Bulletti et al., 2010; 
Zimmermann et al., 2012). Uterine fibroids (leiomyoma) are benign tumours of the 
myometrium. They are common, and by the age of 50 around 70% of Caucasian women and 
more than 80% of women of Afro-Caribbean descent will have at least one fibroid (Baird et 
al., 2003; Stewart et al., 2017). Adenomyosis is a condition where endometrial cells are 
found in the myometrium, causing pain and heavy menstrual bleeding. Endometriosis is a 
condition where endometrial cells are found outside the uterine cavity, which is also 
associated with severe pain and discomfort. All these pathologies have an underlying 
aetiology linked to a reduced endometrial responsiveness to P4, and predispose to a similar 
spectrum of pregnancy complications as those associated with advanced maternal age, 
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including infertility, miscarriage, preterm birth and fetal growth restriction (Al-Sabbagh et 
al., 2012; Li et al., 2014; Vannuccini et al., 2016). These correlations make it very likely that 
women of advanced age also exhibit at least some decidualization problems. My studies 
prompt for an in-depth investigation of the decidualization response of USCs from young 
and older women, as the age-related decline in hormone responsiveness may be conserved 
in humans. One recent study showed that USCs isolated from older women are able to 
mount an in vitro decidualization response (Gibson et al., 2018), however this was not 
compared to USCs from young women and therefore did not address the question of 
whether hormone responsiveness declines in advanced maternal age. It will be important to 
control for uterine pathologies when studying these ageing effects, to be able to account for 
potential confounding factors of any deficiency observed. Since older IVF patients do still 
become pregnant it is also possible that perhaps the age-associated decidualization defects 
are not as pronounced in women as they are in mice. However, given the above-mentioned 
correlations in particular with regard to the shared P4-resistant phenotype, and the hugely 
under-appreciated impact of age on uterine function, this is definitely an area that deserves 
careful and comprehensive investigations in the future. 
 
6.8 Potential impact of ageing physiology on the reproductive 
ageing phenotype 
 
Ageing is accompanied by physiological changes which may contribute to the reproductive 
ageing phenotype which I have described in this thesis. Ageing is associated with a shift in 
body composition, including loss of lean muscle mass and increased visceral fat and hepatic 
lipid deposits. The reason for these alterations in body composition aren’t fully understood, 
but may relate to a decline in resting metabolic rate of 1-2% per decade, increasing 
respiratory quotient, and reduced physical activity (Johannsen and Ravussin, 2010). Most 
adults gradually gain weight throughout their lives at a rate of about 0.5kg/year (Lumsden 
and Hor, 2015), and as such being overweight or obese becomes more prevalent with 
increasing age. Data from the UK office of national statistics indicates that population 
obesity increases with age up to the age of 55-64, however there is a relatively small 
increase in obesity from the 25-34 to the 35-54 age brackets (statistics, 2017) – the age 
group at the highest risk of obstetric complications. Maternal overweight and obesity is an 
independent risk factor for pregnancy complications including pre-eclampsia, gestational 
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diabetes, miscarriage, stillbirth, fetal overgrowth and growth restriction, and congenital 
heart defects (Leddy et al., 2008). The impact of advanced maternal age on perinatal 
outcomes overlaps with these, with increased risk of pre-eclampsia, miscarriage, stillbirth, 
and fetal growth restriction as mentioned previously. It is likely that maternal age interacts 
with obesity in the pathogenesis of these complications, indeed one study found that being 
overweight at any age increases the risk of obstetric complications, however the combined 
effect of maternal age  ³35 and overweight/obesity was particularly high risk for stillbirth 
and preterm delivery (Lamminpaa et al., 2016).  
 Similar to the human the body composition of the C57BL/6 mouse changes with age, 
with increased fat mass and a decrease in lean mass (Houtkooper et al., 2011). As maternal 
obesity is associated with similar obstetric complication as advanced maternal age, it is 
possible that maternal obesity may impact on the reproductive ageing phenotype I have 
described here. Mouse models of diet induced obesity during pregnancy commonly lead to 
fetal and placental overgrowth with increased placental transport (Kim et al., 2014; Nam et 
al., 2017; Rosario et al., 2015). A similar phenotype has been described in human 
pregnancies affected by maternal obesity, with the most striking outcomes being fetal 
macrosomia and placental overgrowth (Altmae et al., 2017; Stang and Huffman, 2016; 
Vinturache et al., 2015). Importantly, I have shown that advanced maternal age in mice is 
associated with developmental variability and fetal growth restriction with no indication of 
the fetal overgrowth that is commonly reported with maternal obesity. This suggests that 
the maternal ageing phenotype is unlikely to be a result of age-related increases in adiposity. 
However, in some cases, maternal obesity is instead associated with fetal growth restriction 
in humans and some mouse models of diet induced obesity (Higgins et al., 2011; Howell and 
Powell, 2017; Luzzo et al., 2012; Radulescu et al., 2013). Fetal growth restriction in 
pregnancies complicated by maternal obesity may result from hypertensive disorders of 
pregnancy such as pre-eclampsia which are more prevalent in obese pregnancies, and are 
associated with fetal growth restriction. Therefore, it is possible that my results are affected 
by obesity-induced hypertension in aged females, which may contribute the restricted fetal 
growth commonly observed in the offspring of aged females.  
 Ageing is also associated with increased insulin resistance and a decrease in glucose 
tolerance. This means that older individuals become progressively hyperinsulinemic and 
glucose intolerant with age, and are significantly more likely to be affected by type 2 
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diabetes prior to pregnancy, or to develop gestational diabetes mellitus (GDM) during 
pregnancy (Anna et al., 2008; Jolly et al., 2000; Lao et al., 2006). This may be a result of the 
increased deposition of visceral fat and obesity which occurs with ageing (Hardy et al., 
2012). Indeed, maternal obesity is a risk factor for GDM (Chu et al., 2007; Leddy et al., 2008), 
and both conditions are associated with increased risk for overlapping adverse perinatal 
outcomes, including macrosomia, pre-eclampsia, and congenital heart malformations 
(Billionnet et al., 2017; Leddy et al., 2008; Wendland et al., 2012). Mouse models of 
maternal obesity fed a high fat and/or high sugar diet exhibit characteristics of gestational 
diabetes including glucose intolerance and hyperinsulinemia, with impacts on fetal growth 
and development (Jones et al., 2009; Liang et al., 2010; Rosario et al., 2015). 
Maternal obesity and diabetes impact on placental development and function 
(Howell and Powell, 2017; Vambergue and Fajardy, 2011). This raises the question of 
whether the fetal and placental defects associated with advanced maternal age are in fact a 
result of the accompanying adiposity and insulin resistance. Most relevant to maternal 
ageing, one study found that high fat diet induced obesity in female mice was associated 
with decreased size of the labyrinth compartment (Kim et al., 2014), similar to that seen in 
placentas from aged females. Placentas from diet induced diabetic mouse models also show 
signs of cellular necrosis and haemorrhage which was not observed in aged pregnancies 
(Liang et al., 2010). Therefore, while it is possible that the reduction in labyrinth size 
observed in placentas from aged females could be a result of maternal-age associated 
obesity or diabetes, placentas from obese/diabetic pregnancies exhibit additional defects 
that are not present in aged, suggesting that age-related placental defects are either not 
driven by maternal obesity/diabetes, or represent a milder phenotype caused by minor age-
associated body composition and metabolic changes compared to the severe changes 
caused by a high fat/high sugar diet.  
A key aspect of the reproductive ageing phenotype I have described is a severely 
reduced decidualization response in aged females. A mouse model of maternal obesity 
induced by a high fat/high sugar diet has been shown to exhibit an impaired decidualization 
response similar to that of aged mice, however, this was again associated with fetal and 
placental overgrowth rather than growth restriction (Rhee et al., 2016), suggesting that 
distinct mechanisms underlie the reproductive defects occurring as a result of maternal 
obesity and advanced maternal age.  
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In the future, it would be useful to directly compare the morphology and 
transcriptome of placentas, and the decidualization response from young, aged, obese, and 
diabetic females to delineate the individual contributions of age, obesity, and insulin 
resistance to the reproductive ageing phenotype. It would also be desirable to characterise 
the age-related physiological changes in female mice to attempt to attribute age-related 
defects to cellular ageing, adiposity, or metabolic defects. This question could also be 
addressed by examining the impact of advanced maternal age on endometrial 
decidualization and placental development in a mouse model which is not affected by age-
related adiposity or insulin resistance. 
 
6.9 Ageing leads to changes in the epigenetic landscape of the 
placenta 
 
In most tissues, ageing is accompanied by changes in the epigenetic landscape, with altered 
patterns of DNA methylation and histone modifications leading to an abnormal chromatin 
state in aged organisms (Pal and Tyler, 2016). This can impact on cellular function and lead 
to age-related diseases (Calvanese et al., 2009). 
 Having already shown that USCs derived from aged females exhibit profound 
differences in their gene expression, I found that these transcriptional differences were 
accompanied by changes in the abundance of H3K4me3 at the promoter regions of genes 
which exhibit differential expression. In line with current knowledge, genes which were 
more highly expressed in aged USCs had more H3K4me3 at their promoter, and vice versa. 
Affected genes included those with relevance to decidualization, such as Hand2 and the 
Hoxa10/11 cluster, suggesting that abnormal distribution of H3K4me3 in aged females 
affects the function of the uterine stroma. In addition, I found that the breadth of H3K4me3 
peaks was significantly reduced in USCs from aged females, at key genes involved in 
decidualization such as Hoxa10 and Hoxa11. Very broad regions of H3K4me3 are associated 
with cell identity genes, and promote the maintenance of open chromatin, transcriptional 
consistency, and occupancy of paused PolII (Benayoun et al., 2014). This may allow these key 
genes to be rapidly and robustly induced when necessary - in this case on initiation of 
decidualization - suggesting that perturbation of broad H3K4me3 domains in aged USCs may 
contribute to the failure/delay of decidualization responses in the aged female. 
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 Studies in humans have suggested that DNA methylation changes in the 
endometrium occur throughout the menstrual cycle, regulating gene expression (Kukushkina 
et al., 2017). In addition, DNA methylation in the human endometrium changes with 
advancing age allowing biological age to be accurately estimated using Horvath’s epigenetic 
clock (Horvath, 2013; Olesen et al., 2018). This suggests that DNA methylation in the 
endometrium may be altered during ageing, with potential effects on uterine function 
during early pregnancy. My results show that uteri from aged mice at E3.5 of pregnancy do 
not exhibit DNA methylation changes at specific loci that could be detected by MeDIP-seq 
analysis, however they do show an overall increase in 5mC enrichment at CpG islands as has 
been commonly described in ageing tissues (Pal and Tyler, 2016). There may be smaller 
changes in DNA methylation which could not be identified by MeDIP-seq, but could 
potentially be detected when measured at single base pair resolution by sequencing of 
bisulphite converted DNA. 
 Although I could not detect age-related changes in DNA methylation in the uterus at 
E3.5, my results showed a significant reduction in 5mC at specific DMRs in the deciduas from 
aged mothers at E11.5. I also found significant global reductions in 5mC in exons, CGIs, and 
promoters in aged decidua at E11.5. This suggested that the deposition of 5mC is perturbed 
in advanced maternal age and was particularly interesting as disruption of the DNA 
methylation landscape in the decidua has been linked with a mouse model of pregnancy 
failure (Brown et al., 2013). DMRs in the E11.5 decidua were enriched for regions associated 
with the mouse phenotype “absent ectoplacental cone”. Although this was surprising as 
these DMRs were present in the maternal decidua, it may suggest that these sites are 
involved in placental development or have a role in the decidua which has not yet been 
established. 
 Noteworthy in this context is also that this reduced DNA methylation was not 
associated with notably changes in the expression levels of DNMTs (Dnmt1, Dnmt3a/b) or 
TET (Tet1, Tet2, Tet3) enzymes, at least not at the mRNA level. Protein amounts should be 
measured in future experiments. Since globally DNA methylation levels and distribution 
were not vastly dramatically altered, however, failures in much more specific targeting or 
protection mechanisms, rather than global changes in DNA methylation levels, seem to be at 
play.  
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 Changes in the global distribution of 5mC between E3.5 and E11.5 in young 
pregnancies, and the emergence of decidual DMRs in aged pregnancies at E11.5 suggested 
that DNA methylation is dynamic and may be remodelled in the uterus/decidua between 
E3.5-E11.5. Through differential methylation analysis with MEDIPS I showed that a large 
number of genomic regions gained methylation between E3.5-E11.5. As DNA methylation 
has been shown to be important for decidualization (Gao et al., 2012), I suggest that DNA 
methylation remodelling may be an important process during decidualization and 
placentation. My results show that this DNA methylation remodelling occurs largely as 
normal in aged pregnancies, however a small number of regions, mainly located at 
promoters, fail to gain methylation. I termed these regions “refractory DMRs”.  Overall, my 
results lead me to suggest that DNA methylation in the aged uterus is largely normal during 
early pregnancy and does not contribute to altered function of the endometrium. However, 
in aged pregnancies, the decidua fails to gain DNA methylation at refractory DMRs which 
may affect development of the placenta, or may be a readout of abnormal decidual 
development in aged pregnancies.  
Although the expression of genes associated with refractory DMRs was not 
significantly affected - in terms of the magnitude of gene expression differences, and 
consistency of direction - refractory DMRs were enriched for binding motifs specific to a 
small number of transcription factors including Ets2 and members of the Klf family, which 
play a role in decidualization at earlier stages of pregnancy (Salamonsen et al., 2003; 
Simmen et al., 2015; Sun et al., 2012). This suggests that abnormal function of Ets2 and 
other TFs, or their regulators, perturbs the deposition of DNA methylation at some TF 
binding sites. This could occur by a number of possible mechanisms. TF binding sites may be 
blocked, potentially by increased occupancy by TF binding to the DNA, or histone 
modifications that promote closed chromatin, thus precluding access of the DNA 
methyltransferase machinery to these binding sites as has been proposed before (Blattler 
and Farnham, 2013; Hervouet et al., 2010; Marchal and Miotto, 2015). This is an attractive 
possibility, in particular since Ets2 expression levels seem indeed higher in aged deciduas, 
implying that increased Ets2 levels lead to longer or tighter occupancy at target sites and 
may prevent the required acquisition of DNA methylation at these sites in a timely manner. 
Alternatively, interaction between DNMTs and TFs such as Ets2 could affect the targeting of 
DNA methylation or may affect the catalytic activity of the DNMTs. Ets2 has been reported 
to physically interact with Dnmt1 and to affect its catalytic activity, although the direction of 
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dys-regulation (increase in Ets2 expression) is opposite to what would be expected in the 
context of decidualization.  In any case, these are attractive possibilities to explore in future 
work aimed at understanding why these specific DMRs are refractory to the acquisition of 
DNA methylation. 
 I found a similar pattern of DNA methylation defects in the trophoblast compartment 
in aged pregnancies, with a set of DMRs that showed decreased methylation in aged 
trophoblast. Trophoblast DMRs were enriched for annotations relating to female infertility, 
stem cell differentiation, and the regulation of biosynthetic processes. This suggests that 
they may be involved in differentiation and development of the trophoblast, and reduced 
methylation at these DMRs in aged placentas may contribute to the abnormal development 
of the trophoblast compartment that is clear in aged pregnancies. Interestingly, like 
refractory DMRs in the decidua, trophoblast DMRs were also significantly enriched for the 
Ets2 binding motif. The enrichment of Ets2 binding motifs in both refractory DMRs and 
trophoblast DMRs suggests they may form in response to a common mechanism, although 
at this time the identity of the factors involved is unknown. These data also corroborate that 
the de-regulated cross-talk between endometrium and trophoblast does indeed affect 
trophoblast differentiation and the trophoblast epigenome, with a paracrine factor affecting 
these processes. As I have shown that trophoblast DMRs are abolished in the placentas of 
embryos transferred from an aged mother to a young surrogate, they must ultimately arise 
as a result of an age-related defect in the maternal uterus. 
 
6.10 Implications of endometrial ageing for human health 
 
The trend of delaying childbirth till later in life clearly has important implications on the 
health of the mother during pregnancy, and development of the baby. It is now well 
established that older mothers are at higher risk of adverse pregnancy outcomes such as 
miscarriage, stillbirth, pre-eclampsia, and fetal growth restriction. As such, women who are 
pregnant or planning to become pregnant beyond the age of 35 should be counselled of 
their increased risk of such adverse outcomes and monitored closely during pregnancy. 
The data I have presented here suggest that abnormal development of the placenta 
mediates abnormal development of the embryo, most commonly leading to fetal growth 
restriction which is known to commonly occur as a result of placental insufficiency (Burton 
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and Jauniaux, 2018). An adverse environment during gestation such as that in growth 
restricted pregnancies can have lifelong effects on the health of the offspring. Growth 
restricted babies are more likely to develop cardiovascular, metabolic, and endocrine 
disease in later life due to the imbalance between the undernourished environment in 
utero, and the plentiful nutrition experienced by most in post-natal life (Kwon and Kim, 
2017). This presents a significant burden to those affected and to healthcare services, and as 
such is may be beneficial to inform prospective parents of the potential long-term 
implications of reproducing in later life to enable informed decisions to be made. 
The findings I have presented here suggest that reduced hormone responsiveness of 
the aged endometrium may underlie the abnormal placental development and adverse 
pregnancy outcomes observed in aged pregnancies – at least in mice. This mechanism may 
be conserved in human pregnancies, indeed the common fetal outcomes of aged pregnancy 
in mice – growth restriction, resorption, congenital heart defects – are mirrored when 
studying human populations (Carolan and Frankowska, 2011; Hollier et al., 2000; Huang et 
al., 2008; Mills and Lavender, 2011), although as discussed earlier there are significant 
differences in the reproductive physiology of mice and humans. My results suggest that 
ageing of the uterus is the most important factor in the mouse with relatively little 
contribution of oocyte ageing to embryo and placental development in aged females – the 
vast majority of embryo resorptions and congenital malformations are rescued by transfer to 
a young foster mother. However, the relative contribution of uterine and oocyte ageing in 
humans may be slightly different, with a relatively smaller impact from the ageing uterus 
and larger from the oocyte. It is well known that human ageing is associated with an 
exponential increase in chromosomal aberrations and aneuploidies, leading to miscarriage 
and aneuploid syndromes in the offspring, whereas the increased prevalence of obstetric 
complications unrelated to the oocyte have been more difficult to tease out in human 
populations, possibly due to variations between different populations and the interaction 
with other age-related physiological changes as described above. Nevertheless, endometrial 
ageing is likely to have a substantial impact on reproductive health and pregnancy in later 
life, and greater understanding of the progesterone resistance that develops with age may 
lead to the development of interventions to improve reproductive performance in older 
pregnancies, and treat conditions such as endometriosis and adenomyosis which are 
associated with progesterone resistance and become increasingly prevalent with age 
(Benagiano et al., 2012; Bulletti et al., 2010; Zimmermann et al., 2012). 
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The importance that is currently bestowed on maternal-age related changes in the 
oocyte has led to an increase in the practice of egg freezing to preserve fertility, as well as 
older women using young donor oocytes. While these interventions may stop the ticking of 
the oocyte ageing clock, they will do nothing to prevent endometrial ageing, and therefore 
will not guarantee a successful, healthy pregnancy. There is currently little evidence-based 
advice or treatment to slow endometrial ageing, however one study suggested that 
suppression of estrous cyclicity in mice by ovariectomy or long-term progesterone treatment 
prevents age-related changes to the transcriptional profile of the myometrium in aged 
females (Chong et al., 2016). The effect of estrous suppression on endometrial ageing is yet 
to be seen, but if this was found to be effective in preventing endometrial decline would be 
a simple and widely available intervention in the form of progesterone-based 
contraceptives. 
 
6.11 Conclusion 
 
The increase in women delaying childbearing till later in life is set to continue for the 
foreseeable future, and so the impact of the increased risk of obstetric complications and 
congenital abnormalities in this group is an important consideration.  
 It is well known that pregnancy in advanced maternal age carries an increased risk of 
chromosomal abnormalities and mitochondrial dysfunction that occur as a result of age-
related changes in the oocyte. However, the contribution of uterine ageing to development 
of the “Great Obstetrical Syndromes” and congenital malformations that are unrelated to 
karyotypic abnormalities in pregnancies in older women is less well understood.  
 In this work I have shown that the ageing uterus is the source of a large proportion of 
the embryonic and placental defects which are common during pregnancy in aged mice. This 
is related to a decline in uterine function during early pregnancy, characterised by a 
reduction in the ability of the endometrium to respond to hormone and growth factor 
signals and undergo decidualization. A blunted decidualization response in aged females is 
likely to perturb the highly orchestrated signalling programme at the feto-maternal 
interface. This has a knock-on effect on development of the placenta, contributing to 
abnormal differentiation of the trophoblast compartment and affecting placental function 
and embryo development. 
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 Abnormal decidualization and development of the placenta with advanced maternal 
age is accompanied by changes in the epigenetic landscape, and abnormal patterns of 
H3K4me3 and DNA methylation, which may contribute to the developmental defects that 
are prevalent in aged pregnancies. 
 In this thesis I have explored and highlighted the issue of declining endometrial 
function with advanced maternal age, and hope that these findings will prompt further 
mechanistic investigation into this area in the mouse, and also fundamentally in humans. 
Increasing our understanding of the effects of advanced maternal age on uterine function 
during pregnancy may allow us to minimise the risk to mother and baby during, and improve 
pregnancy outcomes in older mothers. 
 
6.12 Future directions 
 
In this thesis I have shown that female B6 mice aged 43 weeks and over exhibit a delay in 
placental development, with a transcriptional signature showing retardation by up to 2 days. 
Surprisingly, females aged 43 weeks show much milder transcriptional abnormalities than 
those aged just 2 weeks older. This prompts the question of when in maternal ageing do 
these abnormalities arise, and how rapidly does uterine function decline? It would be 
interesting to analyse placental development in mice at a variety of ages between 8-47 
weeks to answer these questions. 
From my RNA-seq data of pseudo-pregnant uteri and USCs I have identified a number 
of novel candidate genes which are dys-regulated during decidualization in aged 
pregnancies. In the future these candidates could be further investigated to elucidate their 
precise role in decidualization by over-expression and/or CRISPR knockout in USCs. In this 
work I have focussed on age-related defects in USCs, however the luminal epithelium and 
uterine glands display histological changes in aged females (Craig, 1981; Lejeune et al., 1981; 
Maibenco and Krehbiel, 1973; Martin et al., 1970). My results show that some LE markers 
are differentially expressed with age, and that LE proliferation persists in aged females at 
E3.5, suggesting they may also be resistant to the action of P4. This warrants further 
investigation into the function of the luminal and glandular epithelia in advanced maternal 
age. This could be done by isolation of individual cell types by laser capture microdissection 
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followed by genome-wide sequencing, or generation of endometrial epithelial organoids 
derived from young and aged uteri (Boretto et al., 2017; Turco et al., 2017). 
I have also shown that factors secreted by aged USCs during in vitro decidualization 
affect the differentiation of TS cells. This work could be built on by characterising the factors 
which are absent/produced at abnormal levels in USCs from aged females, and studying 
their impact on trophoblast differentiation in vitro. This approach could be expanded by co-
culturing USCs in direct contact with trophoblast cells or explants to more closely 
recapitulate the feto-maternal interface and the effect of USC ageing trophoblast function. 
Recently, it was reported that human TS cells can be derived from human blastocysts and 
trophoblast (Okae et al., 2018). Therefore, this experiment could also be performed using 
human TS cells and USCs to study the communication between the uterine stroma and 
trophoblast in older women. 
My results showed that maternal ageing is accompanied by a decline in the ability of 
the endometrium to respond to hormonal and growth factor signals. This appears to be due 
to decreased expression of steroid hormone receptors and coactivators, particularly Pgr and 
pStat3, however the precise mechanism has not yet been elucidated. My results suggest that 
physical interactions between Pgr and pStat3 in the nucleus are perturbed with age, as 
pStat3 is not able to translocate to the nucleus in vivo. Future studies should confirm the 
absence/reduction of Pgr/pStat3 interaction in aged USCs by co-immunoprecipitation, and 
investigate the effect of abolishing Pgr/pStat3 interactions on the robustness of 
transcriptional activation by Pgr, and the repertoire of target genes with which it interacts. 
The exclusion of pStat3 from the nucleus in the uterine stroma of aged females is likely to 
contribute to the impaired Pgr response, as it interacts with Pgr in the nucleus to facilitate 
transcriptional responses. The mechanism behind this abnormal localisation should be 
studied further, as promoting translocation of pStat3 to the nucleus could improve the 
activation of Pgr target genes, and therefore also the decidualization response.  
 Finally, some of the experiments I have performed could easily be performed using 
cells derived from human endometrial biopsies to determine whether uterine ageing occurs 
in a similar way in humans. For example, USCs can be isolated from endometrial biopsies 
and cultured and decidualized in vitro. These experiments will need to be carefully 
controlled for, in particular with regard to confounding factors such as other uterine 
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pathologies that increase with age. A thorough investigation in this area is much warranted 
on the basis of my findings. 
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Appendix 
 
Supplementary table 1 – List of 42 genes differentially expressed in RNA-seq data (DESeq2 
p<0.05 and Intensity difference p<0.05) between trophoblast from implantation sites in 
young females, and implantation in aged females with a grossly abnormal embryo. Displayed 
as log2 fold change from young to aged. 
 
Gene Description 
Log2 fold 
change 
Sprr2h small proline-rich protein 2H [Source:MGI Symbol;Acc:MGI:1330343] 6.04881159 
Orm2 orosomucoid 2 [Source:MGI Symbol;Acc:MGI:97444] 5.721094281 
Prr9 proline rich 9 [Source:MGI Symbol;Acc:MGI:1925680] 5.126459168 
Gm7257 predicted gene 7257 [Source:MGI Symbol;Acc:MGI:3647831] 5.024863655 
Hrc histidine rich calcium binding protein [Source:MGI Symbol;Acc:MGI:96226] 4.404359793 
Gm9513 predicted gene 9513 [Source:MGI Symbol;Acc:MGI:3779923] 4.205814487 
Orm1 orosomucoid 1 [Source:MGI Symbol;Acc:MGI:97443] 4.083662161 
Prl3d1 
prolactin family 3, subfamily d, member 1 [Source:MGI 
Symbol;Acc:MGI:97606] 4.016602917 
Prl3d3 
prolactin family 3, subfamily d, member 3 [Source:MGI 
Symbol;Acc:MGI:2660938] 3.896496483 
Ceacam15 
carcinoembryonic antigen-related cell adhesion molecule 15 [Source:MGI 
Symbol;Acc:MGI:2141810] 3.55801466 
Prl3d2 
prolactin family 3, subfamily d, member 1 [Source:MGI 
Symbol;Acc:MGI:2660935] 3.532794993 
Prl5a1 
prolactin family 5, subfamily a, member 1 [Source:MGI 
Symbol;Acc:MGI:106332] 3.366017537 
Cts7 cathepsin 7 [Source:MGI Symbol;Acc:MGI:1860262] 3.351687553 
Pfpl pore forming protein-like [Source:MGI Symbol;Acc:MGI:1860266] 3.092158355 
Erv3 endogenous retroviral sequence 3 [Source:MGI Symbol;Acc:MGI:1919245] 2.855199307 
Rimklb 
ribosomal modification protein rimK-like family member B [Source:MGI 
Symbol;Acc:MGI:1918325] 2.818320493 
Prl8a1 
prolactin family 8, subfamily a, member 1 [Source:MGI 
Symbol;Acc:MGI:1920494] 2.807027443 
Htra1 HtrA serine peptidase 1 [Source:MGI Symbol;Acc:MGI:1929076] 2.781584173 
Srd5a1 steroid 5 alpha-reductase 1 [Source:MGI Symbol;Acc:MGI:98400] 2.655812037 
Prl8a2 
prolactin family 8, subfamily a, member 2 [Source:MGI 
Symbol;Acc:MGI:894281] 2.589404407 
Adamts5 
a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 5 (aggrecanase-2) [Source:MGI 
Symbol;Acc:MGI:1346321] 2.256366183 
Gjb2 gap junction protein, beta 2 [Source:MGI Symbol;Acc:MGI:95720] -1.82263817 
Ctsq cathepsin Q [Source:MGI Symbol;Acc:MGI:2137385] -1.981924423 
Ceacam3 
carcinoembryonic antigen-related cell adhesion molecule 3 [Source:MGI 
Symbol;Acc:MGI:3646296] -2.17745023 
Vnn1 vanin 1 [Source:MGI Symbol;Acc:MGI:108395] -2.222526406 
Synb syncytin b [Source:MGI Symbol;Acc:MGI:3045308] -2.276715743 
Rgs17 regulator of G-protein signaling 17 [Source:MGI Symbol;Acc:MGI:1927469] -2.49523986 
Prl7a2 
prolactin family 7, subfamily a, member 2 [Source:MGI 
Symbol;Acc:MGI:1206571] -2.58688511 
Spna1 spectrin alpha 1 [Source:MGI Symbol;Acc:MGI:98385] -2.854647365 
Tpbpb trophoblast specific protein beta [Source:MGI Symbol;Acc:MGI:2151721] -3.08609485 
Spnb1 spectrin beta 1 [Source:MGI Symbol;Acc:MGI:98387] -3.212407375 
Psg26 
pregnancy-specific glycoprotein 26 [Source:MGI 
Symbol;Acc:MGI:1891358] -3.336263763 
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Gene Description 
Log2 fold 
change 
Hba-x 
hemoglobin X, alpha-like embryonic chain in Hba complex [Source:MGI 
Symbol;Acc:MGI:96019] -3.36435228 
Psg17 pregnancy specific glycoprotein 17 [Source:MGI Symbol;Acc:MGI:1347250] -3.480721067 
Psg18 pregnancy specific glycoprotein 18 [Source:MGI Symbol;Acc:MGI:1347251] -3.53887766 
Psg27 
pregnancy-specific glycoprotein 27 [Source:MGI 
Symbol;Acc:MGI:1891359] -3.57915276 
Psg21 
pregnancy-specific glycoprotein 21 [Source:MGI 
Symbol;Acc:MGI:1891353] -4.009178287 
Psg25 
pregnancy-specific glycoprotein 25 [Source:MGI 
Symbol;Acc:MGI:1891357] -4.056768033 
Ceacam5 
carcinoembryonic antigen-related cell adhesion molecule 5 [Source:MGI 
Symbol;Acc:MGI:1920500] -4.104822782 
Cts3 cathepsin 3 [Source:MGI Symbol;Acc:MGI:2151929] -5.17780764 
Ctsm cathepsin M [Source:MGI Symbol;Acc:MGI:1927229] -5.34532527 
Prl8a8 
prolactin family 8, subfamily a, member 81 [Source:MGI 
Symbol;Acc:MGI:1921438] -5.419780078 
 
 
 
Supplementary table 2 – List of 162 genes differentially expressed in RNA-seq data (DESeq2 
p<0.05 and Intensity difference p<0.05) between deciduas from implantation sites in young 
females, and implantation in aged females with a grossly abnormal embryo. Displayed as 
log2 fold change from young to aged. 
Gene Description Log2 fold change 
Gm14085 predicted gene 14085 [Source:MGI Symbol;Acc:MGI:3702173] 6.977279923 
Gpr151 G protein-coupled receptor 151 [Source:MGI Symbol;Acc:MGI:2441887] 5.599317794 
Ptgdr prostaglandin D receptor [Source:MGI Symbol;Acc:MGI:102966] 5.022367813 
Cyp2j11 cytochrome P450, family 2, subfamily j, polypeptide 11 [Source:MGI Symbol;Acc:MGI:2140224] 4.534497434 
Col14a1 collagen, type XIV, alpha 1 [Source:MGI Symbol;Acc:MGI:1341272] 4.355903981 
Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 [Source:MGI Symbol;Acc:MGI:101939] 4.086267072 
Hsd17b1 hydroxysteroid (17-beta) dehydrogenase 1 [Source:MGI Symbol;Acc:MGI:105077] 3.556262188 
A530099J19Rik RIKEN cDNA A530099J19 gene [Source:MGI Symbol;Acc:MGI:2441809] 3.309328058 
Klrb1c killer cell lectin-like receptor subfamily B member 1C [Source:MGI Symbol;Acc:MGI:107538] 3.169925001 
Apcdd1 adenomatosis polyposis coli down-regulated 1 [Source:MGI Symbol;Acc:MGI:3513977] 3.160920188 
Pcolce procollagen C-endopeptidase enhancer protein [Source:MGI Symbol;Acc:MGI:105099] 3.080805944 
Cbln1 cerebellin 1 precursor protein [Source:MGI Symbol;Acc:MGI:88281] 3.045936284 
Mmp1a matrix metallopeptidase 1a (interstitial collagenase) [Source:MGI Symbol;Acc:MGI:1933846] 3.030145164 
Odz3 odd Oz/ten-m homolog 3 (Drosophila) [Source:MGI Symbol;Acc:MGI:1345183] 2.908395232 
Gzma granzyme A [Source:MGI Symbol;Acc:MGI:109266] 2.902567051 
Vcan versican [Source:MGI Symbol;Acc:MGI:102889] 2.894225492 
Hrc histidine rich calcium binding protein [Source:MGI Symbol;Acc:MGI:96226] 2.88675295 
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Dio3 deiodinase, iodothyronine type III [Source:MGI Symbol;Acc:MGI:1306782] 2.833670864 
Ceacam15 carcinoembryonic antigen-related cell adhesion molecule 15 [Source:MGI Symbol;Acc:MGI:2141810] 2.83359125 
Pfpl pore forming protein-like [Source:MGI Symbol;Acc:MGI:1860266] 2.749816513 
Capn6 calpain 6 [Source:MGI Symbol;Acc:MGI:1100850] 2.690411799 
Col6a1 collagen, type VI, alpha 1 [Source:MGI Symbol;Acc:MGI:88459] 2.475213014 
Kcnk2 potassium channel, subfamily K, member 2 [Source:MGI Symbol;Acc:MGI:109366] 2.455201818 
Lrp4 low density lipoprotein receptor-related protein 4 [Source:MGI Symbol;Acc:MGI:2442252] 2.450278883 
Col15a1 collagen, type XV, alpha 1 [Source:MGI Symbol;Acc:MGI:88449] 2.440664072 
Qrfpr pyroglutamylated RFamide peptide receptor [Source:MGI Symbol;Acc:MGI:2677633] 2.395484702 
Tac2 tachykinin 2 [Source:MGI Symbol;Acc:MGI:98476] 2.394534528 
Col6a2 collagen, type VI, alpha 2 [Source:MGI Symbol;Acc:MGI:88460] 2.373667366 
Tshr thyroid stimulating hormone receptor [Source:MGI Symbol;Acc:MGI:98849] 2.331929487 
Atp1a2 ATPase, Na+/K+ transporting, alpha 2 polypeptide [Source:MGI Symbol;Acc:MGI:88106] 2.298029827 
Krt84 keratin 84 [Source:MGI Symbol;Acc:MGI:96700] 2.297680549 
Frem1 Fras1 related extracellular matrix protein 1 [Source:MGI Symbol;Acc:MGI:2670972] 2.272083328 
Prl3d1 prolactin family 3, subfamily d, member 1 [Source:MGI Symbol;Acc:MGI:97606] 2.252700536 
Adamtsl1 ADAMTS-like 1 [Source:MGI Symbol;Acc:MGI:1924989] 2.237833852 
Bmp2 bone morphogenetic protein 2 [Source:MGI Symbol;Acc:MGI:88177] 2.123774278 
4930547N16Rik RIKEN cDNA 4930547N16 gene [Source:MGI Symbol;Acc:MGI:1922567] 2.098223536 
Kazald1 Kazal-type serine peptidase inhibitor domain 1 [Source:MGI Symbol;Acc:MGI:2147606] 2.061065663 
Pcsk5 proprotein convertase subtilisin/kexin type 5 [Source:MGI Symbol;Acc:MGI:97515] 2.032910315 
Ldhd lactate dehydrogenase D [Source:MGI Symbol;Acc:MGI:106428] 2.01264665 
Igf1 insulin-like growth factor 1 [Source:MGI Symbol;Acc:MGI:96432] 1.988569995 
Abat 4-aminobutyrate aminotransferase [Source:MGI Symbol;Acc:MGI:2443582] 1.961148134 
Rcn1 reticulocalbin 1 [Source:MGI Symbol;Acc:MGI:104559] 1.93078679 
2810417H13Rik RIKEN cDNA 2810417H13 gene [Source:MGI Symbol;Acc:MGI:1915276] 1.912848051 
Dhcr24 24-dehydrocholesterol reductase [Source:MGI Symbol;Acc:MGI:1922004] 1.887649206 
Ptn pleiotrophin [Source:MGI Symbol;Acc:MGI:97804] 1.84521885 
Bcmo1 beta-carotene 15,15'-monooxygenase [Source:MGI Symbol;Acc:MGI:1926923] 1.82237174 
Penk preproenkephalin [Source:MGI Symbol;Acc:MGI:104629] 1.816355897 
Hephl1 hephaestin-like 1 [Source:MGI Symbol;Acc:MGI:2685355] 1.803722422 
Kcnip3 Kv channel interacting protein 3, calsenilin [Source:MGI Symbol;Acc:MGI:1929258] 1.772814273 
Prps2 phosphoribosyl pyrophosphate synthetase 2 [Source:MGI Symbol;Acc:MGI:97776] 1.737904321 
Il15ra interleukin 15 receptor, alpha chain [Source:MGI Symbol;Acc:MGI:104644] 1.737427183 
Cdh11 cadherin 11 [Source:MGI Symbol;Acc:MGI:99217] 1.736965594 
Fmo1 flavin containing monooxygenase 1 [Source:MGI Symbol;Acc:MGI:1310002] 1.6966471 
Anln anillin, actin binding protein [Source:MGI Symbol;Acc:MGI:1920174] 1.695924237 
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Prkg2 protein kinase, cGMP-dependent, type II [Source:MGI Symbol;Acc:MGI:108173] 1.685950701 
S100a4 S100 calcium binding protein A4 [Source:MGI Symbol;Acc:MGI:1330282] 1.681200912 
Adamts3 
a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 3 [Source:MGI 
Symbol;Acc:MGI:3045353] 
1.679123328 
F13a1 coagulation factor XIII, A1 subunit [Source:MGI Symbol;Acc:MGI:1921395] 1.597473504 
Cyp11b1 cytochrome P450, family 11, subfamily b, polypeptide 1 [Source:MGI Symbol;Acc:MGI:88583] 1.586736254 
Pi15 peptidase inhibitor 15 [Source:MGI Symbol;Acc:MGI:1934659] 1.533531218 
Nrcam neuron-glia-CAM-related cell adhesion molecule [Source:MGI Symbol;Acc:MGI:104750] 1.530706186 
S100g S100 calcium binding protein G [Source:MGI Symbol;Acc:MGI:104528] 1.528006616 
Acaa2 acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) [Source:MGI Symbol;Acc:MGI:1098623] 1.515917432 
Ccnd1 cyclin D1 [Source:MGI Symbol;Acc:MGI:88313] 1.503489885 
Tdo2 tryptophan 2,3-dioxygenase [Source:MGI Symbol;Acc:MGI:1928486] 1.498164212 
Col1a1 collagen, type I, alpha 1 [Source:MGI Symbol;Acc:MGI:88467] 1.47781787 
Ccr2 chemokine (C-C motif) receptor 2 [Source:MGI Symbol;Acc:MGI:106185] 1.39959221 
Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N [Source:MGI Symbol;Acc:MGI:105045] 1.369320287 
Magi1 membrane associated guanylate kinase, WW and PDZ domain containing 1 [Source:MGI Symbol;Acc:MGI:1203522] 1.322001794 
Top2a topoisomerase (DNA) II alpha [Source:MGI Symbol;Acc:MGI:98790] 1.286707235 
Olfml3 olfactomedin-like 3 [Source:MGI Symbol;Acc:MGI:1914877] 1.276362051 
Kcnd3 potassium voltage-gated channel, Shal-related family, member 3 [Source:MGI Symbol;Acc:MGI:1928743] 1.234420686 
Ugt1a7c UDP glucuronosyltransferase 1 family, polypeptide A7C [Source:MGI Symbol;Acc:MGI:3032636] 1.199774119 
Tlr3 toll-like receptor 3 [Source:MGI Symbol;Acc:MGI:2156367] 1.176174004 
Smad6 MAD homolog 6 (Drosophila) [Source:MGI Symbol;Acc:MGI:1336883] 1.141243912 
Sulf1 sulfatase 1 [Source:MGI Symbol;Acc:MGI:2138563] 1.101518199 
Nrp1 neuropilin 1 [Source:MGI Symbol;Acc:MGI:106206] 0.967663026 
Gimap4 GTPase, IMAP family member 4 [Source:MGI Symbol;Acc:MGI:1349656] 0.939634696 
Peg3 paternally expressed 3 [Source:MGI Symbol;Acc:MGI:104748] -0.103516897 
Prl8a9 prolactin family8, subfamily a, member 9 [Source:MGI Symbol;Acc:MGI:1914560] -0.246265233 
Dsg2 desmoglein 2 [Source:MGI Symbol;Acc:MGI:1196466] -0.330759662 
Gpr126 G protein-coupled receptor 126 [Source:MGI Symbol;Acc:MGI:1916151] -0.344179743 
Obsl1 obscurin-like 1 [Source:MGI Symbol;Acc:MGI:2138628] -0.53652628 
Nt5e 5' nucleotidase, ecto [Source:MGI Symbol;Acc:MGI:99782] -0.536709606 
Pcsk6 proprotein convertase subtilisin/kexin type 6 [Source:MGI Symbol;Acc:MGI:102897] -0.612303906 
Phactr1 phosphatase and actin regulator 1 [Source:MGI Symbol;Acc:MGI:2659021] -0.627987432 
Prl3b1 prolactin family 3, subfamily b, member 1 [Source:MGI Symbol;Acc:MGI:97607] -0.662026097 
1600014K23Rik RIKEN cDNA 1600014K23 gene [Source:MGI Symbol;Acc:MGI:1919246] -0.70824409 
Serpinb9e serine (or cysteine) peptidase inhibitor, clade B, member 9e [Source:MGI Symbol;Acc:MGI:894672] -0.751020415 
Fam43a family with sequence similarity 43, member A [Source:MGI Symbol;Acc:MGI:2676309] -0.768955708 
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Leprel1 leprecan-like 1 [Source:MGI Symbol;Acc:MGI:2146663] -0.777240994 
4933402E13Rik RIKEN cDNA 4933402E13 gene [Source:MGI Symbol;Acc:MGI:1921687] -0.786542213 
Ildr2 immunoglobulin-like domain containing receptor 2 [Source:MGI Symbol;Acc:MGI:1196370] -0.81325738 
Kank3 KN motif and ankyrin repeat domains 3 [Source:MGI Symbol;Acc:MGI:1098615] -0.856641737 
Ak3 adenylate kinase 3 [Source:MGI Symbol;Acc:MGI:1860835] -0.86628093 
Fnd3c2 fibronectin type III domain containing 3C2 [Source:MGI Symbol;Acc:MGI:2685621] -0.868882634 
1600012P17Rik RIKEN cDNA 1600012P17 gene [Source:MGI Symbol;Acc:MGI:1919275] -0.876803307 
Sele selectin, endothelial cell [Source:MGI Symbol;Acc:MGI:98278] -0.880598283 
Lamb1 laminin B1 [Source:MGI Symbol;Acc:MGI:96743] -0.914123125 
Psg27 pregnancy-specific glycoprotein 27 [Source:MGI Symbol;Acc:MGI:1891359] -0.943830623 
Prl7d1 prolactin family 7, subfamily d, member 1 [Source:MGI Symbol;Acc:MGI:97619] -1.00415618 
Prl7a2 prolactin family 7, subfamily a, member 2 [Source:MGI Symbol;Acc:MGI:1206571] -1.010262874 
Taf7l TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor [Source:MGI Symbol;Acc:MGI:1921719] -1.015006045 
Ceacam14 carcinoembryonic antigen-related cell adhesion molecule 14 [Source:MGI Symbol;Acc:MGI:1914334] -1.024280997 
AU015836 expressed sequence AU015836 [Source:MGI Symbol;Acc:MGI:2147954] -1.071683929 
Sct secretin [Source:MGI Symbol;Acc:MGI:99466] -1.087794373 
Ceacam3 carcinoembryonic antigen-related cell adhesion molecule 3 [Source:MGI Symbol;Acc:MGI:3646296] -1.088770952 
4932442L08Rik RIKEN cDNA 4932442L08 gene [Source:MGI Symbol;Acc:MGI:1921682] -1.129283017 
Pappa2 pappalysin 2 [Source:MGI Symbol;Acc:MGI:3051647] -1.140217179 
Steap4 STEAP family member 4 [Source:MGI Symbol;Acc:MGI:1923560] -1.161497382 
Sema3g sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G [Source:MGI Symbol;Acc:MGI:3041242] -1.161794253 
Ctsm cathepsin M [Source:MGI Symbol;Acc:MGI:1927229] -1.177054466 
Psg28 pregnancy-specific glycoprotein 28 [Source:MGI Symbol;Acc:MGI:1891360] -1.189477799 
Psg23 pregnancy-specific glycoprotein 23 [Source:MGI Symbol;Acc:MGI:1891355] -1.194936889 
Psg25 pregnancy-specific glycoprotein 25 [Source:MGI Symbol;Acc:MGI:1891357] -1.199189123 
Tpbpb trophoblast specific protein beta [Source:MGI Symbol;Acc:MGI:2151721] -1.211849766 
Galnt6 No description -1.228336315 
Tpbpa trophoblast specific protein alpha [Source:MGI Symbol;Acc:MGI:98795] -1.253566028 
Prl2c1 Prolactin family 2, subfamily c, member 1 [Source:MGI Symbol;Acc:MGI:3649927] -1.269546215 
Mmp11 matrix metallopeptidase 11 [Source:MGI Symbol;Acc:MGI:97008] -1.281560053 
Psg21 pregnancy-specific glycoprotein 21 [Source:MGI Symbol;Acc:MGI:1891353] -1.291238891 
Fabp3 fatty acid binding protein 3, muscle and heart [Source:MGI Symbol;Acc:MGI:95476] -1.292617255 
Edn1 endothelin 1 [Source:MGI Symbol;Acc:MGI:95283] -1.298201319 
Ntn4 netrin 4 [Source:MGI Symbol;Acc:MGI:1888978] -1.347997195 
Spna1 spectrin alpha 1 [Source:MGI Symbol;Acc:MGI:98385] -1.349186302 
Lama1 laminin, alpha 1 [Source:MGI Symbol;Acc:MGI:99892] -1.359716243 
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Tmc5 transmembrane channel-like gene family 5 [Source:MGI Symbol;Acc:MGI:1921674] -1.367731785 
Crispld2 cysteine-rich secretory protein LCCL domain containing 2 [Source:MGI Symbol;Acc:MGI:1926142] -1.372311474 
Sfrp5 secreted frizzled-related sequence protein 5 [Source:MGI Symbol;Acc:MGI:1860298] -1.375274024 
Ptger3 prostaglandin E receptor 3 (subtype EP3) [Source:MGI Symbol;Acc:MGI:97795] -1.414919781 
Hbb-bh1 hemoglobin Z, beta-like embryonic chain [Source:MGI Symbol;Acc:MGI:96024] -1.444363385 
Cts3 cathepsin 3 [Source:MGI Symbol;Acc:MGI:2151929] -1.445477447 
Prl7b1 prolactin family 7, subfamily b, member 1 [Source:MGI Symbol;Acc:MGI:1922846] -1.520928668 
Nov nephroblastoma overexpressed gene [Source:MGI Symbol;Acc:MGI:109185] -1.532054713 
Inhba inhibin beta-A [Source:MGI Symbol;Acc:MGI:96570] -1.534273709 
Uchl1 ubiquitin carboxy-terminal hydrolase L1 [Source:MGI Symbol;Acc:MGI:103149] -1.565041807 
Tfpi2 tissue factor pathway inhibitor 2 [Source:MGI Symbol;Acc:MGI:108543] -1.597300451 
Krt14 keratin 14 [Source:MGI Symbol;Acc:MGI:96688] -1.618321098 
Tmem132e transmembrane protein 132E [Source:MGI Symbol;Acc:MGI:2685490] -1.623383418 
Ednra endothelin receptor type A [Source:MGI Symbol;Acc:MGI:105923] -1.627956554 
Fam46c family with sequence similarity 46, member C [Source:MGI Symbol;Acc:MGI:1921895] -1.648474189 
Igfbp5 insulin-like growth factor binding protein 5 [Source:MGI Symbol;Acc:MGI:96440] -1.700949518 
Pamr1 peptidase domain containing associated with muscle regeneration 1 [Source:MGI Symbol;Acc:MGI:2445082] -1.796883319 
Ermap erythroblast membrane-associated protein [Source:MGI Symbol;Acc:MGI:1349816] -1.797560119 
9530008L14Rik RIKEN cDNA 9530008L14 gene [Source:MGI Symbol;Acc:MGI:1924596] -1.806899885 
Epb4.2 erythrocyte protein band 4.2 [Source:MGI Symbol;Acc:MGI:95402] -1.843354939 
Cldn11 claudin 11 [Source:MGI Symbol;Acc:MGI:106925] -1.906305442 
Pkhd1l1 polycystic kidney and hepatic disease 1-like 1 [Source:MGI Symbol;Acc:MGI:2183153] -1.955605881 
Mmrn1 multimerin 1 [Source:MGI Symbol;Acc:MGI:1918195] -1.977462661 
Pla2g4d phospholipase A2, group IVD [Source:MGI Symbol;Acc:MGI:1925640] -2.011328006 
Itgb8 integrin beta 8 [Source:MGI Symbol;Acc:MGI:1338035] -2.018378529 
Hemgn hemogen [Source:MGI Symbol;Acc:MGI:2136910] -2.086156644 
Gpm6a glycoprotein m6a [Source:MGI Symbol;Acc:MGI:107671] -2.090047346 
Gdf10 growth differentiation factor 10 [Source:MGI Symbol;Acc:MGI:95684] -2.185169957 
Gm98 predicted gene 98 [Source:MGI Symbol;Acc:MGI:2684944] -2.217397511 
Slc4a1 solute carrier family 4 (anion exchanger), member 1 [Source:MGI Symbol;Acc:MGI:109393] -2.313791045 
Lum lumican [Source:MGI Symbol;Acc:MGI:109347] -2.380527903 
Spnb1 spectrin beta 1 [Source:MGI Symbol;Acc:MGI:98387] -2.41670632 
Hba-x hemoglobin X, alpha-like embryonic chain in Hba complex [Source:MGI Symbol;Acc:MGI:96019] -2.435182932 
Hbb-y hemoglobin Y, beta-like embryonic chain [Source:MGI Symbol;Acc:MGI:96027] -2.705944603 
Igsf1 immunoglobulin superfamily, member 1 [Source:MGI Symbol;Acc:MGI:2147913] -2.974004791 
Klk1 kallikrein 1 [Source:MGI Symbol;Acc:MGI:102850] -3.799975392 
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Supplementary table 3 – List of 75 genes differentially expressed in RNA-seq data (DESeq2 
p<0.05 and Intensity difference p<0.05) between E3.5 uteri from young and aged 
pseudopregnant females. Displayed as log2 fold change from young to aged. 
 
Gene Description 
Log2 fold 
change 
Ppp1r1b 
protein phosphatase 1, regulatory (inhibitor) subunit 1B 
[Source:MGI Symbol;Acc:MGI:94860] 6.00020252 
Ltf lactotransferrin [Source:MGI Symbol;Acc:MGI:96837] 5.594178933 
Add2 adducin 2 (beta) [Source:MGI Symbol;Acc:MGI:87919] 5.37152698 
Uox urate oxidase [Source:MGI Symbol;Acc:MGI:98907] 5.294050013 
Crabp2 
cellular retinoic acid binding protein II [Source:MGI 
Symbol;Acc:MGI:88491] 5.232057922 
Prap1 proline-rich acidic protein 1 [Source:MGI Symbol;Acc:MGI:893573] 5.029754367 
Muc20 mucin 20 [Source:MGI Symbol;Acc:MGI:2385039] 4.9190818 
Padi1 
peptidyl arginine deiminase, type I [Source:MGI 
Symbol;Acc:MGI:1338893] 4.770014633 
Muc4 mucin 4 [Source:MGI Symbol;Acc:MGI:2153525] 4.6953699 
Unc5cl 
unc-5 homolog C (C. elegans)-like [Source:MGI 
Symbol;Acc:MGI:1923839] 4.457631593 
Sftpd 
surfactant associated protein D [Source:MGI 
Symbol;Acc:MGI:109515] 4.417358457 
Bcl2l15 BCLl2-like 15 [Source:MGI Symbol;Acc:MGI:2685412] 4.345126067 
H60c histocompatibility 60c [Source:MGI Symbol;Acc:MGI:3774845] 4.238539627 
Ccl28 
chemokine (C-C motif) ligand 28 [Source:MGI 
Symbol;Acc:MGI:1861731] 4.065596167 
Padi2 
peptidyl arginine deiminase, type II [Source:MGI 
Symbol;Acc:MGI:1338892] 3.9931634 
Arg1 arginase, liver [Source:MGI Symbol;Acc:MGI:88070] 3.956521117 
Slc27a2 
solute carrier family 27 (fatty acid transporter), member 2 
[Source:MGI Symbol;Acc:MGI:1347099] 3.711052267 
Abp1 
amiloride binding protein 1 (amine oxidase, copper-containing) 
[Source:MGI Symbol;Acc:MGI:1923757] 3.66670419 
Sprr2f 
small proline-rich protein 2F [Source:MGI 
Symbol;Acc:MGI:1330349] 3.6606205 
5730469M10Rik 
RIKEN cDNA 5730469M10 gene [Source:MGI 
Symbol;Acc:MGI:1917814] 3.647230167 
Foxc1 forkhead box C1 [Source:MGI Symbol;Acc:MGI:1347466] 3.646881533 
Egfl6 
EGF-like-domain, multiple 6 [Source:MGI 
Symbol;Acc:MGI:1858599] 3.543155233 
Cbr2 carbonyl reductase 2 [Source:MGI Symbol;Acc:MGI:107200] 3.505507333 
Alpl 
alkaline phosphatase, liver/bone/kidney [Source:MGI 
Symbol;Acc:MGI:87983] 3.497439167 
Tacstd2 
tumor-associated calcium signal transducer 2 [Source:MGI 
Symbol;Acc:MGI:1861606] 3.4060581 
Slc40a1 
solute carrier family 40 (iron-regulated transporter), member 1 
[Source:MGI Symbol;Acc:MGI:1315204] 3.404302267 
Mycn 
v-myc myelocytomatosis viral related oncogene, neuroblastoma 
derived (avian) [Source:MGI Symbol;Acc:MGI:97357] 3.345628727 
Slc7a11 
solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 11 [Source:MGI Symbol;Acc:MGI:1347355] 3.300270067 
Cftr 
cystic fibrosis transmembrane conductance regulator homolog 
[Source:MGI Symbol;Acc:MGI:88388] 3.2550155 
Inhbb inhibin beta-B [Source:MGI Symbol;Acc:MGI:96571] 3.2324636 
C2 
complement component 2 (within H-2S) [Source:MGI 
Symbol;Acc:MGI:88226] 3.163670367 
Apobr apolipoprotein B receptor [Source:MGI Symbol;Acc:MGI:2176230] 3.120002933 
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Gene Description 
Log2 fold 
change 
Fcgbp 
Fc fragment of IgG binding protein [Source:MGI 
Symbol;Acc:MGI:2444336] 3.088762733 
Cfb complement factor B [Source:MGI Symbol;Acc:MGI:105975] 3.0129261 
Lad1 ladinin [Source:MGI Symbol;Acc:MGI:109343] 2.905850133 
Greb1 
gene regulated by estrogen in breast cancer protein [Source:MGI 
Symbol;Acc:MGI:2149712] 2.890090733 
Mal2 
mal, T cell differentiation protein 2 [Source:MGI 
Symbol;Acc:MGI:2146021] 2.8559284 
Fut9 fucosyltransferase 9 [Source:MGI Symbol;Acc:MGI:1330859] 2.817215767 
Galnt3 No description 2.775580567 
Myb myeloblastosis oncogene [Source:MGI Symbol;Acc:MGI:97249] 2.7695104 
Cfi 
complement component factor i [Source:MGI 
Symbol;Acc:MGI:105937] 2.7120536 
Bcat1 
branched chain aminotransferase 1, cytosolic [Source:MGI 
Symbol;Acc:MGI:104861] 2.640403533 
Elf3 E74-like factor 3 [Source:MGI Symbol;Acc:MGI:1101781] 2.489441033 
Bhlhe40 
basic helix-loop-helix family, member e40 [Source:MGI 
Symbol;Acc:MGI:1097714] 2.373932933 
Dhcr24 
24-dehydrocholesterol reductase [Source:MGI 
Symbol;Acc:MGI:1922004] 2.361236067 
Myh14 
myosin, heavy polypeptide 14 [Source:MGI 
Symbol;Acc:MGI:1919210] 2.360458367 
Gpr128 
G protein-coupled receptor 128 [Source:MGI 
Symbol;Acc:MGI:2441732] 2.3417932 
Klf4 Kruppel-like factor 4 (gut) [Source:MGI Symbol;Acc:MGI:1342287] 2.299556267 
Cp ceruloplasmin [Source:MGI Symbol;Acc:MGI:88476] 2.257516967 
Slc28a3 
solute carrier family 28 (sodium-coupled nucleoside transporter), 
member 3 [Source:MGI Symbol;Acc:MGI:2137361] 2.1462713 
Krt7 keratin 7 [Source:MGI Symbol;Acc:MGI:96704] 2.090661667 
Gm20547 predicted gene 20547 [Source:MGI Symbol;Acc:MGI:5142012] 2.046076167 
Cdkl1 
cyclin-dependent kinase-like 1 (CDC2-related kinase) [Source:MGI 
Symbol;Acc:MGI:1918341] 1.8998963 
C2 
complement component 2 (within H-2S) [Source:MGI 
Symbol;Acc:MGI:88226] -0.895269833 
Fbn1 fibrillin 1 [Source:MGI Symbol;Acc:MGI:95489] -1.8841821 
Cd34 CD34 antigen [Source:MGI Symbol;Acc:MGI:88329] -1.905820367 
Mmp2 matrix metallopeptidase 2 [Source:MGI Symbol;Acc:MGI:97009] -1.976179633 
Osr2 
odd-skipped related 2 (Drosophila) [Source:MGI 
Symbol;Acc:MGI:1930813] -2.2587181 
Vcan versican [Source:MGI Symbol;Acc:MGI:102889] -2.3753268 
Pdgfra 
platelet derived growth factor receptor, alpha polypeptide 
[Source:MGI Symbol;Acc:MGI:97530] -2.391184933 
Lrrc17 
leucine rich repeat containing 17 [Source:MGI 
Symbol;Acc:MGI:1921761] -2.4015725 
Hand2 
heart and neural crest derivatives expressed transcript 2 
[Source:MGI Symbol;Acc:MGI:103580] -2.416261567 
Serpine2 
serine (or cysteine) peptidase inhibitor, clade E, member 2 
[Source:MGI Symbol;Acc:MGI:101780] -2.4604312 
Apcdd1 
adenomatosis polyposis coli down-regulated 1 [Source:MGI 
Symbol;Acc:MGI:3513977] -2.531863367 
Col15a1 collagen, type XV, alpha 1 [Source:MGI Symbol;Acc:MGI:88449] -2.607754567 
F2r 
coagulation factor II (thrombin) receptor [Source:MGI 
Symbol;Acc:MGI:101802] -2.784162867 
Tmem132c 
transmembrane protein 132C [Source:MGI 
Symbol;Acc:MGI:2443061] -2.907442467 
Tex15 testis expressed gene 15 [Source:MGI Symbol;Acc:MGI:1934816] -3.042044533 
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Gene Description 
Log2 fold 
change 
Mtap2 
microtubule-associated protein 2 [Source:MGI 
Symbol;Acc:MGI:97175] -3.0499195 
Mest mesoderm specific transcript [Source:MGI Symbol;Acc:MGI:96968] -3.675537467 
Fst follistatin [Source:MGI Symbol;Acc:MGI:95586] -3.811741367 
Lamc3 laminin gamma 3 [Source:MGI Symbol;Acc:MGI:1344394] -3.816011361 
Cxcl15 
chemokine (C-X-C motif) ligand 15 [Source:MGI 
Symbol;Acc:MGI:1339941] -3.922341333 
Ndp 
Norrie disease (pseudoglioma) (human) [Source:MGI 
Symbol;Acc:MGI:102570] -4.79584922 
Ttr transthyretin [Source:MGI Symbol;Acc:MGI:98865] -5.350652667 
 
 
Supplementary table 4 - Genes commonly up- or down-regulated in E3.5 uteri from aged 
females by RNA-seq (shown as Log2 fold change), and in E3.5 uteri from gene knockout mice 
by microarray analysis. Differential expression and direction of change in the associated KO 
mouse is indicated by green cells. 
 
Probe 
Log2 fold 
change Pgr up 
Pgr 
down 
Bmp 
up 
Bmp2 
down 
Wnt4 
up 
Wnt4 
down Egfr up 
Egfr 
down 
Ltf 5.594179                 
Sftpd 4.41735855                 
Gabrp 4.2301169                 
Sprr2f 3.6606205                 
573046
9M10Ri
k 3.6472303                 
Slc40a1 3.4043025                 
Mycn 3.3456284                 
Inhbb 3.2324638                 
Lad1 2.9058498                 
Mal2 2.8559285                 
Tmem4
5b 2.646802                 
Cp 2.2575174                 
Muc1 2.2284354                 
Krt7 2.0906615                 
Nrtn 2.059478                 
Epsti1 2.037082                 
Myo5c 2.0169658                 
Sgpp2 1.9916013                 
Glis3 1.9185133                 
061004
0J01Rik 1.8765116                 
Tspan8 1.857882                 
573055
9C18Ri
k 1.8522244                 
Alcam 1.827052                 
Rnf128 1.769124                 
Tmem2
0 1.767132                 
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Probe 
Log2 fold 
change Pgr up 
Pgr 
down 
Bmp 
up 
Bmp2 
down 
Wnt4 
up 
Wnt4 
down Egfr up 
Egfr 
down 
Krt19 1.765891                 
Tmcc3 1.7321795                 
Capn5 1.6746078                 
F5 1.6656057                 
Lrig1 1.6276775                 
Six4 1.6119552                 
Cndp2 1.483544                 
Prom1 1.4701465                 
Wnk2 1.4675837                 
Mbp 1.4366543                 
Dsp 1.422717                 
Clu 1.4189513                 
P2ry14 1.4127219                 
Stxbp6 1.3413641                 
Laptm5 1.3313734                 
Slc15a2 1.3010027                 
281047
4O19Ri
k 1.2572924                 
160002
9D21Ri
k 1.2539195                 
St14 1.2289347                 
Dsg2 1.2095853                 
Tmem3
0b 1.1833545                 
Grb7 1.156587                 
Hsd17b
11 1.1517256                 
Dlx5 1.1409769                 
Ephx1 1.140866                 
Mal 1.1389353                 
Mapka
pk3 1.1100836                 
Krt8 1.0746023                 
Car2 1.0716176                 
Rab25 1.0503268                 
Ifitm1 1.0389709                 
Pdgfa 0.9433034                 
Ehf 0.9285977                 
Reln 0.9228894                 
Kcnk1 0.9141556                 
Ngfr 0.8837457                 
Cldn7 0.875958                 
181001
9J16Rik 0.8567223                 
Krt18 0.7616294                 
Phactr1 0.7453968                 
Cdh1 0.7437                 
Vav3 0.7003964                 
Camk2
n1 0.6603548                 
Meis1 0.6365033                 
Casp1 0.5395123                 
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Probe 
Log2 fold 
change Pgr up 
Pgr 
down 
Bmp 
up 
Bmp2 
down 
Wnt4 
up 
Wnt4 
down Egfr up 
Egfr 
down 
Epb4.1l
5 0.4850833                 
Adamts
2 -1.1776839                 
Limk1 -1.1843187                 
Adam1
2 -1.6752146                 
Apln -1.68126636                 
Fads3 -1.8989812                 
Fscn1 -2.0768049                 
Clic6 -2.11356427                 
Daam2 -2.1295806                 
Adora2
b 
-
2.25447598
7                 
Pcsk5 -2.321739                 
Hand2 -2.4162614                 
Dact1 -2.787129                 
Tmod2 -3.0639783                 
Slc2a3 -3.466418                 
Fst -3.8117418                 
 
 
Supplementary table 5 – List of 112 genes differentially expressed in RNA-seq data (DESeq2 
p<0.05 and Intensity difference p<0.05) in uterine stromal cells from young females prior to 
decidualization, and after 4 days of in vitro decidualization. Displayed as log2 fold change 
from 0d to 4d in young USCs, and aged USCs. 
 
Probe Description 
Log2 fold 
change young 
Log2 fold 
change aged 
Zbtb16 
zinc finger and BTB domain containing 16 [Source:MGI 
Symbol;Acc:MGI:103222] 10.48319223 7.8408429 
Prl8a2 
prolactin family 8, subfamily a, member 2 [Source:MGI 
Symbol;Acc:MGI:894281] 9.804755933 5.945765 
Fmo3 
flavin containing monooxygenase 3 [Source:MGI 
Symbol;Acc:MGI:1100496] 9.547525927 4.566104013 
Postn 
periostin, osteoblast specific factor [Source:MGI 
Symbol;Acc:MGI:1926321] 9.1631688 6.672819967 
Lcn2 lipocalin 2 [Source:MGI Symbol;Acc:MGI:96757] 8.867341233 0.2168918 
Art3 
ADP-ribosyltransferase 3 [Source:MGI 
Symbol;Acc:MGI:1202729] 7.7539719 -0.7883424 
Sult1a1 
sulfotransferase family 1A, phenol-preferring, member 
1 [Source:MGI Symbol;Acc:MGI:102896] 7.4135518 6.967767333 
Folh1 
folate hydrolase 1 [Source:MGI 
Symbol;Acc:MGI:1858193] 7.151643267 4.6980099 
Hif3a 
hypoxia inducible factor 3, alpha subunit [Source:MGI 
Symbol;Acc:MGI:1859778] 7.105283933 4.77025181 
Myocd myocardin [Source:MGI Symbol;Acc:MGI:2137495] 6.862529 4.275450473 
Cd34 CD34 antigen [Source:MGI Symbol;Acc:MGI:88329] 6.751656063 -0.714828667 
Gpr64 
G protein-coupled receptor 64 [Source:MGI 
Symbol;Acc:MGI:2446854] 6.743909 -0.312738 
Mme 
membrane metallo endopeptidase [Source:MGI 
Symbol;Acc:MGI:97004] 6.507193567 0.7846721 
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Probe Description 
Log2 fold 
change young 
Log2 fold 
change aged 
A730046J19
Rik 
RIKEN cDNA A730046J19 gene [Source:MGI 
Symbol;Acc:MGI:2442684] 6.4158691 0.0166699 
Krt23 keratin 23 [Source:MGI Symbol;Acc:MGI:2148866] 6.373122567 0.0166699 
Slc38a5 
solute carrier family 38, member 5 [Source:MGI 
Symbol;Acc:MGI:2148066] 6.2688025 0.0166699 
Serpina3n 
serine (or cysteine) peptidase inhibitor, clade A, 
member 3N [Source:MGI Symbol;Acc:MGI:105045] 6.122508253 3.32612225 
Stmn2 stathmin-like 2 [Source:MGI Symbol;Acc:MGI:98241] 6.1039385 0.34430151 
Ly6c1 
lymphocyte antigen 6 complex, locus C1 [Source:MGI 
Symbol;Acc:MGI:96882] 6.088597033 2.274099167 
Chrdl1 chordin-like 1 [Source:MGI Symbol;Acc:MGI:1933172] 5.93420747 0.734004417 
Itgbl1 
integrin, beta-like 1 [Source:MGI 
Symbol;Acc:MGI:2443439] 5.892322333 2.174647067 
Rapgef5 
Rap guanine nucleotide exchange factor (GEF) 5 
[Source:MGI Symbol;Acc:MGI:2444365] 5.865334333 1.5483278 
Sult1e1 
sulfotransferase family 1E, member 1 [Source:MGI 
Symbol;Acc:MGI:98431] 5.803165967 0.4513386 
Tcf23 
transcription factor 23 [Source:MGI 
Symbol;Acc:MGI:1934960] 5.661076457 3.206934377 
Vat1l 
vesicle amine transport protein 1 homolog-like (T. 
californica) [Source:MGI Symbol;Acc:MGI:2142534] 5.647358367 0.646326133 
Aldh1a7 
aldehyde dehydrogenase family 1, subfamily A7 
[Source:MGI Symbol;Acc:MGI:1347050] 5.628256663 5.026000853 
Fam46c 
family with sequence similarity 46, member C 
[Source:MGI Symbol;Acc:MGI:1921895] 5.606365167 2.151824723 
Bcmo1 
beta-carotene 15,15'-monooxygenase [Source:MGI 
Symbol;Acc:MGI:1926923] 5.600545233 2.2722412 
Cldn1 claudin 1 [Source:MGI Symbol;Acc:MGI:1276109] 5.573591523 2.706958757 
Nrcam 
neuron-glia-CAM-related cell adhesion molecule 
[Source:MGI Symbol;Acc:MGI:104750] 5.553652967 0.940865467 
Hsd11b2 
hydroxysteroid 11-beta dehydrogenase 2 [Source:MGI 
Symbol;Acc:MGI:104720] 5.534508033 1.604482767 
Tgfa 
transforming growth factor alpha [Source:MGI 
Symbol;Acc:MGI:98724] 5.472005367 -0.451506933 
Nt5e 
5' nucleotidase, ecto [Source:MGI 
Symbol;Acc:MGI:99782] 5.285162333 2.63875305 
Ccdc88c 
coiled-coil domain containing 88C [Source:MGI 
Symbol;Acc:MGI:1915589] 5.0575814 1.195681867 
Fabp4 
fatty acid binding protein 4, adipocyte [Source:MGI 
Symbol;Acc:MGI:88038] 5.0423107 0.772995233 
Col15a1 
collagen, type XV, alpha 1 [Source:MGI 
Symbol;Acc:MGI:88449] 4.91367749 2.5260314 
Mt2 
metallothionein 2 [Source:MGI 
Symbol;Acc:MGI:97172] 4.770019383 3.605217568 
Ly6a 
lymphocyte antigen 6 complex, locus A [Source:MGI 
Symbol;Acc:MGI:107527] 4.5385236 0.6830375 
Aldh1a1 
aldehyde dehydrogenase family 1, subfamily A1 
[Source:MGI Symbol;Acc:MGI:1353450] 4.327248633 3.999938391 
Lbp 
lipopolysaccharide binding protein [Source:MGI 
Symbol;Acc:MGI:1098776] 4.299177473 0.9357202 
Fam65b 
family with sequence similarity 65, member B 
[Source:MGI Symbol;Acc:MGI:2444879] 4.263789309 -0.555210533 
Rgs2 
regulator of G-protein signaling 2 [Source:MGI 
Symbol;Acc:MGI:1098271] 4.19970341 1.167640267 
Lama2 laminin, alpha 2 [Source:MGI Symbol;Acc:MGI:99912] 4.187990577 2.234587733 
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Probe Description 
Log2 fold 
change young 
Log2 fold 
change aged 
Podxl 
podocalyxin-like [Source:MGI 
Symbol;Acc:MGI:1351317] 4.1814549 -0.2903301 
Sez6l 
seizure related 6 homolog like [Source:MGI 
Symbol;Acc:MGI:1935121] 4.084291047 2.574537821 
Pdk4 
pyruvate dehydrogenase kinase, isoenzyme 4 
[Source:MGI Symbol;Acc:MGI:1351481] 3.990984933 1.032657733 
Ccdc141 
coiled-coil domain containing 141 [Source:MGI 
Symbol;Acc:MGI:1919735] 3.9611922 0.4562093 
Thsd7a 
thrombospondin, type I, domain containing 7A 
[Source:MGI Symbol;Acc:MGI:2685683] 3.95674784 1.422839867 
Fkbp5 
FK506 binding protein 5 [Source:MGI 
Symbol;Acc:MGI:104670] 3.908226467 0.897722867 
Gpm6a 
glycoprotein m6a [Source:MGI 
Symbol;Acc:MGI:107671] 3.897684433 0.033415467 
Mest 
mesoderm specific transcript [Source:MGI 
Symbol;Acc:MGI:96968] 3.866498949 -0.118829633 
Gda 
guanine deaminase [Source:MGI 
Symbol;Acc:MGI:95678] 3.852076333 1.230579467 
Muc16 mucin 16 [Source:MGI Symbol;Acc:MGI:1920982] 3.73595034 0.451338633 
Cfh 
complement component factor h [Source:MGI 
Symbol;Acc:MGI:88385] 3.724656233 1.882306933 
A2m 
alpha-2-macroglobulin [Source:MGI 
Symbol;Acc:MGI:2449119] 3.684481813 -0.189722647 
Ms4a4d 
membrane-spanning 4-domains, subfamily A, member 
4D [Source:MGI Symbol;Acc:MGI:1913857] 3.68159794 1.258300921 
Cdkn1c 
cyclin-dependent kinase inhibitor 1C (P57) 
[Source:MGI Symbol;Acc:MGI:104564] 3.66303451 0.874659067 
Smpd3 
sphingomyelin phosphodiesterase 3, neutral 
[Source:MGI Symbol;Acc:MGI:1927578] 3.6365646 -0.1955956 
Tsc22d3 
TSC22 domain family, member 3 [Source:MGI 
Symbol;Acc:MGI:1196284] 3.596432367 1.4796912 
Ctla2a 
cytotoxic T lymphocyte-associated protein 2 alpha 
[Source:MGI Symbol;Acc:MGI:88554] 3.576968667 0.953448667 
Tmtc1 
transmembrane and tetratricopeptide repeat 
containing 1 [Source:MGI Symbol;Acc:MGI:3039590] 3.5702268 1.674721567 
Ncoa4 
nuclear receptor coactivator 4 [Source:MGI 
Symbol;Acc:MGI:1350932] 3.560808367 0.1548964 
Emcn endomucin [Source:MGI Symbol;Acc:MGI:1891716] 3.558063423 -0.295343667 
Ap1s2 
adaptor-related protein complex 1, sigma 2 subunit 
[Source:MGI Symbol;Acc:MGI:1889383] 3.490244233 0.4652957 
Gpr115 
G protein-coupled receptor 115 [Source:MGI 
Symbol;Acc:MGI:1925499] 3.484537916 1.0537904 
Rasd1 
RAS, dexamethasone-induced 1 [Source:MGI 
Symbol;Acc:MGI:1270848] 3.4225667 2.541639687 
Dlg2 
discs, large homolog 2 (Drosophila) [Source:MGI 
Symbol;Acc:MGI:1344351] 3.315330133 2.09080088 
Net1 
neuroepithelial cell transforming gene 1 [Source:MGI 
Symbol;Acc:MGI:1927138] 3.3055887 -0.047524333 
Gm6768 
predicted gene 6768 [Source:MGI 
Symbol;Acc:MGI:3648259] 3.275000867 0.197589633 
Actn3 actinin alpha 3 [Source:MGI Symbol;Acc:MGI:99678] 3.265299533 0.377490773 
Itga10 
integrin, alpha 10 [Source:MGI 
Symbol;Acc:MGI:2153482] 3.25660497 0.3097703 
Itga2 integrin alpha 2 [Source:MGI Symbol;Acc:MGI:96600] 3.253656343 1.16884148 
Megf6 
multiple EGF-like-domains 6 [Source:MGI 
Symbol;Acc:MGI:1919351] 3.186586677 1.5268416 
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Probe Description 
Log2 fold 
change young 
Log2 fold 
change aged 
Capn6 calpain 6 [Source:MGI Symbol;Acc:MGI:1100850] 3.165517377 -0.12765 
Krt19 keratin 19 [Source:MGI Symbol;Acc:MGI:96693] 3.138473717 -0.34604352 
Col11a1 
collagen, type XI, alpha 1 [Source:MGI 
Symbol;Acc:MGI:88446] 3.130930833 2.3257644 
Clca1 
chloride channel calcium activated 1 [Source:MGI 
Symbol;Acc:MGI:1316732] 3.1217567 0.483757 
Ptprq 
protein tyrosine phosphatase, receptor type, Q 
[Source:MGI Symbol;Acc:MGI:1096349] 3.087149867 0.684141967 
Cdo1 
cysteine dioxygenase 1, cytosolic [Source:MGI 
Symbol;Acc:MGI:105925] 3.069659067 4.347902767 
Gabra3 
gamma-aminobutyric acid (GABA) A receptor, subunit 
alpha 3 [Source:MGI Symbol;Acc:MGI:95615] 3.068406033 1.54982408 
Mt1 
metallothionein 1 [Source:MGI 
Symbol;Acc:MGI:97171] 3.062686233 2.1952893 
Aldh6a1 
aldehyde dehydrogenase family 6, subfamily A1 
[Source:MGI Symbol;Acc:MGI:1915077] 3.057717067 0.523397567 
Lum lumican [Source:MGI Symbol;Acc:MGI:109347] 3.0385072 2.52277844 
A730049H0
5Rik 
RIKEN cDNA A730049H05 gene [Source:MGI 
Symbol;Acc:MGI:1921766] 3.0276826 0.544990767 
Frem1 
Fras1 related extracellular matrix protein 1 
[Source:MGI Symbol;Acc:MGI:2670972] 2.880669767 2.483629793 
Plxna4 plexin A4 [Source:MGI Symbol;Acc:MGI:2179061] 2.872199533 0.287972467 
Fgl2 
fibrinogen-like protein 2 [Source:MGI 
Symbol;Acc:MGI:103266] 2.855010167 2.905942323 
Fibin 
fin bud initiation factor homolog (zebrafish) 
[Source:MGI Symbol;Acc:MGI:1914856] 2.840006333 1.8275965 
Gm20488 
predicted gene 20488 [Source:MGI 
Symbol;Acc:MGI:5141953] 2.837578467 0.976945367 
Olfml3 
olfactomedin-like 3 [Source:MGI 
Symbol;Acc:MGI:1914877] 2.837482667 1.1953327 
Errfi1 
ERBB receptor feedback inhibitor 1 [Source:MGI 
Symbol;Acc:MGI:1921405] 2.826762167 0.618389867 
Abcb1b 
ATP-binding cassette, sub-family B (MDR/TAP), 
member 1B [Source:MGI Symbol;Acc:MGI:97568] 2.815717633 -1.563645033 
Sgk1 
serum/glucocorticoid regulated kinase 1 [Source:MGI 
Symbol;Acc:MGI:1340062] 2.766427367 0.446731333 
Adamts1 
a disintegrin-like and metallopeptidase (reprolysin 
type) with thrombospondin type 1 motif, 1 
[Source:MGI Symbol;Acc:MGI:109249] 2.736711867 1.446210233 
Shroom4 
shroom family member 4 [Source:MGI 
Symbol;Acc:MGI:2685570] 2.701693967 -0.116016967 
Fgf7 
fibroblast growth factor 7 [Source:MGI 
Symbol;Acc:MGI:95521] 2.694014913 2.202090967 
Parm1 
prostate androgen-regulated mucin-like protein 1 
[Source:MGI Symbol;Acc:MGI:2443349] 2.691764833 0.7215971 
Rbbp8 
retinoblastoma binding protein 8 [Source:MGI 
Symbol;Acc:MGI:2442995] 2.658159367 -0.635270933 
Fmo2 
flavin containing monooxygenase 2 [Source:MGI 
Symbol;Acc:MGI:1916776] 2.633288533 3.181531012 
Itm2a 
integral membrane protein 2A [Source:MGI 
Symbol;Acc:MGI:107706] 2.625492633 1.0449875 
Itga1 integrin alpha 1 [Source:MGI Symbol;Acc:MGI:96599] 2.604744367 0.252555467 
Olr1 
oxidized low density lipoprotein (lectin-like) receptor 1 
[Source:MGI Symbol;Acc:MGI:1261434] 2.590810167 1.724422267 
Htra1 
HtrA serine peptidase 1 [Source:MGI 
Symbol;Acc:MGI:1929076] 2.558684233 2.063658333 
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Probe Description 
Log2 fold 
change young 
Log2 fold 
change aged 
Ctla2b 
cytotoxic T lymphocyte-associated protein 2 beta 
[Source:MGI Symbol;Acc:MGI:88555] 2.524623 0.924925167 
Mertk 
c-mer proto-oncogene tyrosine kinase [Source:MGI 
Symbol;Acc:MGI:96965] 2.515193567 -0.586141433 
Prrg3 
proline rich Gla (G-carboxyglutamic acid) 3 
(transmembrane) [Source:MGI 
Symbol;Acc:MGI:2685214] 2.4875803 -0.205412127 
Pdgfc 
platelet-derived growth factor, C polypeptide 
[Source:MGI Symbol;Acc:MGI:1859631] 2.467168067 1.324884233 
Usp53 
ubiquitin specific peptidase 53 [Source:MGI 
Symbol;Acc:MGI:2139607] 2.4646975 1.1340332 
Loxl3 
lysyl oxidase-like 3 [Source:MGI 
Symbol;Acc:MGI:1337004] 2.457788033 0.851176167 
Bicd1 
bicaudal D homolog 1 (Drosophila) [Source:MGI 
Symbol;Acc:MGI:1101760] 2.430138467 0.308702833 
Slco2a1 
solute carrier organic anion transporter family, 
member 2a1 [Source:MGI Symbol;Acc:MGI:1346021] 2.3859458 -0.682518267 
Gprc5b 
G protein-coupled receptor, family C, group 5, 
member B [Source:MGI Symbol;Acc:MGI:1927596] 2.1485134 0.999197833 
A330021E22
Rik 
RIKEN cDNA A330021E22 gene [Source:MGI 
Symbol;Acc:MGI:2443778] -2.1501082 -0.231326433 
Cxcl12 
chemokine (C-X-C motif) ligand 12 [Source:MGI 
Symbol;Acc:MGI:103556] -3.106840367 -0.201007267 
Sfn stratifin [Source:MGI Symbol;Acc:MGI:1891831] -3.200778867 -0.150829967 
Oxtr 
oxytocin receptor [Source:MGI 
Symbol;Acc:MGI:109147] -3.30073332 -1.2289851 
Sprr1a 
small proline-rich protein 1A [Source:MGI 
Symbol;Acc:MGI:106660] -3.5106827 -2.124680833 
Rgs5 
regulator of G-protein signaling 5 [Source:MGI 
Symbol;Acc:MGI:1098434] -3.795466717 1.2585441 
Pcp4l1 
Purkinje cell protein 4-like 1 [Source:MGI 
Symbol;Acc:MGI:1913675] -3.8322291 0.15259964 
Rgs4 
regulator of G-protein signaling 4 [Source:MGI 
Symbol;Acc:MGI:108409] -3.860807113 -0.977440967 
Gjb2 
gap junction protein, beta 2 [Source:MGI 
Symbol;Acc:MGI:95720] -6.080767517 0.0166699 
Myb 
myeloblastosis oncogene [Source:MGI 
Symbol;Acc:MGI:97249] -6.140042833 -0.033997633 
Myh1 
myosin, heavy polypeptide 1, skeletal muscle, adult 
[Source:MGI Symbol;Acc:MGI:1339711] -6.291334433 0.0166699 
S100g 
S100 calcium binding protein G [Source:MGI 
Symbol;Acc:MGI:104528] -8.149190433 -0.033997767 
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Supplementary table 6 – Motif enrichment analysis, showing transcription factors with 
significantly enriched motifs in a) decidua DMRs, b) refractory DMRs, c) trophoblast DMRs. 
 
a) 
 
 
 
 
 
 
 
 
 
 
b)  
 
Database  ID  p-value  Adjusted p-value  
HOCOMOCOv11 core 
MOUSE mono meme 
format 
TAF1_MOUSE.H11MO.0.A 6.54E-06 2.34E-03 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
KLF4_MOUSE.H11MO.0.A 1.91E-05 6.81E-03 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
KLF5_MOUSE.H11MO.0.A 2.41E-05 8.58E-03 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
SP5_MOUSE.H11MO.0.C 3.23E-05 1.15E-02 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
KLF3_MOUSE.H11MO.0.A 3.52E-05 1.25E-02 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
ETS2_MOUSE.H11MO.0.A 3.67E-05 1.31E-02 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
SP4_MOUSE.H11MO.0.B 4.11E-05 1.46E-02 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
E2F4_MOUSE.H11MO.0.A 8.01E-05 2.83E-02 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
KLF1_MOUSE.H11MO.0.A 1.02E-04 3.58E-02 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
ZN281_MOUSE.H11MO.0.A 1.09E-04 3.82E-02 
HOCOMOCOv11 core 
MOUSE mono meme 
format 
KLF15_MOUSE.H11MO.0.A 1.14E-04 3.99E-02 
 
Database  ID  p-value  Adjusted p-value  
HOCOMOCOv11 core 
MOUSE mono meme 
format 
ETS2_MOUSE.H11MO.0.A 3.61E-05 1.28E-02 
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c) 
 
Database  ID  p-value  Adjusted p-value  
HOCOMOCOv11 core 
MOUSE mono meme 
format 
ETS2_MOUSE.H11MO.0.A 1.34E-04 4.70E-02 
 
 
 
Supplementary figure 1 – Heatmap showing the expression of 162 genes differentially 
expressed between young and Aa deciduas, in young deciduas, aged deciduas, and deciduas 
from young mothers in a time-course of development. 
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Supplementary figure 2 - Gross morphology of embryos and placentas at E11.5 from a litter from 
an aged female. Arrowhead indicates a forebrain defect. Placentas were stained with Haemotoxylin 
and Eosin, by IHC for Prl2c2 (Plf), or by DBA staining to mark uterine natural killer cells (uNK cells). 
(Dissection and histology performed by MH and LW, DBA staining performed by LW). 
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Supplementary figure 3 - Expression of genes involved in decidualization in USCs at 0d 
and/or 4d of in vitro decidualization. DESeq2 *p<0.05. Next page, Expression of genes 
involved in decidualization in E3.5 uteri DESeq2 *p<0.05. 
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Supplementary figure 4 – GO analysis of genes dys-regulated in USCs isolated at E3.5 from 
aged females, compared with those from aged females, from RNA-seq data. DESeq p<0.05 
and/or intensity difference p<0.05. 
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Supplementary figure 5 – Distribution of H3K4me3 peaks in genomic features: a) peaks 
called in young USCs, b) peaks called in aged USCs. 
 
 
 
 
 
Supplementary figure 6 – Gene ontology analysis of genes associated with the top 5% 
broadest H3K4me3 peaks in uterine stromal cells. 
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Supplementary figure 7 – Distribution of differentially methylated regions in genomic 
features: a) 214 DMRs in aged E11.5 deciduas b) 89,685 regions differentially methylated 
between young E3.5 uteri and E11.5 deciduas, c) 334 trophoblast DMRs. 
 
 
Supplementary figure 8 – Overlap between differentially methylated regions, CpG islands, 
and promoters. 
 
 
 
 
 
 
  216
Supplementary figure 9 – Overlap between maternal-age-related DMRs identified in E11.5 
decidua, E11.5 trophoblast, and refractory DMRs in decidua. 
 
 
 
 
Supplementary figure 10 – Heatmap showing the change in 5mC enrichment between E3.5 
uteri and E11.5 from deciduas from young and aged females, at 214 decidua DMRs. 
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Supplementary figure 11 – Expression of genes within 2kb of a trophoblast DMR in a) E11.5 
trophoblast from young and aged mice (RNA-seq) and b) transfer trophoblast (RNA-seq) 
from Y->Y transfer and A->Y transfer pregnancies. 
 
a) 
 
 
 
b) 
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Supplementary figure 12 – Expression of components of the DNA methylation and histone 
lysine methylation machinery in deciduas from young and aged females at E11.5. DESeq2 
*p<0.05 
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Supplementary figure 13 – Genomic annotation enrichment analysis of trophoblast DMRs 
with GREAT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
